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ABSTRACT
THE ROLE OF THE METALLOCHAPERONE HYPA IN THE ACID SURVIVAL AND
ACTIVITIES OF NICKEL ENZYMES IN HELICOBACTER PYLORI
FEBRUARY 2018
HEIDI Q. HU, B.S., SUFFOLK UNIVERSITY

Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Michael J. Maroney
Helicobacter pylori is a bacterium that has colonized the human gastric mucosa of over
50% of the world population. Persistent infection can cause gastritis, peptic ulcers, and cancers.
The ability of H. pylori to colonize the acidic environment of the human stomach is dependent on
the activity of the nickel containing enzymes, urease and NiFe-hydrogenase. The nickel
metallochaperone, HypA, was previously shown to be required for the full activity of both
enzymes. In addition to a Ni-binding site, HypA also contains a structural Zn site, which has been
characterized to alter its averaged structure depending on pH and the presence of nickel.
Site-directed mutagenesis of the HypA Zn- and Ni-binding residues were used to
elucidate mechanistic details in the involvement of HypA in Ni-delivery to enzymatic targets.
Cellular studies were conducted to characterize the acid survival and enzymatic activities in a
panel of hypA isogenic strains of H. pylori in collaboration with geneticists at the Uniformed
Services University of Health Sciences (Bethesda, MD). In vitro studies were conducted on
purified HypA variant proteins, correlating structural changes to the metal binding sites, and
further probing the biophysical interactions with Ni(II) and protein binding partners.
Our studies indicated that NiFe-hydrogenase was not required for acid survival in H.
pylori cultures. Only mutations of the conserved Cys residues in the HypA Zn site were found to
exhibit varying degrees of acid sensitivity and loss of activity in Ni-containing enzymes. The
same Cys residues were found to be important for the maturation of both urease and NiFe-

v

hydrogenase, indicating that these residues were critical for the function of HypA as a
metallochaperone. Our mutagenesis studies found that Ni(II) binds to HypA at the N-terminus,
coordinating the N-terminal amine of Met1 as an essential ligand, the loss of which lead to acid
sensitivity and loss of enzymatic activities in isogenic strain. We also found that protein-protein
interactions between HypA and dimeric UreE (an essential Ni-metallochaperone for urease) were
enhanced in the presence of Ni(II) in both neutral and acidic conditions. Further, the presence of
HypA protected UreE from degradation. Taken together, we concluded that HypA is acting as a
co-metallochaperone along with dimeric UreE in Ni-delivery for urease maturation.
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CHAPTER 1
INTRODUCTION
1.1

Helicobacter pylori Persistence
Helicobacter pylori is a gram-negative bacterium that colonizes human gastric mucosa.

Physicians first isolated and characterized H. pylori in the 1980s as a causative agent for peptic
ulcers.1 In the decades following its discovery, it was revealed as a prevalent human pathogen
that has infected more than half of the world population.2 Genetic studies indicated the pathogen
co-evolved with human populations and may contribute some benefits,3, 4 such as lower risk of
esophageal cancers, celiac disease, allergy, and asthma.5-7 However, untreated infections can
persist for decades and develop into gastric cancers in a small percentage of infected individuals.5,
8

With such high infection rates, stomach cancers accounted for 8.8% of estimated cancer related

deaths in 2012, with up to 90% of new cases were attributed to chronic H. pylori infections.9
Despite high prevalence of colonization in the population, H. pylori infections are
asymptomatic and remain untreated in most individuals leading to persistent infections and
increased cancer risks.10 The bacteria utilize a series of adaptations to maintain persistent
infection in the stomach, which includes multiple strategies for acid adaptation 11 and immune
evasions12 that may induce virulence or bestow benefits to asymptomatic carriers (Figure 1.1).

1

Figure 1.1: H. pylori strategy for persistent gastric colonization.
One major strategy is acid acclimation include (1a) motility and chemotaxis towards neutral pH
in the mucus layer and (1b) rapid neutralization of cytoplasmic pH using the urease enzyme
activity. Another strategy is immune system evasion involving (2a) avoiding constant attachment
to host cells, effector proteins or nucleic acids (2b) injected into host cells through the bacteria
type IV secretion system and/or (2c) secreted to induce host anti-inflammatory response.
1.1.1

Acid Adaptations
Despite colonizing the acidic niche of the human stomach, H. pylori is an acid-

acclimated neutralophilic bacterium.13 H. pylori grow best under neutral and microaerophilic
conditions in vitro.14 Unlike other acid-tolerant neutralophiles, such as Escherichia coli and
Salmonella typhimurium, which are only able to survive passing through the acidic stomach
environment, H. pylori form dense colonies and persist for decades.11-13 This acclimation requires
H. pylori to maintain the periplasmic and cytoplasmic pH close to neutral in acidic medium to
allow for growth and division (Figure 1.1).13
1.1.1.1 Regulation
The acidity of the human stomach varies based on location and food buffering, the
colonizing bacteria must be ready to respond to ever changing acidic stress. Hence, persistent
colonization by H. pylori requires acclimation to both acute and chronic response to acid stress.11
In chronic resistance to acid stress, the bacterium relies on transcriptional up-regulations of acid

2

acclimation genes,11 which is largely controlled by the ArsR/S two-component system, with
cross-talk to other regulatory systems such as the nickel regulatory system.11,

15-17

The multi-

domain ArsS integral membrane protein spans the cytoplasmic membrane, allowing for pHsensing in the periplasm and corresponding phosphorylation cascade in the cytoplasm. 15 Acidic
pH in the periplasm activates the ArsS histidine kinase activity in the cytoplasm by
autophosphorylation and subsequent phosphorylation of the response regulator ArsR.18 P-ArsR
binds to the promoter region of multiple acid-responsive genes and regulates transcription.15-18
Transcripts must then be translated into proteins that perform functions to adapt to acidic pH,
which is a slow process. In contrast, acute acid stress in H. pylori is handled by being in a
constant state of readiness with constitutive expression of a large arsenal acid resistant proteins,12
which expedite the relief of acid stress.
H. pylori transcriptional response to acid stress has been studied under different
conditions in several studies,19-23 in addition to similar proteomic studies.24,

25

Although some

identified targets appear to be dependent on growth conditions, most studies agree on several acid
acclimation adaptation strategies including motility and ammonia production.
1.1.1.2 Oxidative Damage Resistance
Robust DNA repair pathways and diverse antioxidant systems in H. pylori afford
additional protection from the acidic environment.12 H. pylori express a diverse repertoire of
proteins for detoxifying reactive oxygen species such as superoxide dismutase (SOD), catalase
(KatA), and peroxiredoxins such as AhpC.26 Additionally, the pathogen reduces host nitric oxide
production by host cells with arginase activity.12, 26, 27 However, many homologues of oxidative
stress regulators commonly found in bacteria are absent in the H. pylori genome.26 Proteomic
analysis of O2-stressed H. pylori confirmed by time-dependent RT-PCR analysis indicated
transcriptional up-regulation of SOD and down-regulation of AhpC over a period of 8 – 48
hours.28, 29 Chronic acid stressed proteomic and transcriptomic studies in H. pylori show similar
regulation profiles for SOD and AhpC.22-24 The oxygen- and acid-responsive expression of

3

antioxidant proteins in H. pylori protects the pathogen against both oxidative stress from the host
immune system and increased cellular damage caused by acid stress.12, 26
DNA repair proteins such as RecA, that are classically up-regulated in bacterial SOS
response under cell stress, are constitutively active in H. pylori,30 and contribute to efficient
colonization.31 Instead of a classic SOS response to DNA damage, H. pylori up-regulates natural
competence,32, 33 presumably to increase genetic diversification.12 In individuals with persistent
infection, this response may contribute to the increased cancer risk because it increases the
potential of acquiring additional virulence genes by H. pylori, particularly in individuals with
multiple strain infections.10 The constitutively active antioxidant and DNA repair mechanisms in
H. pylori indicate a state of stress-readiness in response to a rapidly changing acidic environment
of the stomach constituting both acute and persistent acid resistance.
1.1.1.3 Motility
Upon initial introduction of H. pylori to the human stomach, the bacteria are exposed to
the highly acidic lumen (pH ~2).13, 34 H. pylori can only able to survive for minutes under this
harsh luminal pH and must quickly migrate into the mucus layer (pH ~5) where most colonies are
found.11,

35

Chemotactic migration towards neutral pH niches have been demonstrated both in

vitro and in vivo (Figure 1.1).19, 35 Acidic growth induced transcriptional up-regulation of motility
and chemotaxis genes,19-21 which has been confirmed to be essential for efficient gastric
colonization.36-39
1.1.1.4 Ammonia Production
The constant readiness strategy is also used by H. pylori as a defense against acute acid
stress by having a consistent supply of apo-urease (Figure 1.1). Apo-urease represents
approximately 10% of all nascent protein synthesized by H. pylori grown under both neutral
conditions and under acid stress.40 The apo-enzyme remains inactive until the di-nickel active site
is assembled, which requires the accessory proteins encoded in the ureEFGH genes as well as
hypA and hypB41 (discussed in Section 1.2.5). Active urease catalyzes the hydrolysis of urea to

4

ammonia and carbamate, which spontaneously degrades to another molecule of ammonia and
carbon dioxide,42 resulting in the following net reaction34:
(NH2 )2 CO + H2 O → CO2 + 2 NH3

Eq. 1.1

All NH3 produced is protonated to NH4+ (pKa ~ 9.4) removing H+ in the cytoplasm in large
quantities and effectively neutralizes the cytoplasmic pH of the bacterium.11, 34 Core urease genes
ureAB as well as associated accessory proteins are required for acid survival in the presence of
urea, and are up-regulated during acid stress.11
Transcriptional up-regulation also included the ureI gene, which is located between the
ureAB genes (for the core enzyme) and ureEFGH genes (for maturation proteins).43 The gene
product, UreI, is a proton-gated transmembrane channel that transports urea (the substrate for
urease) into the cytoplasm from the periplasmic space under acid stress. 11, 43 Disruption of the
UreI channel results in loss of acid acclimation in H. pylori.44-46 Thus, the activity of the massive
quantity of urease produced by H. pylori is regulated in at least three levels: by acid-responsive
(1) transcriptional up-regulation19-23 and (2) substrate availability from UreI44-46; and by Ni2+
availability and accessory protein interactions required for (3) post-translational maturation.11, 43
By synthesizing a large supply of apo-urease and then tightly controlling its activity, the
bacterium is constantly ready for acute acid stress, but also guards against over alkalization of the
cytoplasm from overproduction of NH3/NH4+ by urease. Additional NH3/NH4+ derives from the
hydrolysis of short-chain amides by aliphatic amidases: AmiE and AmiF.11 The amiE and amiF
genes are transcriptionally up-regulated in response to acid stress.19-23
The robust NH3/NH4+ production pathways in H. pylori are accompanied by specialized
NH4+ utilization/dispersal system.11 NH4+ produced by urease have been shown to be incorporated
into amino acids.47 However, many of the genes associated with nitrogen assimilation are missing
from the H. pylori genome.11 The glutamate (Glu) and glutamine (Gln) synthesis pathways occurs
through the activities of glutamate dehydrogenase and glutamine synthetase.11 However, the
aspartate (Asp) and asparagine (Asn) synthesis pathway is missing from the H. pylori genome.11
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Instead, the bacterium first deamidates Asn in the periplasm, and then transports the resulting Asp
into the cytoplasm.48 The same deamidation and transport system also exists for Gln/Glu, and are
the only pathways for H. pylori to uptake these amino acids.48 These deamidation
enzymes/transporters pathways allows H. pylori to buffer the periplasm by preventing additional
NH3/NH4+ from entering the cytoplasm.11,

48

These NH3/NH4+ utilization enzymes have been

shown to improve acid tolerance in H. pylori.49
1.1.1.5 Periplasm Buffering
Growing and dividing in acidic medium requires H. pylori to buffer both the cytoplasmic
and periplasmic pH to maintain proper proton motive force.13, 34 In addition to deamidation of
Asn and Gln in the periplasm, H. pylori also expresses two carbonic anhydrase enzymes that
catalyzes the pH-dependent interconversion of CO2 and HCO3+.50,

51

These catalysts of the

dehydration/hydration reaction are pH-dependent and therefore buffer the pH of the periplasmic
space at ~6.11, 50
1.1.2

Immune Evasion
Most H. pylori colonies are found in the mucus layer close to the gastric epithelium

surface with less than 30% attaching to the tissue (Figure 1.1).35 Avoidance of attachment to the
host cell surface promotes the key strategy of avoiding detection by the host immune system and
corresponding pro-inflammatory response.35 In addition to avoidance, H. pylori also preferentially
activate anti-inflammatory responses in the host innate immune response system.12
Attachment of H. pylori to cell surfaces trigger host detection and inflammatory
responses, to which the bacteria respond by secreting/injecting various toxins that alter the host
immune response and nutrient recruitment (Figure 1.1).12 Some of these toxins have been found
to skew host T cell responses, which have been linked to the mechanism of reduced of allergic
responses in asymptomatic hosts.12 Other toxins, such as those encoded in the cytotoxinassociated gene (cag) pathogenicity island (PAI) have been extensively studied and linked to the
increased virulence and cancer risks.10 The cag PAI encode multiple gene products, including a
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bacterial type IV secretion system (T4SS) that is used for horizontal gene transfer and to inject
bacterial proteins and nucleic acids into host cells.10,

12

CagA is the most well-studied gene

product from the cag PAI and has been shown to be phosphorylated by kinases within the host
cell and then subsequently altering host cell signaling.10, 12
The translocation of CagA into host cells from H. pylori, increased infection rates, and
host cell transformations, have been linked to the strains with high NiFe-hydrogenase (H2ase)
activity.52 H2ases catalyze the reversible oxidation of molecular hydrogen:
H2 ⇋ 2 H + + 2 e−

Eq. 1.2

The H. pylori H2ase has been characterized as a membrane-bound respiratory enzyme that
oxidizes molecular H2 (presumed to be produced by other intestinal flora) as an alternate source
of energy.53 It is also the only other known Ni containing enzyme in H. pylori (in addition to
urease), with accompanying accessory proteins required for enzyme maturation, some of which
are shared with urease (discussed in Sections 1.2 and 1.3).43
1.2

Nickel Trafficking
Reactive transition metals such as Cr, Mn, Fe, Co, Ni, and Cu are not available as free

ions within the cell because they can mediate oxidative damage to DNA, proteins, and lipids.54
Instead, cellular metal contents are tightly regulated through metal trafficking systems.55
Transition metals that do not serve as enzymatic co-factors within a cell are treated as toxic
substances and quickly sequestered or exported.55 For cells producing enzymatic targets that
require a specific metal co-factor, a metal trafficking system for that specific metal controls the
availability within the cell.55 For H. pylori, Ni is a required co-factor for the enzymatic activities
of NiFe-H2ase and urease (affecting energy usage and acid acclimation), and therefore an
important resource that is controlled by a specific Ni-trafficking system (Figure 1.2).43, 56
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Figure 1.2: Select Nickel trafficking components in H. pylori.
Like other metal trafficking systems, the Ni-trafficking system in H. pylori contained
proteins for the import, export , and storage of Ni, as well as accessory proteins for the targetspecific delivery of Ni co-factor, and protein(s) to regulate the transcription of the Ni-trafficking
proteins (Figure 1.2).56
1.2.1

Regulation
The H. pylori genome coded for a well-characterized Ni-responsive regulator (NikR),

which has been targeted for Ni-responsive transcriptomic studies in this organism.57 A surprising
number of genes found in Ni- and nikR-responsive transcriptomic studies overlapped with ironresponsive genes in the same organism.58, 59 A number of genes in the Ni-trafficking system were
additionally regulated by acid stress.17, 20, 21, 46, 60, 61
The homo-tetrameric H. pylori NikR bound to AT-rich promoter regions of the genome,62
which can result in activation or repression of targeted genes.57,
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61-64

Like other characterized

NikR proteins, Ni bound to H. pylori NikR with high affinity (nM – pM range).62, 65 The whole
array of accessory protein genes: hypA, hypB, slyD, and ureE, has been shown to be required to
compete for Ni-binding with NikR to prevent premature down-regulation of the Ni-importer
genes.66 DNA-binding affinity has generally been characterized for Ni-bound NikR with apparent
dissociation constant (Kd) ranging from low to high nM.62, 67 DNA-binding has also been reported
for NikR bound to metals other than Ni (Zn and Co).67 Unlike other NikR proteins, both apo- and
Ni-bound states H. pylori NikR have been shown to bind targeted DNA elements with some
selectivity at neutral or acidic pH conditions.68
Ni-dependent and NikR-targeted transcriptome studies show that NikR can both up- and
down-regulate various transcripts in response to Ni(II) treatment (Figure 1.2).57 This is unusual
compared to other well-studied NikR proteins, such as E. coli NikR.56 Surprisingly, Ni-NikR
down-regulates the transcription of genes that lead to the expression of the enzymatic target,
NiFe-H2ase,57 but not of accessory protein known to be involved in NiFe-H2ase maturation (hypA,
hypB, slyD, and groES)

57

Unsurprisingly, Ni-NikR down-regulated known Ni-importer genes

such as nixA, fecA3, frpB4, and exbBD/tonB.57, 61 It also down-regulated the transcription of the
iron-responsive regulator, fur, in response to Ni.57,

61

These Ni-importers were also down-

regulated in response to acid, demonstrating the intermingled network of transcriptional
regulation by acid, iron, and Ni.19-21
NikR bound to its own promoter region only under Ni-bound and low pH conditions as
shown by deoxyribonuclease (DNase) footprinting.68 This binding presumably promotes its own
transcription in acid shock and Ni-rich conditions, although this in vitro acid-responsive
transcriptional response has not been confirmed in transcriptomic studies.19-23
Ni-NikR promotes the transcription of the genes ureAB, which promotes the expression
of apo-urease, but not of the associated accessory proteins.57 It has been shown that although the
full ureAB-IEFGH transcript may be synthesized at all pH levels, but the resulting mRNA was
cleaved and degraded at neutral pH within the accessory protein transcript.69 The ureAB and
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ureIEFGH gene has also been shown to be transcriptionally regulated by acid.19-21 Ni-NikR also
up-regulates transcripts coding for the Ni-storage proteins Hpn and Hpn2.57
Curiously, many of the genes coding for accessory proteins involved in the Ni-delivery
and maturation of Ni-enzymes (ureIEFGH, hypA, and hypB) were not found to be
transcriptionally regulated by NikR. Instead, these accessory proteins were transcriptionally upregulated in response to acid stress.19-21 Potentially, the mRNA of ureIEFGH may be posttranscriptionally degraded too rapidly to be detected in Ni/NikR-dependent transcriptomic
studies.69
1.2.2

Import
Known nickel importers in H. pylori include both outer and inner membrane components

that import nickel or nickel-complexes into the periplasm or the cytoplasm, respectively (Figure
1.2) which were all transcriptionally down-regulated by Ni-NikR.57, 61, 70 At the inner membrane,
a Ni-permease NixA has been shown to specifically transport Ni2+ into the cytoplasm at high
affinity.71 However, interruption of the nixA gene only reduces urease activity by about 50%,
which alluded to a yet undiscovered Ni-importer at the inner membrane level.11, 43
Many of the outer membrane Ni-importers are also linked to the Fe-trafficking pathway.
Outer membrane importers FecA3 and FrpB4 were both originally identified as importers of Fesiderophore complexes, which were energized by the TonB/ExbB/ExbD complexes.58 However,
in H. pylori the genes encoding these outer membrane importers have been found to be
differentially regulated by Ni and NikR, by acid, and by the iron responsive regulator, Fur.11 Ni-,
Fe-, and pH-dependent studies on deletion strains of these outer membrane importers indicate that
these energy-dependent outer membrane transporters import Fe-complexes at neutral conditions,
and import Ni-complexes under acid stress and low Ni conditions.72 A putative ABC-type Nicomplex transporter in the outer membrane has been identified in crystallographic studies as
CeuE-ABC,73 as a Ni- or Co-complex importer. Binding studies indicated that the importer bind
to Ni-(L-His)2,73 similar to the E. coli ABC-type Ni-importer NikABCDE.74
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1.2.3

Export
The gene cluster cznCBA in the H. pylori genome were identified as functional

homologues of a metal efflux pump that convey cadmium, zinc, and nickel (Czn) resistance to the
cell as well as modulate urease activity.75 The cznA gene is homologous to inner membrane
cation-proton antiporters in other organisms, and deletions of either cznA or cznC genes resulted
in increased urease activity.75 Additionally, recombinant CznB and CznC proteins both bind to
Ni-NTA resin.75 Together, the complex was postulated to be a proton-driven exporter of Ni2+ as a
mechanism for down-regulating urease activity,75 presumably to prevent urease activity from
making the cytoplasm alkaline. The cznCBA cluster has not been identified amongst genes
reported to be transcriptional regulated by Ni and NikR or by acid in literature. Since the exporter
also exports other toxic metals, regulation may be controlled by a yet unidentified metal
responsive regulator, analogous to the NikR/RcnR regulatory pair for import/export of Ni in E.
coli.56
1.2.4

Storage
Two genes in the H. pylori genome have been identified as metal storage proteins, hpn

and hpn2 (also known as hpnl for hpn-like) that increased whole cell Ni-content in growth on Nisupplemented media.76 These two proteins have been shown to be transcriptionally up-regulated
in response to Ni and NikR,57, 61 but only hpn2 was found to be up-regulated by acid.21 Both of
these proteins are small (7 – 8 kDa) His-rich proteins, with Hpn2 also rich in Gln, that form larger
oligomers with each monomer binding from 2 – 5 units of metal.76 The Hpn protein have been
shown to interact with Hpn2, the accessory/delivery proteins HypA and HypB, and the urease
small subunit UreA, either directly or indirectly.76 His-rich motifs are also found in
accessory/delivery proteins SlyD and GroES (discussed in 1.2.5.3).
1.2.5

Delivery
Delivery of Ni cofactors to enzymatic targets is accomplished by accessory proteins that

are specific for each enzyme target as well as for each metal cofactor.43, 56 Typically, these are
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organized as an operon for each enzyme target such as the ureIEFGH operon in H. pylori that is
specifically required for the maturation of urease.43 The genes coding for accessory proteins
required for the maturation of NiFe-H2ase are not organized as a discrete cluster. Instead,
hypBCD is organized as a discrete cluster away from a second cluster of hypEF, and leaving hypA
by itself in yet another location in the genome.43, 77 The genes hypCDEF have been characterized
to be involved in iron incorporation in E. coli NiFe-H2ase and not considered part of the Nitrafficking system.43 Still other genes, slyD and groES have been linked to the maturation of
NiFe-H2ase and urease, but are not required for activity.78, 79
1.2.5.1 Ni-chaperones
Metallochaperones are a class of accessory proteins that specifically escort the metal
cofactor to a specific enzyme target, which prevents the presence of free metal ions inside the cell
and provides enzyme specificity.55 This requires the metallochaperone to bind the target metal
with a moderate affinity (facilitating bind and release) and to participate in protein-protein
interactions (providing enzyme specificity). In H. pylori HypA and UreE2 are the Ni-chaperones
for NiFe-H2ase and Urease, respectively.43 Unlike other well characterized metallochaperones,
HypA is required for the activity of both NiFe-H2ase and urease under conditions where Ni is not
supplemented in the growth media.80
The ureE gene encoded in H. pylori genome is essential for urease activity for cells
grown under Ni-limiting or Ni-excess conditions.43, 81 The corresponding gene product is a 39kDa homodimer, UreE2, with a single 6-coordinate Ni site at the dimer interface involving
residues His102 and His152 and ligands from the solvent.82 The His152 ligand in H. pylori UreE2
is typically disordered in crystal structures, and located near the C-terminal region of the protein
that is known to degrade over time.82-85 The low number of Ni-site (one per dimer) of H. pylori
UreE2 is unusual compared to orthologues found in K. aerogenes and B. pasteurii, which bound
six and two Ni per dimer, respectively.41, 43, 86 The increased number of UreE2 Ni sites in these
organisms are accompanied by increased number of histidine residues at the C-terminal regions.43,
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86

Urease activity is increased in variant strains by encoding additional poly-His tails to the C-

terminus of the endogenous ureE gene, demonstrating the improved Ni-sequestration in UreE2
increases urease activity.86 It has been suggested that the reduced number of Ni sites in H. pylori
UreE2 is a mechanism for controlling the activity of the abundant apo-urease within the cell,
where urease made up approximately 10% of total protein in H. pylori and only ~0.1% in K.
aerogenes.43 Despite only having one Ni site per dimer, H. pylori UreE2 binds Ni with high
affinity (Kd ~ 0.15 μM),83 and has been demonstrated to be required for sequestering Ni away
from NikR and preventing premature shut down of the Ni-import pathway.66
H. pylori UreE2 directly interacts with other urease accessory proteins, including UreG
(discussed in Section 1.2.5.2) and HypA (Section 1.3.3) in facilitating Ni-delivery to urease.41, 43
It has been suggested that UreE2 becomes part of a macromolecular complex in urease maturation
like in K. aerogenes,41, 43 however crystallographic and biochemical evidence suggests otherwise
(discussed in Section 1.2.5.2).87
The other known Ni-chaperone in H. pylori is HypA, the structure and protein-protein
interactions of which have been extensively studied and are discussed in Section 1.3.
1.2.5.2 GTPases and other Accessory Proteins
H. pylori HypB and UreG belong to the SIMIBI (for signal recognition particle, MinD,
and BioD) class of P-loop GTPase involved in the Ni-insertion into NiFe-H2ase and urease.88
Enzymatic activities of NiFe-H2ase and urease in the deletion strains of hypB or ureG indicate
that ureG is required for urease activity, and hypB is required for both NiFe-H2ase and urease
activity in cells grown without Ni supplementation.80,

89

Abolishing the GTPase activities in

HypB or UreG by site directed mutagenesis resulted in lack of NiFe-H2ase and urease activities.89
Like other SIMIBI class of GTPases, UreG exhibit dimerization-dependent enhancement of GTP
hydrolysis, which is dependent on the presence of Ni (or Zn) and nucleotide, but additionally
enhanced by bicarbonate.83, 87, 90, 91 HypB GTP hydrolysis was also enhanced under conditions that
favor dimerization which requires Ni and nucleotide, but additionally enhanced by potassium.
13

Both HypB and UreG bind one Ni per dimer at the dimeric interface. Ni bound to UreG
with much lower affinity (Kd ~ 10 μM) than Zn (Kd ~ 0.33 μM),92 which forms a pyramidal site at
the dimer interface involving two Cys ligands and two His ligands along with a buffer anion. 91
The crystal structure of dimeric HypB (PDB ID: 4LPS) shows Ni-binding to four Cys residues at
the dimer interface,93 with a moderate affinity (Kd ~ 1 μM) (discussed in APPENDIX 1).
H. pylori HypB and UreG directly interact with Ni-chaperones HypA and UreE2,
respectively, presumably facilitating GTP hydrolysis and Ni-insertion into NiFe-H2ase and
urease.43 The direct interaction of HypB with HypA has been observed in cross-linking studies94
and corresponded to low affinity binding (Kd ~ 60 μM) (discussed in Section 1.3.3).95 Direct
binding of UreG to UreE2 has a moderate affinity (Kd ~ 4 μM),83 and other methods suggest
HypA competes with UreG for binding to UreE2 (discussed in Section 1.3.3).96
H. pylori UreG has also been structurally characterized as part of a macromolecular
urease maturation complex additionally involving UreF and UreH.87 Unlike the maturation
complexes in K. aerogenes, the H. pylori urease maturation complex involves the prior formation
of UreH-UreF2-UreH’ precomplex, onto which the UreG2 complex docks on the UreF2 interface
(Figure 1.3).87 Size exclusion chromatography coupled with multi-angle light scattering (SECMALS) studies suggest that bicarbonate stimulated GTP hydrolysis induces the dissociation of
UreG2 from the macromolecular complex; with subsequent metal analysis also indicating Ni
dissociation from UreG2.87 These observations suggested that GTP-hydrolysis in UreG2 has
multiple functional implications (discussed in Section 1.3.3). Where the role of UreF and UreH
(UreD in K. aerogenes) orthologous is known,41 the functional role of these proteins has not been
studied in detail in H. pylori, where the difference in maturation complex organization suggest
different roles for these proteins.87 This is supported by tandem affinity pull-down studies using
affinity tagged UreA, where UreA interactions with UreG and HypB was observed but not with
UreF or ureH.97
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Figure 1.3: H. pylori UreG/UreF/UreH complex
Crystal structure of urease maturation complex demonstrating UreG2 docked on top of UreF2,
which is flanked by UreH on each side (PDB ID: 4HI0).87
1.2.5.3 Folding Chaperone and Ni-storage
H. pylori genes slyD and groES coded for proteins that have both folding chaperone
domains as well as metal binding domains rich in Cys and His residues.78, 98 The His- and Cysrich tails in the corresponding SlyD and GroES proteins have been characterized to increase Nitolerance and potentially convey some Ni-storage function,78,

98

but were not transcriptionally

regulated by Ni-NikR.57 GroES Ni-sequestration contributes to the Ni-insertion into NiFe-H2ase,
but not urease.78
The SlyD protein also contains a prolyl isomerase activity domain in addition to folding
chaperone and metal binding domains.79 SlyD has been shown enhance urease activity by
competing for Ni with H. pylori NikR (along with the rest of the urease accessory proteins),
therefore preventing shut down of Ni-importers.66 The deletion of both slyD and hypA is resulted
in the transcript reduction of Ni-importer genes, but not of each gene individually, which suggests
these two genes shared some function in vivo.66 One possible role shared by HypA and SlyD may
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be to supply Ni to HypB through protein-protein interaction, as the direct interaction between
SlyD and HypB has been demonstrated to enhance HypB GTP-hydrolysis.98 SlyD has also been
studied in its capacity to transform host cells either as an external treatment (simulating excreted
toxic protein),99 or expressed inside host cells (to simulate SlyD protein injected by the bacterial
T4SS into host cells).100
1.3

The Unique H. pylori Metallochaperone HypA

1.3.1

The hypA gene required for two Ni-enzymes in H. pylori
The hypA, or homologous genes, are found in of all organisms that express NiFe-H2ase

with the gene product generally characterized as a Ni-metallochaperone specifically for NiFeH2ase maturation.43, 56 In H. pylori, the hypA gene was found to be additionally required for the
maturation of urease under Ni-limiting conditions.66,

80

The hypA-requirement for urease

maturation is abolished in Ni-supplemented media (1 – 5 μM NiCl2).80 Additionally, cross-linking
studies showed the purified HypA protein directly interacts with the urease-specific Ni-chaperone
UreE2.81 The dual role of HypA in Ni-enzyme maturation led to extensive studies of this protein.

Figure 1.4: Multiple sequence alignment of HypA proteins.
The conserved nickel binding site at the N-terminus are highlighted in green, the conserved
CXXC zinc binding motifs are highlighted in yellow, and the non-conserved flanking His
residues at the zinc binding site highlighted in cyan. Rigidly conserved (*), moderately conserved
(:), and slightly (.) conserved residues are as marked at the bottom of the sequences.
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1.3.2

Metal Sites
The hypA gene codes for a small protein with only 113 amino acids (13 kDa) that has

been shown to directly bind to Ni, Zn, UreE2, HypB, and Hpn.76,

81, 94, 101

Multiple sequence

alignments of the HypA amino acid sequence with orthologs reveal the location of two conserved
metal sites (Figure 1.4). The N-terminal MHE-motif constitutes part of the Ni site and two CXXC
motifs make up the structural Zn site of the protein. Structural studies of the Ni site by X-ray
absorption spectroscopy (XAS) demonstrated a 6-coordinate paramagnetic site with all N/O
(nitrogen or oxygen) ligands of which at least one is an imidazole, presumably His2.101,

102

However, nuclear magnetic resonance (NMR) studies of Ni-titration into the N-terminal extended
HypA variant (extra Gly-Ser residues at the N-terminus remaining from cleavage of affinity tag,
henceforth known as GSHypA) shows a diamagnetic, and therefore planar site (Figure 1.5).103
We hypothesized the change in Ni site structure in this N-terminal extension HypA variant is
caused by the loss of N-terminal amine ligation, which will be tested with another N-terminal
extension variant of HypA (discussed in CHAPTER 2 and CHAPTER 3).
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Figure 1.5: Planar and 6-coordinate HypA nickel sites.
The 6-coordinate and paramagnetic Ni site was characterized in native HypA by XAS.101, 102
NMR structure (PDB ID: 2KDX) of GSHypA was characterized to have a planar and diamagnetic
Ni site.103 Cartoon representation of the GSHypA structure is shown in gray, where the sidechains
of the non-native N-terminal overhang and the Ni- and Zn-binding residues are represented in
sticks and colored. The nitrogen (blue), oxygen (red), sulfur (yellow), and hydrogen (white)
atoms are colored the same in all sidechains, whereas the carbon atoms are colored differently for
Ni-binding residues (green), Zn-binding residues (cyan), and non-native (magenta) residues.
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Figure 1.6: Ni- and pH-dependent dynamics HypA zinc site.
View of Zn-binding site from the cartoon representation of GSHypA the NMR structure (PDB
ID: 2KDX)103 in gray. The proposed Ni-binding residue are shown in green. The Zn-binding
residues are as labeled with the sidechains represented in sticks with the carbon (cyan), nitrogen
(blue), sulfur (yellow), and hydrogen (white) atoms shown in colors. Corresponding pH- and Nidependent average structures of the HypA Zn sites as previously characterized by XAS101, 102 are
shown to the right.
The two invariant CXXC Zn-binding motifs in H. pylori HypA are flanked by two
adjacent His residues (Figure 1.4). The average structure of the Zn site in WT-HypA was shown
to vary in a pH- and Ni-dependent fashion (Figure 1.6).102 At pH 7.2 (simulating the cytoplasmic
pH of H. pylori living in near neutral conditions) with or without Ni-bound, the averaged Zn site
consist of four Cys ligands.101,

102

At pH 6.3 (simulating the cytoplasmic pH of H. pylori

experiencing acid shock conditions), the averaged Zn site consist of one His and three Cys
ligands without Ni-bound; and further changes to two His and two Cys ligands with Ni-bound.101,
102

Site-directed mutagenesis studies have been conducted on the structure of the HypA Zn-site.102

Each of the Cys or His residues were mutated to Ala (loss of ligand); and each of the Cys residues
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were additionally mutated to Asp (ligand substitution).102 XAS studies of these Zn site variants
show that any Cys mutations resulted in an average structure of two His and two Cys ligands, like
the WT-HypA Zn-site structure at pH 6.3 with Ni-bound.102 Any mutation to the flanking His
residues resulted in an average Zn site structure of a four Cys ligands, like the WT-HypA Zn site
structure at pH 7.2 with Ni-bound.102 Lysate from ∆hypA strains of H. pylori treated with
reconstituted WT-HypA or His-mutated Zn site variant proteins recovered urease activity, but
treatment with reconstituted Cys-mutated Zn site variant HypA protein did not rescue urease
activity.102 The Zn site variant strains of H. pylori were additionally constructed and the role of
the HypA dynamic Zn site in Ni-enzyme maturation and acid survival were tested (discussed in
CHAPTER 3).
1.3.3

Protein-protein interactions
HypA interactions with protein partners HypB and UreE2 have been characterized by

cross-linking and NMR studies.

81, 94 95, 104

Interaction of purified H. pylori HypA and HypB

proteins were first studied in chemical cross-linking studies where a heterodimeric complex
(HypB-HypA) was observed.94 Subsequent studies of the HypA-HypB interaction were
conducted using the N-terminal extension variant GSHypA. Isothermal titration calorimetry
(ITC) studies of the GSHypA binding to HypB indicated weak binding (Kd ~ 60μM) between the
two proteins.95 NMR studies of GSHypA found that residues perturbed by interaction with HypB
were the same as those perturbed by Ni-binding, indicating that HypA interacted with HypB close
to its Ni-binding site.95 It was unclear whether the N-terminal extension in GSHypA affected the
binding between the two proteins, particularly since the HypA-HypB interaction interface has
been mapped to the Ni-binding domain (discussed in APPENDIX 1). Mutagenesis studies of
HypB indicate that the N-terminal 24-residues were critical for interaction with HypA, which
were well away from the metal- and GTP-binding residues.95 Ni-binding has been reported to
both increase and decrease GTP-hydrolysis in HypB93,

95, 105

hydrolysis has not been reported (discussed in APPENDIX 1).
20

and the effect of HypA on GTP-

Direct interaction between purified H. pylori HypA and UreE2 was first characterized in
chemical cross-linking studies, from which a heterodimeric complex (HypA-UreE resolved at 34
kDa on SDS-PAGE) was observed.81 The presence of a 34-kDa heterodimer of HypA-UreE but
not the HypA-UreE2 heterotrimeric complex in denaturing conditions indicated that the
conditions used did not promote cross-link formation between the dimeric UreE2 species.
Biolayer interferometry (BLI) and surface plasmon resonance (SPR) were also used for studies of
the HypA and UreE2 interaction. These studies were carried out at neutral pH without reducing
agents (in buffer containing 10 mM HEPES, pH 7.4, 150 mM NaCl, 0.01% Surfactant P-20) with
the smaller HypA (13 kDa) tethered to a surface and then UreE2 were flowed over HypA-tethered
surfaces where binding was detected. These methods identified complex and strong interactions
between UreE2 and tethered-HypA assigned to a high affinity binding (Kd ~ 5.4 nM) and
subsequent conformational change (Kd ~ 1 μM), which is unaffected by the presence of Ni or
Zn.96 Additionally, BLI studies show that HypA outcompeted UreG for binding to UreE2,
however metal-dependent dimer formation of UreG indicated a multiple step interaction.96
Indeed, studies using the N-terminal extension variant GSHypA found the opposite
effect, where the Ni-bound GSHypA-UreE2 complex dissociated in the presence of UreG and
GTP, where a UreG2-UreE2 complex forms in its place.90 These results indicated that UreE2 does
not form heterocomplex with both UreG and HypA simultaneously, but rather bind to either one
or the other.96 Mutagenesis studies of UreE2 identified the C-terminal motif (residues 158 – 170)
as the interaction interface with GSHypA.104 NMR studies of GSHypA identified the Ni-binding
domain as the interaction interface with UreE2.104 Additionally, ITC was used to monitor the
binding occurring with titration of GSHypA into UreE2. These titration experiments were
performed at neutral pH without reducing agent (in buffer containing 20 mM HEPES, 100 mM
NaCl, pH 7.2), where either apoGSHypA, apo-ZnGSHypA or Ni-ZnGSHypA were titrated into
apo-UreE2 or Ni-UreE2. These titrations found that GSHypA bound to UreE2 in a single
observable binding event with moderate affinity (Kd ~ 1 – 2 μM), which were unaffected by the
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presence of metals. It is unclear whether the HypA-UreE2 interactions were affected by Nterminal modification in GSHypA variant protein or in response to acid shock (discussed in
CHAPTER 3 and CHAPTER 4).
The requirement for HypA in urease maturation in H. pylori has been hypothesized to
involve Ni-transfer to UreE2.90, 106 Ni-transfer from GSHypA to full length UreE2 (treated with a
light-dependent protein crosslinking moiety that has Ni-dependent fluorescence) was
demonstrated after separation of the two proteins on SDS-PAGE.104 However, separation of the
GSHypA-UreE2 complex did not occur under non-denaturing conditions with or without the
presence of metals, and has only been observed in the presence of UreG2 and GTP.90, 104 These
trends indicate the mechanistic involvement of HypA in urease maturation is more complex than
simple Ni-transfer from HypA to UreE2 (discussed in CHAPTER 4).
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CHAPTER 2
HYDROGENASE ACTIVITY DOES NOT CONTRIBUTE TO HELICOBACTER PYLORI
ACID SURVIVAL
Portions of this chapter has been published: Faith C. Blum; Heidi Q. Hu; Stephanie L. Servetas;
Stéphane L. Benoit; Robert J. Maier; Michael J. Maroney; and D. Scott Merrell. Structurefunction analyses of metal-binding sites of HypA reveal residues important for hydrogenase
maturation in Helicobacter pylori. PLOS ONE, 2017.
2.1

Introduction
Helicobacter pylori is a prevalent human pathogen that colonizes the gastric mucosa and

chronic infection is associated with development of stomach ulcers and cancers (discussed in
CHAPTER 1, Section 1.1).1, 2 Ni-dependent enzymes urease and NiFe-hydrogenase (H2ase) have
been associated with its ability for infecting the acidic environment of the human stomach.3, 4
Despite thriving in the acidic human stomach, H. pylori is not an acidophile and thus,
must acclimate to the low pH environment found in the stomach (discussed in CHAPTER 1,
Section 1.1.1).5 This is in large part accomplished by urease (discussed in CHAPTER 1, Section
1.1.1.4), which neutralizes the gastric microenvironment and buffers the bacterial cytoplasm by
catalyzing the conversion of urea into ammonia and carbon dioxide.5-7 The importance of urease
in the H. pylori life cycle is evidenced by the fact that this enzyme represents approximately 10%
of the total protein syntheses in the cell.8 As such, urease represents a major nickel sink within H.
pylori. Insertion of the Ni cofactors into the urease active site requires the accessory proteins
UreEFGH, as well as HypA and HypB, which are typically associated with the insertion of Ni
into NiFe-H2ase.9, 10
H2ase and urease, therefore, compete for maturation within H. pylori, as both enzymes
require the accessory proteins HypA and HypB for inserting the Ni co-factor into their active sites
(discussed in Sections 1.2.5.1 and 1.3). NiFe-H2ase is the only other known Ni-containing
enzyme in H. pylori.11 H2ases catalyzes the reversible oxidation of molecular hydrogen: H2 ⇋
2 H + + 2 e− . However, the H. pylori NiFe- H2ase has been categorized as an H2-uptake type
H2ase.12 The oxidation of H2 (presumed to be produced by the intestinal flora of the host) by
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H2ase was thought to be an alternate source of energy for H. pylori.12 The heterotrimeric H2ase
complex is composed of HydA, the small subunit that contains multiple [Fe-S] clusters; HydB,
the large subunit that contains the [NiFe] site; and HydC, a membrane-anchored b-type
cytochrome.13 Deletion of hyd results in reduced colonization in animal models, which is
attributed to the inability of the mutants to use H2 as an energy source within the animal host.12
The energy generated by H2 oxidation is intricately linked to powering the H. pylori type IV
secretion systems (T4SS), which is used for horizontal gene transfer and injection of the CagA
cytotoxin and other effectors into host cells and surrounding tissues to modify the host immune
response.14

Figure 2.1: Contributions of Ni enzyme maturation pathways in H. pylori to acid resistance.
HypA distributes Ni cofactors (green circles) within H. pylori to enzyme targets urease and
H2ase. Insertion of Ni into urease can occur under Ni abundant conditions in the absence of HypA
(dash line); but H2ase maturation cannot be accomplished without HypA. Activation of urease
contributes to acid resistance, but H2ase activity is herein shown not to contribute to acid
resistance (red X). Figure reproduced from Blum et. al. PLOS ONE, 2017, 12, e0183260[15].
Proper Ni- and Zn-coordination of the HypA Ni-metallochaperone has been shown to be
required for the activation of both urease and H2ase in H. pylori10, 16 (extensively characterized
and discussed in CHAPTER 3). Despite its pivotal role in regulating the activity of both known
Ni-dependent enzymes, the transcription of the hypA gene was not regulated by Ni,17 but is

33

instead up-regulated in response to acid stress (discussed in Section 1.2.1).18-20 This aciddependent up-regulation of hypA potentially contributes to the maturation for both Ni-containing
enzymes (Figure 2.1). Where the role of urease in acid stress response has been extensively
characterized in H. pylori,4, 6, 21 it is unclear whether H2ase also play a role. H2ase mutant strains
exhibit impaired acid resistance in Escherichia coli K-12,22,

23

salmonella enterica serovar

Typhimurium,24 and shigella flexneri.25 However, to our knowledge the role of H. pylori H2ase in
acid resistance has not yet been investigated.
2.2

Results

2.2.1

Enzyme activities of ∆hydB variant strain of H. pylori

Figure 2.2: H. pylori ∆hydB has no detectable H2ase activity and WT-like urease activity.
Cell lysates of the G27 wild-type strain (WT), urease mutant strain (∆ureB), and H2ase mutant
strain (∆hydB) were used to measure (A) H2ase activity by measuring the rate of H2-oxidation and
(B) urease activity by measuring the rate of NH3 production. The enzyme activities in each strain
were normalized against the total protein in the lysate to obtain the specific activity, and then
further normalized against the specific activity of the WT-strain to obtain the relative activity as
%WT. Three biological replicates were tested for each strain, and the mean and standard
deviation are graphed. Figure reproduced from Blum et. al. PLOS ONE, 2017, 12, e0183260[15].

34

To determine the role of the H2ase in H. pylori acid resistance, a deletion mutation of
hydB in the G27 strain background was generated. The H2 oxidation activity in the lysates of the
∆hydB strain were measured using a methyl violet assay; the parental WT strain and a urease
mutant strain (∆ureB) were included as controls (Figure 2.2A). As expected,10, 12 the ∆hydB strain
did not exhibit H2ase activity (H2 oxidation < 0.1% of WT, similar to buffer alone).
Unexpectedly, the ∆ureB strain showed increased H2ase activity as compared to that of WT; this
increased activity was consistent across all experiments (range of 130-170%). To confirm that
deletion of H2ase had no effect on urease activity as previously described,16 urease activity was
measured using a modified phenol-hypochlorite assay for NH3 production (Figure 2.2B). The
∆hydB strain exhibited urease activity similar to the parent WT strain.
2.2.2

H2ase does not contribute to acid resistance in H. pylori

Figure 2.3: ∆hydB strain of H. pylori G27 is not attenuated for acid survival.
The wild-type (WT) strain, urease mutant strain (∆ureB), and hydrogenase mutant strain (∆hydB)
were incubated for 1 hour in PBS adjusted to pH 6.0 (A and B) or to pH 2.3 (C and D), in the
absence (A and C) or presence (B and D) of 5 mM urea. The number of colony-forming units
(CFU) was measured at 0 min (T0) and at 60 min (T60), and percent survival was calculated as
CFU at T60 divided by CFU at T0. Data from individual biological replicates are shown as points,
with the bar plotted at the mean. Open symbols indicate that no bacteria were recovered and thus,
the CFU are plotted as a function of the limit of detection (100 CFU/mL). Three biological
replicates were performed. For panels A-C, a one-way ANOVA followed by Dunnett’s test for
multiple comparisons was performed; the comparison was made only to WT. In panel D, the
same statistical tests were performed on the log-transformed data. **** = p < 0.0001. Figure
reproduced from Blum et. al. PLOS ONE, 2017, 12, e0183260 [15].
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The contribution of H2ase to H. pylori acid resistance was assessed after exposure of
bacteria to pH 6.0 or pH 2.3 buffers for one hour in the presence or absence of 5 mM urea, and
then measuring the surviving colony forming units (CFU). All strains survived at pH 6.0,
independent of the presence or absence of urea (Figure 2.3AB). Conversely, at pH 2.3 without
urea, all strains exhibited significantly impaired survival (limit of detection [LOD] = 100, Figure
2.3C). At pH 2.3 in the presence of urea, the ∆ureB strain was extremely acid sensitive, which
was expected since the ∆ureB strain is unable to utilize urea to neutralize low pH. In contrast,
survival of the WT and ∆hydB strains was comparable. This result confirmed the ex vivo urease
activities measured in the corresponding strains (Figure 2.3D). Thus, unlike in other pathogenic
bacteria, H2ase appears to play no role in acid resistance in H. pylori.

Figure 2.4: ∆hydABCDE strain of H. pylori 26695 is not attenuated for acid survival.
The wild-type (WT) 26695 strain, urease mutant strain (∆ureAB), and H2ase mutant strain
(∆hydABCDE) were incubated for 1 hour in PBS adjusted to pH 6.0 (A and B) or to pH 2.3 (C
and D), in the absence (A and C) or presence (B and D) of 5 mM urea. The number of colonyforming units (CFU) was measured at 0 min (T0) and at 60 min (T60), and percent survival was
calculated as CFU at T60 divided by CFU at T0. Data from individual biological replicates are
shown as points, with the bar plotted at the mean. Open symbols indicate that no bacteria were
recovered and thus, the CFU are plotted as a function of the limit of detection (1000 CFU/mL).
Three biological replicates were performed. For panels A-C, a one-way ANOVA followed by
Dunnett’s test for multiple comparisons was performed; the comparison was made only to WT. In
panel D, the same statistical tests were performed on the log-transformed data. **** = p <
0.0001. Figure reproduced from Blum et. al. PLOS ONE, 2017, 12, e0183260 [15].
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Given the high degree of genetic diversity seen between strains of H. pylori,26, 27 these
results were verified in an additional H. pylori strain. The ∆hydABCDE mutant strain,28
previously constructed from H. pylori 26695 as the parent WT strain, in addition to a ureasenegative control (∆ureAB) were tested for acid survival. As shown in Figure 2.4, the results
obtained with the 26695 strain background were comparable to those obtained with G27. En
masse, these data indicate that H2ase does not contribute to the acid resistance of H. pylori.
2.3

Discussion
Mutation of H2ase or urease resulted in the expected loss of each respective enzymatic

activity (Figure 2.2).29 Unexpectedly, the deletion of ureB consistently resulted in an increase in
H2ase activity above that seen in the wild-type parental strain (Figure 2.2A). Interestingly, the
reverse did not hold true; deletion of H2ase resulted in only a slight increase (~12%) in urease
activity in the G27 background (Figure 2.2B), as was previously observed in the 26695
background.16 Both the urease and the H2ase maturation pathways require intracellular nickel and
the accessory proteins HypA and HypB.10 However, urease is the major nickel sink,8,
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suggesting that the equilibrium between the two pathways favors urease. Deletion of urease is
hypothesized to increase the Ni available to the H2ase maturation pathway, resulting in an
increase in H2ase activity. While deletion of H2ase also increases the Ni available to the urease
maturation pathway, however to a much lesser extent, therefore only a small increase of urease
activity was observed in the ∆hydB strains.
Though a role for H2ase in acid resistance has been shown in several other pathogenic
bacteria, the [NiFe] uptake-type H2ase of H. pylori does not appear to contribute to acid
resistance (Figure 2.1, Figure 2.3, Figure 2.4). Though the reason for this variation across
pathogens is not completely clear, several interesting differences across the various species are
apparent. For example, Salmonella enterica serovar Typhimurium carries three H2 uptake-type
H2ases (hya, hyb and hyd), in addition to two H2-evolving H2ases (hyc and hyf). Deletion of hya,
but not hyb or hyd, results in loss of acid resistance and impaired survival inside macrophages.24
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Though the exact mechanism by which Hya contributes to the acid stress response of S.
Typhimurium is unknown, a mechanism involving energy conservation by Hya via recycling of
H2 produced by Hyc has been proposed.24,
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Similarly, in Shigella flexneri, deletion of the

hydrogen-uptake-type H2ase hya results in an acid sensitive mutant strain,25 while in Escherichia
coli, deletion of the hydrogen-evolving H2ase encoded by hyc results in acid sensitivity in
anaerobic growth conditions.23 It is worth noting that each of these other pathogens that rely on a
H2ase for acid resistance have limited mechanisms for dealing with acid stress as compared to
urease activity in H. pylori. Indeed, acid neutralization is accomplished quickly by H. pylori
urease; when incubated in unbuffered HCl as low as pH 3, H. pylori increases the pH to neutral
within 1 min.8 Despite living in the human stomach, H. pylori is not an acidophile, and appears to
synthesize a large amount of urease (up to 10% of the nascent protein content) for protection
against a sudden decrease in pH.8 With such a robust mechanism for acid neutralization, and so
much energy committed to urease synthesis and nickel sequestration, perhaps H. pylori simply
does not need to dedicate a second nickel-containing enzyme (H2ase) to cope with acid stress.
A loss of acid resistance was observed in strains of H. pylori lacking urease, but not in
strains lacking H2ase (Figure 2.3 and Figure 2.4). Previous studies have shown that H2ase mutant
strains of H. pylori are deficient for colonization in mouse and Mongolian gerbil models of
infection.12, 14 The degree of deficiency varies depending on the animal model and/or H. pylori
strain background.12, 14 Given the lack of a pH-sensitive phenotype, the role of H2ase during H.
pylori animal infection may solely be the previously proposed utilization of H2 as an energy
source.12 The energy generated by robust H2 oxidation activity was associated with increased
incidents of gastric carcinogenesis in Mongolian gerbil infection models, likely by increasing the
translocation of the CagA cytotoxin into host cells, which was demonstrated ex vivo.14 The
translocation of CagA, as well as other effectors, through associated T4SS into host cells or
surrounding tissues has been known to modulate the host immune system.33, 34 CagA translocation
promoted denser initial infections (2 – 6 weeks post inoculation), but increases host inflammatory
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responses with prolonged colonization (12 weeks), accompanied by development of gastric
cancers in Mongolian gerbil infection models.14 Thus, diverting Ni and HypA toward the H2ase
maturation pathway does not contribute to acid acclimation in H. pylori, but instead boost initial
infection efficiencies12, 14 by powering the translocation of CagA.14
2.4

Method

2.4.1

Bacterial growth
Growth of G27 background strains of H. pylori were performed at the Merrell Lab, part

of the Department of Microbiology and Immunology at the Uniformed Services University of
Health Sciences, Bethesda, MD. Growth of 26695 background strains of H. pylori were
performed at the Maier Lab, part of the Department of Microbiology at the University of Georgia,
Athens, GA. Strains are listed and described in Table 2.1. H. pylori strains were maintained at 80°C in brain heart infusion (BHI) broth (BD) supplemented with 20% (v/v) glycerol
(CalBioChem) and 10% (v/v) fetal bovine serum (FBS, Gibco). H. pylori G27 and G27-derived
strains were grown on 4.4% (w/v) Columbia agar (Acumedia) supplemented with 5% (v/v) horse
blood (HemoStat), 0.2% (w/v) β-cyclodextrin (Sigma), 10 µg/mL vancomycin (Amresco), 2.5
U/mL polymyxin B sulfate (Sigma), and 8 µg/mL amphotericin B (Amresco). Liquid growth of
G27 strains was accomplished in Brucella broth (Acumedia) supplemented with 10% (v/v) FBS
and 10 µg/mL vancomycin. G27 cultures were grown at 37°C under microaerophilic conditions
(10% CO2, 5% O2, and N2 as balance) achieved using an Anoxomat (Advanced Instruments Inc).
H. pylori 26695 and 26695-derived strains were grown on Brucella agar plates (Becton
Dickinson) supplemented with 10% sheep blood (Hemostat) in CO2 incubators (Thermo
Scientific) under microaerophilic conditions (5% CO2, 4% O2, and N2 as balance). Liquid growth
of 26695 strains was performed in BHI broth supplemented with 0.4% β-cyclodextrin (Sigma)
under microaerophilic conditions (5% CO2, 5% O2, and N2 as balance). For both strains, selection
was performed with 25 µg/mL kanamycin (Gibco) or 30 µg/mL chloramphenicol (Sigma), as
appropriate. Liquid H. pylori cultures were grown with shaking at 110 RPM. Escherichia coli
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Top10 cells were grown at 37°C on 4% LB agar plates (MoBio) or in liquid in LB broth
(Invitrogen) with shaking at 225 RPM. Selection was performed with 100 µg/mL ampicillin
(Affymetrix).
Table 2.1: Strains, plasmids, and primers used in this study
Strains
Description

Reference

DSM1

G27 WT

35

DSM43

G27 ∆ureB (∆ureB::kan), KanR

36

DSM1569

E. coli TOP10 containing pDSM1569, KanR

This study

DSM1570

This study

26695

G27 ∆hydB (∆hydB::kan), KanR
WT

SLB1333

26695 ∆ureAB (∆ureAB::cat), CmR

This study

SLB1166

26695 ∆hydABCDE (∆hydABCDE::cat), CmR
Description

28

38

Primers

pTM117 vector with KanR gene
pGEM T-Easy vector with KanR gene fused with sequence
upstream and downstream of hydB
Sequence (5′-3′)

hydB_us_F

GCAATGTGCTTTATTACTTGATG

This study

hydB_us_R

GTTAGTCACCCGGGTACCGAGCTCGACATGTTAA
TCCCTTACTCTTTG
CTAGAGTCGACCTGCAGGCATGCAAGGGACACGC
ATGGATAAAATG
GGTTATGGTTATACCAAAGAATGA

This study

39

hydB_conf_F

GAGCTCGGTACCCGGGTGACTAACTAGGAGGAAT
AAATG
CTTGCATGCCTGCAGGTCGACTCTAGAGGATCCCC
GGGTCATTATTCCCTCCAGGTACTA
CCAGTTAAGGAGTGGCG

hydB_conf_R

GGATATTTCCAATGCCTAAAATTAG

This study

ureABR2

TCCCTAAAGGGATTTTCAAGATGT

40

ureCAMF2

40

C1

CCCAGTTTGTCGCACTGATAACCATGTGTTCGTGG
ATGGCAA
GATATAGATTGAAAAGTGGAT

C2

TTATCAGTGCGACAAACTGGG

40

ureCAMR1

ATCCACTTTTCAATCTATATCATTCTCCTATTCTTA
AAGTGTTTT
CATGGGGGCGTGGTGGATTA

40

Plasmids
pDSM199
pDSM1569

hydB_ds_F
hydB_ds_R
NP_kan_F
NP_kan_R

ureABF1

Table reproduced from Blum et. al. PLOS ONE, 2017, 12, e0183260 [15].

40

37

Reference
This study
Reference

This study
This study

39

This study

40

40

2.4.2

Mutant construction of ∆hydB and ∆ureAB
Construction of ∆hydB and ∆ureAB strains in the G27 H. pylori background strains were

performed at the Merrell Lab, part of the Department of Microbiology and Immunology at the
Uniformed Services University of Health Sciences, Bethesda, MD. Construction of ∆ureAB strain
in the 26695 H. pylori background strains were performed at the Maier Lab, part of the
Department of Microbiology at the University of Georgia, Athens, GA. A ∆hydB deletion
insertion strain containing a kan cassette replacing the coding sequence for hydB (HPG27_
RS03075) was constructed as follows. H. pylori G27 (Table 2.1) genomic DNA was used as a
template for polymerase chain reaction (PCR) to amplify fragments of DNA flanking hydB. The
primer pair hydB_us_F and hydB_us_R was used to amplify a 490-bp fragment upstream of hydB
(containing coding sequence for hydA). The upstream primer contained an additional 24-bp
complementary sequence to the 5′ sequence of the kan cassette. The primer pair hydB_ds_F and
hydB_ds_R was used to amplify a 683-bp fragment downstream of hydB (containing coding
sequence for hydC); the forward primer contained an additional 26-bp sequence that was
complementary to the end of the kan cassette. Primer pairs NP_kan_F and NP_kan_R were used
to amplify aphA3, which encodes a KanR gene, from pDSM199. The three fragments were
assembled using splicing-by-overlap-extension (SOE) PCR. The spliced PCR product was ligated
into the pGEM-T Easy vector (Promega) and transformed into E. coli TOP10 cells.
Transformants were selected with ampicillin and screened for growth of white colonies on X-gal
and IPTG. The desired SOE product was confirmed by Sanger sequencing. The plasmid
containing the sequenced product was named pDSM1569, and the E. coli strain containing
pDSM1569 was named DSM1569. The 2061-bp SOE product was amplified from E. coli using
primers that annealed to the backbone of the plasmid, and 500 ng of the resulting linear DNA was
transformed into H. pylori G27. Transformants were selected for on HBA plates containing
kanamycin. Incorporation of the kan cassette to replace hydB was confirmed by Sanger
sequencing using hydB_conf_F and hydB_conf_R primers. The resultant mutant strain was
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named DSM1570 (Table 2.1). A ∆ureAB deletion insertion strain containing a cat cassette
replacing the coding sequence for ureAB (HP0073 and HP0072) was constructed in H. pylori
26695 using a SOE PCR method as described previously.40
2.4.3

Hydrogenase activity
H2ase activity of H. pylori strains were performed at the Maroney Lab, part of the

Department of Chemistry and Program of Molecular and Cellular Biology at the University of
Massachusetts Amherst, Amherst, MA. Hydrogen oxidation activity was measured at room
temperature (~23˚C) using whole cell lysates of various H. pylori strains. Cells were grown as
previously described29 and approximately 108 cells were pelleted and frozen at -80˚C prior to
lysis. Upon thawing, cells were resuspended in 750 μL of ice-cold H. pylori lysis buffer (50 mM
HEPES at pH 7.0 with 1 mM phenylmethansulfonyl fluoride (PMSF)) and then kept on ice
during lysis by pulsed sonication (500 Hz) at 40% amplitude for 14 seconds. H2 consumption was
measured as previously described41 with slight modifications. Briefly, an aliquot of whole cell
lysate was used to test H2 oxidation activity by monitoring the reduction of methyl viologen
(MV) inside an anaerobic chamber (COY Labs, Grass Lake, MI) with a constant atmosphere of
primarily N2 with 3 – 4 % H2 and 0 – 20 ppm O2. Oxidized-MV (colorless) is the electron
acceptor in the H2 oxidation reaction catalyzed by H2ase in the lysate resulting in reduced-MV
(blue). The appearance of reduced-MV was monitored at A578 nm (ε = 9.78 mM-1 • cm-1)42 where
two reduced-MV were expected for every H2 oxidized.41 The reaction was initiated by adding 30
μL of whole cell lysate to 1 mL of deoxygenated H2ase Reaction Buffer (50 mM Tris-HCl, 2 mM
methyl viologen, pH 8.0) in a glass vial. After an initial lag time, the reaction mixture was
transferred to a quartz cuvette and the appearance of methyl viologen reduction was monitored at
A578 nm for 45 – 150 minutes, of which the slope of the linear increase in absorbance over time is
taken as the rate. The lag is due to anaerobic activation that occurs upon exhaustion of trace
oxygen levels.43 Reaction initiated by lysis buffer alone was used to correct for background
activity/instrument drift, which is in the same order of magnitude (H2-OX ~10-8 µmol/min) as the
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ΔhydB strain (where no activity was expected) and less than 1% of any other strains tested. The
specific H2 oxidation activity was obtained by normalizing against the total protein in the whole
cell lysate. Three biological replicates were tested for each strain (unless otherwise noted) and the
specific H2 oxidation activity of each strain was normalized against the activity of the wild-type
strain to obtain percent H2ase activity relative to wild-type.
2.4.4

Urease activity
Urease activity of H. pylori strains were performed at the Maroney Lab, part of the

Department of Chemistry and Program of Molecular and Cellular Biology at the University of
Massachusetts Amherst, Amherst, MA. Urease activity assays of whole cell extracts of H. pylori
wild-type, ∆ureB, and ∆hydB strains were performed as previously described.29 Briefly, for each
strain, overnight liquid cultures of H. pylori were used to inoculate 5 mL liquid cultures to an
optical density at 600 nm (OD600) of 0.05, and then allowed to grow for 22 hr. At that point, the
OD was measured and 1 OD unit of H. pylori was pelleted by centrifugation. The supernatants
were removed and the bacterial pellets were stored at -20C until ready for urease assays. The
frozen cells were thawed and resuspended in 750 µL of ice-cold lysis buffer (HEPES buffer at pH
7.0, 1 mM PMSF, and 1x protease inhibitor cocktail). Resuspended cells were kept on ice during
lysis, which was performed by sonication at 70% power for 6 pulses (2 sec each). The lysate was
centrifuged at 15,000 x g for 10 min to remove insoluble material from the soluble whole cell
extracts. The protein concentration of soluble whole cell extracts was determined by Bradford
assays using the Pierce Coomassie Protein Assay Kit (Thermo Fisher Scientific). Urease activity
was determined using a modified phenol-hypochlorite method (Section 2.4.4), which measures
the amount of ammonia released from the soluble whole cell extract in the presence of urea.44, 45
Five µL of whole cell extract was added to 245 µL of urease reaction buffer (50 mM HEPES, 25
mM urea, at pH 7.0), and incubated at 37ºC for 20 min to allow for ammonia production. The
reaction was quenched by the sequential addition of 375 µL of phenol-hypochlorite buffer A (100
mM phenol, 167.8 mM sodium nitroprusside) and of 375 mL of phenol-hypochlorite buffer B
43

(125 mM NaOH, 0.044% NaClO). The assay mixture was incubated at 37ºC for 30 minutes to
allow for color development, due to the conversion of phenol to indophenol, and measured at A625
nm.

Assays were performed alongside a standard curve created using known amounts of

ammonium chloride in place of the whole cell extract. The specific urease activity was
determined by calculating the nmol of ammonia produced per µg of total protein in each whole
cell extract. Relative urease activity of each strain was determined by normalizing against the
specific activity of the wild-type strain to obtain percent urease activity relative to wild-type.
Three biological replicates were tested for each strain.
2.4.5

Acid survival assay
Acid survival of G27 background strains of H. pylori were performed at the Merrell Lab,

part of the Department of Microbiology and Immunology at the Uniformed Services University
of Health Sciences, Bethesda, MD. Acid survival of 26695 background strains of H. pylori were
performed at the Maier Lab, part of the Department of Microbiology at the University of Georgia,
Athens, GA. Liquid cultures of H. pylori G27 were inoculated to an OD600 of 0.05 from an
overnight starter liquid culture and were then grown for 18-19 h to an OD600 of approximately
0.9-1.0. 1-mL aliquots were pelleted at 2500-3000 x g and were resuspended in 1 mL phosphate
buffered saline (PBS) at pH 6.0 or pH 2.3, and with or without supplementation with 5 mM urea.
To prepare the resuspension solutions, urea was added from a freshly made 100 mM (in PBS)
stock, as appropriate, and the pH of the solutions was adjusted using 6 M HCl. Immediately after
resuspension, a 100-µL aliquot of H. pylori was removed, serially diluted in Brucella broth to 107

, and 10 µL aliquots of each dilution were plated to determine the colony-forming units (CFU) at

T0 for each condition. The remaining H. pylori were incubated at 37°C for 1 h with shaking. At 1
h, a second 100-µL aliquot was removed, serially diluted, and plated to determine the CFU at T60
for each condition. CFU counts were quantified after 4-5 d of growth. A similar protocol was
used to monitor acid survival of the 26695 strains with the following minor exceptions. Liquid
cultures of 26695 wild-type and mutant strains were grown for 26-30 h to an OD600 of
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approximately 0.34-0.42. Cells were serially diluted up to 10-5 in PBS at pH 7.3 and 10 µL of the
10-1 - 10-5 dilutions were plated in triplicate. Percent survival was calculated for each strain and
condition using the equation T60 / T0 x 100%. Three biological replicates were performed for each
isolate and for each strain background.
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CHAPTER 3
HYPA METAL BINDING RESIDUES AFFECT HELICOBACTER PYLORI UREASE
ACTIVITIES AND ACID SURVIVAL
Portions of this chapter have been published: (1) Johnson, R. C, Hu, H. Q., Merrell, D. S., and
Maroney, M. J. (2015) Dynamic HypA zinc site is essential for acid viability and proper urease
maturation in Helicobacter pylori. Metallomics 7, 674 – 682. (2) Hu, H. Q., Johnson, R. C.,
Merrell, D. S., and Maroney, M. J. (2017) Nickel Ligation of the N-Terminal Amine of HypA Is
Required for Urease Maturation in Helicobacter pylori. Biochemistry 56, 1105 – 1116. (3) Blum,
F. C., Hu, H. Q., Servetas, S. L., Benoit, S. L., Maier, R. J., Maroney, M. J., and Merrell, D. S.
(2017) Structure-function analyses of metal-binding sites of HypA reveal residues important for
hydrogenase maturation in Helicobacter pylori. Plos one 12, e0183260.
3.1

Introduction

The HypA metallochaperone is found in all bacteria that express NiFe-H2ase and is typically
associated with Ni-insertion into that enzyme, however it is also required for full activation of
urease activity in H. pylori.1 The H. pylori HypA protein has been extensively studied and
discussed in detail in 1.3. Briefly, the small HypA protein (13 kDa) contains two metal sites and
interacts with several proteins in the nickel trafficking pathway.2 Specifically, it directly interacts
with urease accessory protein, UreE2, which has been linked to its requirement for urease
activation.3-6
The H. pylori HypA structural Zn is coordinated by two conserved CXXC motifs with
flanking His residues, and the Ni is coordinated by the conserved N-terminal MHE-motif (Figure
1.4).7-10 Coordination of the structural Zn have been previously demonstrated to alternate between
Zn(Cys)4 at neutral pH and Zn(Cys)2(His)2 at acidic pH with Ni-bound (Figure 1.6).8 Cys residues
in the H. pylori HypA conserved CXXC motifs have been systematically mutated to Ala (to
simulate loss-of-ligand) and to Asp (to simulate ligand-substitution) in the Zn site. The nonconserved flanking His residues in the Zn site have also been mutated to Ala individually.
Structural characterizations of these protein variants concluded the loss or substitution of any Cys
or His residues in the HypA Zn site resulted in loss of dynamics in the Zn site structure, in which
the variants no longer alternate between the Zn(Cys)4 and Zn(Cys)2(His)2 structure in a pH- and
Ni-dependent manner.9, 11
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The H. pylori HypA Ni site was also investigated to resolve a controversy regarding the
coordination and magnetic properties of the site. The unmodified HypA Ni site has been shown to
be 6-coordinate and paramagnetic,8 but the Ni site of the N-terminally modified GSHypA
(residues Gly-Ser remained after cleavage of affinity tag) was shown to be 4-coordinate and
diamagnetic (Figure 1.5).10 The difference in Ni sites point to the N-terminal amine of HypA as a
potential Ni ligand and its importance in determining the overall structure of the site. Sitedirected mutagenesis was used to extend the N-terminus of the HypA protein by inserting a Leu
residue between the conserved Met1 and His2, creating the Met1_His2insLeu variant (hereafter
known as L2*-HypA). N-terminal extension strategies have been successfully used to probe the
ligation of N-terminal amine in Ni-containing proteins, such as RcnR and Ni-SOD.12, 13 The sideby-side comparison of the Ni site structures, magnetic properties and cellular response of the WTand L2*-HypA would clarify the controversial HypA Ni site as well as establish the role of the Nterminal amine in Ni-ligation.14
In collaboration with the Merrell lab at the Uniformed Services University of Health
Sciences (Bethesda, MD), the cellular responses to the HypA variants were investigated by
replacing the intrinsic hypA gene in H. pylori strain G2715 with the coding sequence for the metal
site variant HypA proteins. These corresponding hypA isostrains if H. pylori were then tested for
acid survival as well as urease and H2ase activities. Although H2ase activity has been shown to be
non-essential for the acid survival of H. pylori16 as described in CHAPTER 2, it is still an
important indicator of HypA function as a metallochaperone.
In addition to the hypA metal site variant strains, several control strains were produced
from the parental G27 H. pylori, including the hypA::kan-sacB, the hypA-restorant, and ∆ureB
strains.11, 15, 17 The hypA::kan-sacB strain contains an interrupted hypA gene, and therefore does
not produce functional HypA protein.11 The hypA-restorant (hereafter known as hypA-R) strain of
which the native hypA coding sequence was replaced by another copy of the WT-hypA, controls
for genetic manipulations of the hypA gene and is expected to behave like the WT parent strain.11
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The ∆ureB strain, in which the gene coding for the large subunit of urease (ureB) is interrupted,
does not have a functional urease, and is therefore not expected to survive acid shock or have
urease activity.11, 17

Figure 3.1: Summary of H. pylori metal site variants and strategies
Multiple protein sequence alignment of HypA homologues performed by the Clustal Omega 1.2.1
algorithm. The residues are colored by properties of the side chain for hydrophobic (red), acidic
(blue), basic (magenta), and other (green) type side chains. Rigidly (*), moderately (:), or slightly
(.) conserved residues are marked below the alignment. Positions of the metal site variant are
highlighted in green for Ni site, and in yellow and cyan for Zn site. Metal site variants described
in this chapter are shown in corresponding colored boxes. WT metal sites previously
characterized by XAS are shown on the left.8, 9 Cellular response characterization strategies of H.
pylori variant strains are shown on the right.
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3.2

Results

3.2.1

Zn site variants
A total of 10 Zn site variants strains were tested for cellular response by characterization

of each strain for acid survival, urease activity, and H2ase activity as summarized in Figure 3.1.
3.2.1.1 Acid survival
The 10 Zn site variant strains were grown along with the four control strains: the parent
WT (G27) strain, hypA::kan-sacB, hypA-R, and ∆ureB, in acid survival challenge for one hour
with or without urea supplement. All 14 of these H. pylori strains showed similar robust survival
profiles when exposed to pH 6 in the presence or absence of 5mM urea (Figure 3.2AB).
Conversely, when exposed to pH 2.3, all of the H. pylori strains, including the WT, showed a
dramatic decrease in survival; less than 0.01% of the inoculum survived at pH 2.3 in the absence
of urea (Figure 3.2C). However, when urea was supplemented to the pH 2.3 buffer, we began to
detect differences in acid resistance across the various strains (Figure 3.2D). As expected, the WT
H. pylori strain and the hypA-R were able to efficiently utilize the supplemented urea as a
substrate for the urease system and survive the acidic challenge. Also, as expected the urease
deficient ΔureB strain was incredibly acid sensitive; no surviving bacteria were detected (limit of
detection 500 CFU/mL equating to 0.0001% survival). The hypA::kan-sacB strain that carried an
insertion in the hypA coding sequence was also deficient in its ability to resist acidic stress (< 3%
survival). This result confirmed previous studies that indicated that hypA is necessary for efficient
urease activity.1,

4, 18

For the various Zn-binding site mutants, mutation of Cys77, His79, and

His95 of HypA resulted in no changes in acid resistance. Conversely, significant decrease in acid
resistance, as compared to the wild type strain, were observed for the C74D, C91A, and C94A
mutant strains: 17.6%, 2.1% and 1.7% average survival, respectively. This finding suggests that
these zinc-binding site residues play a critical role in acid survival, presumably by affecting the
ability of HypA to provide nickel to the urease maturation pathway.
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Figure 3.2: Acid survival of H. pylori hypA Zn site variant strains
A decrease in acid survival was observed for specific amino acid mutations in the HypA protein
Zn site. The hypA variant strains and controls were exposed to various acid shock environment
for 1 hour: pH 6 (A), pH 6 containing 5 mM urea (B), pH 2.3 (C), and pH 2.3 containing 5 mM
urea (D). Percent survival was calculated for each strain. The data shown represent mean ±
standard deviation. A* indicates that acid resistance was significantly reduced when compared to
wild type (p < 0.01, one-way ANOVA followed by Dunnett’s test for multiple comparisons.)
Figure from [Johnson, et. al. Metallomics, 7, 674-682 (2015) [11] reprinted by permission of The
Royal Society of Chemistry.
3.2.1.2 Urease activities
The acid survival data suggested that the C74, C91 and C94 residues play a critical role
in the ability of HypA to facilitate urease maturation.1, 4, 18 We next directly investigated urease
activity of each of the 10 Zn-binding site mutants of hypA, along with the ∆ureB, the hypA::kansacB, the hypA-R and WT strains. The hypA-R strain showed three-fold less urease activity than
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the WT H. pylori strain, which may be a consequence of genetic manipulation. Consequently,
urease activities were normalized to the hypA-R strain. Since the ∆ureB strain of H. pylori is
missing the nickel-containing  subunit of the urease enzyme and should have no urease
activity,17 the average urease activity of the ∆ureB strain was subtracted from the measurements
of all strains to correct for any background levels of ammonia present in whole cell extract.
As shown in Figure 3.3, we identified two classes of mutations of the HypA structural
zinc site, those that had no effect on urease activity (WT-like), and those that decreased urease
activity. This latter class can be subdivided into moderately deficient and severely deficient
(hypA::kan-sacB-like) subclasses. Mutations of non-conserved His residues (H79A and H95A)
that flanked the HypA CXXC motifs resulted in strains that retained WT-like activity, suggesting
that these His residues are not important for urease maturation. In contrast, all mutations
involving Cys residues in the HypA CXXC motifs were deficient in urease activity to some
extent (less than 15% compared with the hypA-R strain), indicating the importance of the Cys
residues in the proper function of HypA in the urease maturation pathway. Comparisons of the
urease activities in the Cys mutant strains with the hypA::kan-sacB stain revealed more subtle
phenotypes. The activity of C77D, C91D, and C94D were statistically different (p < 0.05) from
the hypA::kan-sacB strain (12 – 13% compared with the hypA-R strain) constituting a moderately
deficient phenotype (Figure 3.3A). The remaining Cys mutants, C74A, C74D, C77A, C91A, and
C94A, showed activity levels similar to the hypA::kan-sacB strain (> 4% compared with hypA-R
strain). These urease activity results corroborate the acid survival phenotypes, where C74D,
C91A, and C94A mutants were found to be both acid-sensitive and severely deficient in urease
activity. Contrary to the acid survival results, C74A and C77A mutants which were not acid
sensitive under our test conditions, but were found to be severely deficient in urease activity.
These findings suggest that, although all Cys residues in the CXXC motifs are important for
proper HypA function in the urease maturation pathway, there is a gradient of importance based
on the residue position as well as the type of mutation.
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Figure 3.3: Urease and H2ase activities of hypA Zn site variant strains
The urease activities of each hypA Zn site variant and control strains were measured, the activity
of the ∆ureB strain (less than 1%) was subtracted from each as background, and then the data was
normalized against the activity of the hypA-R strain (A). The H2 oxidation from each strain of H.
pylori was normalized against the activity of the WT strain (B). A * indicates activity that was
significantly different from the hypA::kan-sacB control (p < 0.05), and ND = none detected. Panel
A was previously published in [Johnson, et. al. Metallomics, 2015, 7, 674-682 [11] and
reproduced by permission of The Royal Society of Chemistry. Panel B was reproduced from
[Blum et. al. PLOS ONE, 12, e0183260 (2017) [16].
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3.2.1.3 Hydrogenase Activity
The H2ase activities of the Zn site variant strains of H. pylori were also investigated.
Although H2ase is not required for acid survival in H. pylori16 (discussed in CHAPTER 2), its
activity still contribute to the metabolism and virulence of the pathogen (discussed in Section
1.1.2).19, 20 Since HypA is a known Ni-metallochaperone involved in H2ase activation (discussed
in Section 1.3),2, 21 the H2ase activities of the Zn site variant hypA strains in comparison to urease
activities of the same strains should reveal the role of specific residues in proper function.
The overall activities of the Zn site variant strains are summarized in Figure 3.3B, in
comparison to WT, ∆ureB, hypA::kan-sacB, and hypA-R control strains. The relative (to WT
strain G27) specific H2ase activities of the Zn site variant strains can also be separated into two
different categories, which are either (1) unaffected or (2) H2ase-deficient in activities. The latter
group can be subcategorized into mildly or severely deficient in H2ase activities. Mutations of the
non-conserved His residues (H79A and H95A) that flanked the HypA Zn site did not affect H 2ase
activity (91% and 106% of WT activity, respectively), and are similar to the control strain hypAR (96% of WT). This confirmed observations from the urease activities, indicating that the His
residues are not important for the overall function of HypA as a metallochaperone. The H 2ase
activity of the ∆ureB strain is 154% of WT; the increase in activity could be a result of the lack of
urease in this strain to compete for the Ni co-factor and therefore increases the Ni-availability for
H2ase activation. All mutations to the conserved Cys residues in the HypA CXXC motifs resulted
in deficiency in H2ase activity. Amongst these strain, C74A, C74D, C91A, and C94A were
subcategorized as severely deficient in H2ase activity (9 – 15% of WT), and C77A, C77D, C91D,
and C94D were mildly deficient in H2ase activity (36 – 68% of WT). These trends conform to the
urease activity pattern observed in the same hypA variant strains, confirming that the conserved
Cys residues are more important for the function of HypA than the flanking His residues.
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3.2.2

Ni site N-terminal extension variant (L2*)
The N-terminal extension variant, L2*-HypA, was characterized in vitro for overall

protein properties as well as Ni site structure and magnetic properties.14 The L2*-hypA variant
strain of H. pylori was also assessed for acid survival, urease activity, and H2ase activity.14
3.2.2.1 L2* mutation did not alter protein properties
To ensure that the insertion of Leu into the N-terminal MHE-motif did not disrupt the
overall fold of the purified HypA protein variant, the secondary and quaternary structures of
purified WT- and L2*-HypA were investigated. Circular dichroism of purified WT-HypA and
L2*-HypA proteins show that the N-terminal mutation has not disrupted the mostly α-helical
characteristics of the purified protein (Figure 3.4A) either with or without Ni bound. These results
show that the L2*-HypA variant has not altered its overall fold as compared to WT.
To further analyze the overall size and shape of the purified HypA, size exclusion
chromatography in combination with multi-angle light scattering (SEC-MALS) was used to
analyze both the molecular weight and the hydrodynamic radius of the purified HypA proteins.
Previously, SEC was used to estimate the “size” of HypA in solution based on its elution volume
in comparison to known molecular weight standards. However, elution volume from a SEC
column is dependent on the hydrodynamic radius of the eluted molecule, and the estimated
“molecular weight” calculated from standard curve assumed that the eluted molecule is
approximately globular shape. HypA has been reported to have an elongated shape with two
distinct lobes in the solution NMR structure of H. pylori HypA (PDB ID: 2KDX)10 and in the
crystal structure of T. kodakarensis HypA(PDB ID: 3A43).22 Therefore, elution volume alone is
an unreliable method for estimating “size” of the HypA protein, and have led to the HypA protein
being reported as a solution dimer in the past.7,

23

Using elution volume alone, HypA was

estimated to be ~23 kDa for both WT- and L2*-HypA, based on a calibration curve using known
molecular weight standards, which is consistent with a solution dimer (the calculated monomeric
molecular weight of WT-HypA is 13.2 kDa). MALS calculates absolute molecular mass based on
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light scattering properties of the molecule, independent of the hydrodynamic radius or shape. 24
Using MALS analysis, the absolute mass of WT- and L2*-HypA were calculated to be 13.01 ±
0.007 and 13.37 ± 0.021 kDa respectively (Figure 3.4B), which is consistent with a monomeric
solution structure for both WT- and L2*-HypA. The similarity between WT- and L2*-HypA in
CD spectroscopy and SEC-MALS analyses confirmed that the overall fold and oligomeric
structure of the overall protein was not altered in the L2*-HypA variant.

Figure 3.4: CD and SEC-MALS characterization of WT- and L2*-HypA
Comparison of CD and SEC-MALS characterization of WT- and L2*-HypA indicate that
insertion mutation did not alter the general secondary and quaternary structure of the protein.
Figures reprinted with permission from [Hu, et. al. Biochemistry, 56, 1105-1115 (2017) [14]. Copy
right 2017 American Chemical Society.
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3.2.2.2 L2* mutation changes Ni-coordination
The controversy over the HypA Ni-binding site structure in the literature points to the
unmodified WT-HypA Ni site having a six-coordinate and therefore paramagnetic site,8, 9 and the
N-terminally modified GSHypA variant (PDB: 2KDX) having a four-coordinate planar and
diamagnetic site.10 Direct comparison of the structures of the Ni sites in WT- and L2*-HypA by
XAS was made to investigate the role of the N-terminal amine as a potential ligand in the Ni site
of WT-HypA.
Comparison of the Ni K-edge x-ray absorption near-edge structure (XANES) region of
the XAS spectra obtained from WT-HypA and L2*-HypA Ni(II) complexes in NaBr buffer show
a clear difference that corresponds to a change in the coordination number/geometry of the Ni site
(Figure 3.5A). Typically, two types of high-energy bound-transitions may be observed in the preedge XANES region of the XAS spectra of Ni(II) complexes.25 These features are associated with
transitions involving promotion of a 1s electron into the 3d manifold (1s  3d) or into the 4pz
orbital (1s  4pz) of the Ni(II) complex and are observed near 8331 and 8336 eV, respectively. 25
In the case of Ni-WT-HypA, no discernable pre-edge features were observed. The small
(unresolved) 1s  3d (plus shakedown) transition is consistent with a centrosymmetric Ni(II) site,
and the absence of a peak associated with a 1s  4pz transition rules out a four-coordinate planar
site.25 The XANES analysis is therefore consistent with a six-coordinate Ni site in WT-HypA, in
agreement with the paramagnetism associated with the site by Evans magnetic susceptibility
measurements (see below).
In contrast, a clear feature corresponding to a 1s  4pz transition (plus shakedown) is
observed on the Ni-L2*-HypA K-edge that indicated the loss of at least one axial ligand from the
Ni site compared to WT-HypA (Figure 3.5A, inset).25 The 1s  4pz feature in the Ni-L2*-HypA
spectrum appears as an unresolved shoulder on the Ni K-edge, and is therefore more consistent
with a five-coordinate pyramidal geometry than with a four-coordinate planar complex, where a
resolved maximum is expected.25 A second set of Ni K-edge XAS data were collected on a Ni-
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L2*-HypA sample in NaCl buffer (20 mM HEPES, 200 mM NaCl, 1mM TCEP, pH 7.2) to rule
out buffer effects on the geometry of the Ni site. The similarity of the XANES spectra in NaCl
and NaBr buffers (Figure 3.5B) indicates the geometries of the Ni site was not affected by buffer,
and confirms the five-coordinate pyramidal Ni(II) structural assignment in L2*-HypA.

Figure 3.5: Ni K-edge XANES overlay of HypA complexes
Ni K-edge XANES region overlay of WT- and L2*-HypA (A) bound to Ni and Zn in NaBr
buffer; and of the L2*-HypA bound to both Ni and Zn in NaBr or NaCl buffer (B), with the preedge regions shown in inset. Figure reproduced with permission from [Hu, et. al. Biochemistry,
56, 1105-1115 (2017) [14]. Copy right 2017 American Chemical Society.
Six-coordinate Ni(II) complexes with octahedral geometry are invariably high-spin with
S = 2, while four-coordinate planar Ni(II) complexes are invariably low-spin and diamagnetic.26
Five-coordinate complexes may be either high- or low- spin depending on the relative strengths
of the axial and in-plane ligand fields.25 Magnetic susceptibility measurements using Evans’
NMR method27, 28 (Section 3.4.12) show that the WT-HypA Ni complex is high-spin (μ = 3.52 μB,
well within the range typically observed for Ni(II) complexes: μ = 2.8 – 4.0 μB 26). In contrast, the
Ni(II) complex of L2*-HypA protein is diamagnetic.
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3.2.2.3 Loss of two Ni protein ligands occurs in L2*-HypA
To further characterize the changes in the Ni site structure in WT- and L2*-HypA
proteins, the EXAFS regions of the XAS spectra were analyzed. One limitation of EXAFS
analysis is that the models cannot distinguish scattering atoms with Z ± 1, which means the
structural models cannot easily distinguish between a N- vs. O-donor ligand, or a S-donor vs. a
Cl- ligand.29 Fits were generated using parameters for N-donors and are represented as N/O in
Table 3.1 to emphasize this lack of distinction. To address the issue of S vs. Cl ligation, samples
were prepared in a buffer containing NaBr, rather than NaCl. This practice increases the
confidence of models containing S ligand donors, and can also identify solvent accessible metal
sites in those cases where Br- becomes a ligand.
Models to interpret the EXAFS data were developed beginning with the coordination
number determined by XANES and magnetic studies (see in 3.2.2.2 above). Models were
developed by first using single-scattering analysis. Multiple-scattering scaffolds were added to
the best single-scattering models to account for features in the FT-EXAFS spectra arising from
the second and third coordination sphere scattering atoms resulting from the coordination of His
imidazole ligands (depicted in Figure 3.6, and described in method Section 3.4.9) as previously
described.30,

31

Imidazoles were fit as rigid rings with a single adjustable distance. Integer

numbers of rings were added to “count” the number of imidazole ligands. A separate model was
developed that incorporated a rigid, bidentate 1,2-ethylenediammine-like unit (depicted in Figure
3.6, and described in methods Section 3.4.9) similar to the bidentate coordination of αketoglutarate Fe-binding in nonheme Fe(II) enzymes used in prior models.32,

33

This model

simulates the formation of five-membered chelate rings that form when the binding of the Nterminal amine is accompanied by backbone amide binding, which lead to the ordering of second
coordination sphere C atoms similar to prior models of backbone amidate ligation in the active
site of NiSOD.34, 35
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Figure 3.6: Pictorial representations of multiple scattering scaffolds
Multiple scattering scaffolds were used for calculating the scattering paths for fitting the Ni-WTand L2*-HypA EXAFS data (described in detail in the method Section 3.4.9). Green sphere
represents Ni atom, blue sticks represent nitrogen, and white sticks represent carbon with the
atom ID number labeled on each atom as identified in the corresponding crystal structures.36, 37
The angle between the Ni to the coordinated nitrogen and the adjacent carbon on the imidazole
rings are labeled, and α is the difference between these two angles divided by two, indicated here
as 0˚ or 7˚ tilt. Figure reproduced with permission from [Hu, et. al. Biochemistry, 56, 1105-1115
(2017) [14]. Copy right 2017 American Chemical Society.

Table 3.1: XANES and EXAFS Analysis of WT- and L2*-HypA Ni complexes
XANES analysis
EXAFS analysisa

HypA
WT

L2*

K-edge
Energy
(eV)

8342.8

8342.5

1s →3d
peak area

1s → 4p z

<0.05

no

Coordination
-2
(x10 eV) observed Number

<0.05

yes

6

5

σ2
(x10-3 Å2)
4(8)
3(2)

Shell
1N/O
3N/O
(1 Imid0˚)
BBAm
BBAm

r (Å)
2.21(5)
2.08(2)
1.92(3)
1.97(3)

6(3)

1N/O
1Br
1 Imid7˚
BBAm

2.04(3)
2.42(2)
1.94(4)
1.82(1)

4(4)
11(3)
5(5)
1(1)

a

ΔEo
(eV)
2(1)

R factor
(%)
3.53

0(1)

3.49

Uncertainties in the fitted parameters are shown in parentheses.
Table reproduced with permission from [Hu, et. al. Biochemistry, 56, 1105-1115 (2017) [14].
Copy right 2017 American Chemical Society.
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The best fit for Ni-WT-HypA EXAFS is a six-coordinate complex (Figure 3.7A, Table
3.1; with alternate fits in APPENDIX 2, Table A2.1) with exclusively N/O-donor ligands at
distances ranging from 1.92 – 2.21 Å, and includes multiple-scattering paths that describe an
imidazole with 0˚ tilt (Imid0˚) and binding of one bidentate backbone amide (BBAm) unit. The
inclusion of the BBAm was required to generate a fit with a R-factor < 5 %. Although both
imidazole ligands and five-membered chelate rings feature carbon atoms in the second
coordination sphere at similar Ni-C distances, the two ligands are distinguished by scattering
from atoms in the third coordination sphere (C and N) that contribute to scattering intensities
between 3 – 4 Å (uncorrected for phase shifts) FT-EXAFS (Figure 3.6), and exist only for
imidazole ligation. The imidazole in the Ni-WT-HypA fit likely arises from Ni binding to the
His2 sidechain, which has been shown to be critical to Ni- binding and function.7
The L2*-HypA Ni-EXAFS obtained in buffer NaBr was modeled as a 5-coordinate Ni(II)
site that featured one Br- ligand at a Ni-Br distance of 2.42 ± 0.2 Å and four N/O-donor ligands
ranging from 1.82 – 2.04 Å, and included multiple-scattering paths that were consistent with one
imidazole ligand with a 7˚tilt (Imid7˚) and a bidentate BBAm unit (Figure 3.7B, Table 3.1; with
additional fits in APPENDIX 2, Table A2.2). The multiple-scattering paths used to fit the WTHypA EXAFS are mostly preserved in the L2*-HypA Ni site (although at slightly different
distances and angles), including the bidentate backbone N coordination and a His imidazole.
However, the BBAm unit is not required to generate a fit to the L2*-HypA data with an R-factor
< 5 %, though the alternative fit requires the presence of two His imidazole ligands (see
additional fits in Table A2.2). It is not clear where the second His imidazole would come from,
and the single His fit is consistent with the nickel occupying the same locus (the N-terminus) of
the protein as in WT-HypA and preserving the coordination of the His2 sidechain. In comparison
with the WT-HypA Ni site structure, two N/O-donor ligands were lost, one of which was
substituted by a Br- ligand originating from the buffer in L2*-HypA. The bromide scattering atom
is required to generate a fit with an R-factor < 5 % when BBAm is used to model backbone N
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coordination. Additionally, a systematic shortening of the average distances of Ni-N/O ligation by
0.14 Å in the Ni-L2*-HypA complex is consistent with the observed spin-state change measured
by Evans’ NMR method (Section 3.4.12).
To confirm the 5-coordinate fitting model with exogenous Br- ligand, the EXAFS of a
Ni-L2*-HypA sample in buffer with NaCl was analyzed. The best 5-coordinate model for this
data set include the bidentate BBAm scaffold, as well as a S/Cl-donor at a reasonable distance of
2.25 Å, consistent with the XANES analysis and the best fits in NaBr buffer. A S/Cl donor is
required to generate a fit with R-factor < 5 % (APPENDIX 2, Table A2.3 and Figure A2.1).

Figure 3.7: Ni K-edge EXAFS overlay of HypA complexes
Data (color) and best fit models (black) of the Ni K-edge EXAFS represented in k3-weighted
unfiltered data (top) and Fourier-transformed (k = 2 – 14 Å-1) data uncorrected for phase shifts
(bottom) for (A) Ni-ZnWT-HypA and (B) Ni-ZnL2*-HypA in 20 mM HEPES, 200 mM NaBr,
and 1 mM TCEP (pH 7.2). Figures reprinted with permission from [Hu, et. al. Biochemistry, 56,
1105-1115 (2017) [14]. Copy right 2017 American Chemical Society.
3.2.2.4 The Zn site in L2*-HypA is unchanged compared to WT
In addition to the Ni K-edge, the Zn K-edge XAS spectra were also obtained for Ni- and
Zn-bound WT- and L2*-HypA and confirm that Zn site coordination involving two conserved
CXXC motifs is unperturbed in L2*-HypA. The Zn K-edge XANES spectra of WT- and L2*HypA overlay well, indicating that no significant change in geometry at the Zn site has occurred
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(APPENDIX 2, Table A2.4, and Figure A2.2). The zinc EXAFS spectra for both WT- and L2*HypA were best fitted with a model featuring four S-donors with Zn-S distances of ~2.34 Å and
an imidazole ligand with a 2˚ tilt (Imid2˚) at a distance of 2.18 Å, although acceptable fits with
exclusively Cys ligands are also consistent with the data (APPENDIX 2, Table A2.4, and Figure
A2.2). Possible coordination of the flanking His residue demonstrates that the dynamic nature of
the HypA Zn site is preserved in WT- and L2*-HypA.11, 23
3.2.2.5 L2*-hypA variant H. pylori strain is acid sensitive
To investigate the cellular effect of the N-terminal extension of the HypA protein in H.
pylori, the chromosomal hypA gene was replaced with the coding sequence for L2*-HypA. This
mutant strain (DSM1475) expresses the L2*-HypA protein under the control of the endogenous
promoter (see method Section 3.4.2). As the hypA gene has been shown to be vital for urease
activity in H. pylori,38 and therefore an integral part of the acid survival mechanism, the ureadependent acid survival was assessed for this variant strain. H. pylori strains were challenged for
one hour at mild (pH 6) or harsh (pH 2.3) acidic shock conditions either with or without urea
supplement, and then plated to assess for surviving colony-forming units (CFU). In addition to
the L2*-hypA strain, the parental WT strain, the ΔureB strain where a subunit of the urease
enzyme has been deleted, the hypA::kan-sacB strain where the hypA gene was interrupted, and
the hypA-R strain where the hypA gene was restored after deletion were tested concurrently as
controls (Figure 3.8). Under mild acid shock conditions, all tested strains survived with or
without urea supplement (Figure 3.8AB). Without urea supplement, harsh acid shock was lethal
for all strains tested (Figure 3.8C). At harsh acid shock conditions with urea supplement, distinct
phenotypes for each strain were revealed with WT and hypA-R strains each exhibiting unimpaired
acid survival, whereas the acid survival of L2*-hypA strain along with the hypA::kan-sacB and
ΔureB strains were significantly reduced compared to WT (p < 0.0001) (Figure 3.8D). To further
confirm the results obtained with the L2*-hypA mutant, the strain was independently remade and
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tested in a single replicate of the acid survival assay; this mutant strain displayed similar acid
survival phenotype as the original L2*-hypA mutant strain (data not shown).

Figure 3.8: Acid survival of L2*-hypA variant H. pylori strain
H. pylori strains were exposed to PBS for 1 hour at pH 6 or 2.3 with or without 5 mM urea: (A)
pH 6, (B) pH 6 with 5 mM urea, (C) pH 2.3, and (D) pH 2.3 with 5 mM urea. Each bar represents
the mean percent survival ± the standard deviation. * = acid survival that was significantly
reduced compared to that of wild type (p < 0.0001; one-way analysis of variance followed by
Dunnett’s test for multiple comparisons). Figures reprinted with permission from [Hu, et. al.
Biochemistry, 56, 1105-1115 (2017) [14]. Copy right 2017 American Chemical Society.
3.2.2.6 L2*-hypA variant strains of H. pylori is deficient in urease and H2ase activity
To confirm that the acid sensitive phenotype in L2*-hypA strain was a result of urease
deficiency, urease activity was measured using a modified phenol-hypochlorite assay for NH3
production. In 30 minutes, the clarified lysates of H. pylori strains produced 109, 0.47, 0.77, 86,

67

and 0.33 nmol NH3 per μg of total protein for WT, ∆ureB, hypA::kan-sacB, hypA-R, and L2*hypA strains respectively. These results confirmed the trend observed in acid survival tests, with
hypA-R strain having WT-like urease activity, whereas L2*-hypA strain along with negative
control strains ΔureB and hypA::kan-sacB had less than 1% of WT relative urease activity (Figure
3.9A). These results show that insertion of a single Leu residue into the N-terminal Ni-binding
motif of HypA (L2*-hypA variant) is sufficient to nearly eliminate urease activity and to severely
impair urea-dependent acid survival of H. pylori.
H2ase activity of the L2*-hypA strain of H. pylori as well as accompanying controls were
assessed (Figure 3.9B) and compared to the corresponding urease activity. The control strains
hypA-R and ∆ureB exhibited H2ase activity levels similar to the WT parental strain at 92% and
128% of WT, respectively. In contrast, the H2ase activity of L2*- hypA variant strain was
comparable to the hypA::kan-sacB strain, where no functional hypA gene is present. This
confirms that the L2*-hypA variant strain lacks H2ase activity as well as urease activity,
indicating that proper Ni-ligation in HypA is required for its function as a Ni metallochaperone.

Figure 3.9: Urease and H2ase activities of L2*-hypA variant and control strains
The urease activities of L2*-hypA variant and control strains were measured and then normalized
against the activities of the WT strain (A). The H2 oxidation from each strain of H. pylori was
normalized against the activity of the WT strain (B). Each bar represents the average ± standard
deviation of three technical replicates from two independent growths. Panel A was previously
published and reproduced with permission from [Hu, et. al. Biochemistry, 56, 1105-1115 (2017)
[14]. Copy right 2017 American Chemical Society. Panel B was reproduced from [Blum et. al.
PLOS ONE, 12, e0183260 (2017) [16].
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3.2.2.7 L2*-HypA retains protein-protein interaction with UreE but loses Ni-binding
affinity
The L2*-hypA strain could lead to cellular urease deficiency by two potential
mechanisms. Firstly, the L2*-HypA mutation could disrupt protein-protein interactions between
HypA and the known interaction partner, dimeric UreE, in the urease maturation pathway.4
Alternatively, insertion of a Leu at the N-terminal MHE-motif could disrupt the Ni-binding
properties of HypA directly. These mechanisms are not mutually exclusive, and both would result
in impaired Ni delivery and the loss of urease activity and acid survival phenotype that is
observed for the L2* hypA strain.

Figure 3.10: Binding of WT- and L2*-HypA to UreE dimer by ITC
Binding curves of WT-HypA (left) or L2*-HypA (right) to WT-UreE dimer measured by
isothermal titration calorimetry (ITC) in buffer consisting of 20 mM HEPES, 200 mM NaCl, and
1 mM TCEP (pH 7.2). The top panels show the heat response from each injection, which are
integrated to generate the enthalpy of binding plotted in the bottom panels [WT (squares) and L2*
(stars)]. Binding of WT- and L2*-HypA to the UreE WT dimer is each fitted to OneSite models
as described in the text. Figures reprinted with permission from [Hu, et. al. Biochemistry, 56,
1105-1115 (2017) [14]. Copy right 2017 American Chemical Society.
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To assess whether the L2* mutation of HypA affected protein-protein interaction
between HypA and UreE, binding of purified HypA to UreE was monitored using isothermal
titration calorimetry (ITC). Concentrated WT- or L2*-HypA proteins were injected into WTUreE dimers30,

39

and the change in heat from each injection was integrated and the resulting

binding curve was fitted to OneSite models (see method Section 3.4.10, Figure 3.10A). The
number of sites (N) in each case was fitted to be ~1.5 HypA per UreE dimer. The larger than
expected value of N (HypA:UreE dimer >1) is likely due to the tendency of H. pylori UreE
protein to degrade slowly over time at the C-terminal Ni-binding motif. This degradation was
previously observed in mass spectrometry of purified UreE and was reported as a cause for the
disorder of the C-terminal region in crystal structures.

30, 40

The degradation was also observed in

SDS-PAGE, resulting in a lower molecular weight band, which was carefully monitored posttitration to ensure that full-length UreE is comparable in each titration (APPENDIX 2, Figure
A2.3). The degradation of UreE makes the concentration of full-length UreE in a sample
uncertain and invariably less than expected, thus complicating an accurate determination of N.
Despite the larger than expected N values, WT- and L2*-HypA binding to UreE dimer were fitted
to similar N values (1.5 ± 0.1 and 1.6 ± 0.2) and affinities (with apparent Kd values of 0.96 ± 0.09
and 0.69 ± 0.11 μM respectively, Table 3.2). This finding suggests that the L2* variant did not
disrupt the protein-protein interactions with the urease maturation pathway (through dimeric
UreE).
Table 3.2: Apparent Binding to HypA as Measured by ITC
binding partner
UreE (dimer)

HypA
WT
L2*

K d (μM)
0.96 ± 0.94
0.69 ± 0.11

N
1.5 ± 0.1
1.6 ± 0.2

ΔH (kcal/mol)
-6.27 ± 0.06
-3.86 ± 0.06

WT
1.0 ± 0.2
0.88 ± 0.01
-4.99 ± 0.07
L2*
59
±
12
0.39
±
0.07
-1.30 ± 0.29
Ni
Table was previously published and reproduced with permission from [Hu, et. al. Biochemistry,
56, 1105-1115 (2017) [14]. Copy right 2017 American Chemical Society.
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Another mechanism by which L2*-HypA could hinder urease maturation is through
lowering the ability of HypA to bind Ni. This was also addressed using ITC to measure the
difference in Ni binding affinity between WT- and L2*-HypA. ITC titrations involving injection
of NiCl2 (dissolved in the same buffer as the protein) into the respective HypA protein, where the
heat of injection was monitored and integrated. The resulting binding curves were each fitted to
OneSite models (see method Section 3.4.10). The results indicated that WT-HypA bound
approximately one nickel per protein (N = 0.88 ± 0.01) with an apparent Kd of 1.0 ± 0.2 μM
(Figure 3.11, Table 3.2), which is consistent with prior studies.9 Titration of NiCl2 into L2*-HypA
at the same concentrations resulted in curves that did not reach saturation after the addition of two
equivalents of Ni (data not shown), indicating a much lower Ni affinity for L2*-HypA. A more
concentrated NiCl2 solution was subsequently used for the L2*-HypA titration to push the
titration to apparent saturation. The resulting heat of binding was best fitted with a OneSite model
with an apparent Kd = 59 ± 12 μM and N = 0.39 ± 0.07 (Figure 3.11 right, Table 3.2).
However, it clear that the amount of heat generated by Ni binding to L2*-HypA is very
small, making Kd and N difficult to measure. For this reason, the Ni-binding affinities of WT- and
L2*-HypA, were also measured by NiCl2 titration into HypA protein solutions monitored by
changes in absorbance in the UV-Vis spectra. The absorption spectra of samples with a constant
concentration of WT or L2*-HypA mixed with increasing concentrations of Ni2+ (dissolved in the
same buffer) were measured. The apparent Kd was calculated from the change in absorption
maxima in response to total Ni concentration (see Method Section 3.4.11, Figure 3.12). The
apparent Kd was calculated to be 1.1 ± 1.0 μM for Ni-binding to WT-HypA, corroborating the
ITC data. The apparent Kd was calculated to be 27 ± 4 μM for Ni-binding to L2*-HypA, which is
of the same order of magnitude as the value found using ITC, and ~ 20-fold greater than WT.
Thus, inserting a Leu residue into the Ni-binding motif of HypA (L2*-HypA) significantly
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decreases its ability to bind Ni, rendering it unable to deliver this metal efficiently to the urease
maturation pathway.

Figure 3.11: Ni2+ binding to WT- and L2*-HypA measured by ITC
ITC binding curves of titrations of Ni into WT-HypA (blue) and L2*-HypA (green) in a buffer
consisting of 20 mM HEPES, 200 mM NaCl, 1 mM TCEP (pH 7.2). The top panels show the
heat response of each injection, which are integrated to generate the enthalpy of binding plots in
the bottom panels [WT (circles) and L2* (stars)]. The binding curves are graphed to the same
scale on the y-axes for WT- and L2*-HypA to emphasize the difference in enthalpy response with
a more appropriately scaled y-axis for Ni-L2* binding also shown (inset). Binding Ni to WT- and
L2*-HypA is fitted to a OneSite models in both cases, as described in the text. Figures reprinted
with permission from [Hu, et. al. Biochemistry, 56, 1105-1115 (2017) [14]. Copy right 2017
American Chemical Society.
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Figure 3.12: Ni2+ binding to WT- and L2*-HypA measured by UV absorption
Ni2+ addition to 50 μM of Apo-ZnWT- and Apo-ZnL2*-HypA monitored by UV-Vis absorption.
(A) Spectra of Apo-ZnHypA are shown in gray and are subtracted from the Ni-ZnHypA spectra
of WT- (top, blue) and L2*-HypA (bottom, green), where the Ni-dependent absorption maxima at
269 nm and 244 nm respectively. (B) Ni titration curve of WT- and L2*-HypA obtained from
plotting the change in absorption at the maxima are against the total nickel concentration with fits
for Kd shown as dashed (WT) and dotted (L2*) lines (see methods Section 3.4.11 for detailed
fitting procedures). Figures reprinted with permission from [Hu, et. al. Biochemistry, 56, 11051115 (2017) [14]. Copy right 2017 American Chemical Society.
3.3

Discussion
H. pylori is a prevalent human pathogen that colonizes the acidic stomach using multiple

adaptations (discussed in detail in Section 1.1.1).41 One of the most prominent adaptations for
acid acclimation is the use of the Ni-dependent enzyme urease (discussed in Section 1.1.1.4).41, 42
Briefly, urease catalyzes the hydrolysis of urea to carbon dioxide and ammonia, which neutralize
the cytoplasmic and periplasmic pH of the bacteria under acid shock conditions. 43 Up to 10% of
the total protein synthesized by the bacteria is urease to ensure for fast response to acid
exposure.44 However, under neutral conditions, excessive activation of urease can over alkalinize
the internal pH of the bacteria leading to cell death. Therefore, the activity of urease is regulated
at multiple levels in response to acid shock and Ni availability (discussed in CHAPTER 1).42
Assembly of the di-nickel active site requires several accessory proteins (discussed in Section
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1.2.5), which include the Ni-metallochaperones UreE and HypA.43 HypA is also involved in Niacquisition for the only other Ni-dependent enzyme in H. pylori, NiFe-H2ase.2
Properties of the HypA protein have been extensively studied and are discussed in detail
in Section 1.3. Briefly, HypA contains a structural Zn site that coordinates the metal by two
conserved CXXC motifs and features non-conserved flanking His residues; and a Ni site at the
conserved N-terminal MHE-motif.8-10 The work described in this chapter probed the functional
consequences of properly constructed Zn and Ni binding sites, as well as identifying key
ligands.11, 14
3.3.1

Dynamics of the HypA Zn site
The structural Zn sites in HypA were previously shown to change coordination in a pH

and nickel-dependent manner, adopting a Zn(Cys)4 conformation at neutral pH (7.2), and a
Zn(Cys)2(His)2 conformation at more acidic pH (6.3) (Figure 3.1) in the presence of Ni.8, 9 These
two structures were correlated with other physical properties of HypA, including nickel binding
stoichiometry and thermal stability, with the lower pH form associated with greater thermal
stability.9 Mutagenesis studies revealed that altering any Cys residue in the two CXXC motifs (to
Ala or Asp) resulted in adoption of the acidic conformation (Zn(Cys)2(His2)), and any mutation of
the flanking His residues resulted in the neutral conformation (Zn(Cys)4), in the presence of Ni at
both pH values, as determined by EXAFS analysis.9 The loss of pH-responsive dynamics in the
HypA Zn site variants were important tools for probing the role of HypA in urease and H 2ase
maturation within the cell and in acid survival.
Urease activities of clarified lysate from H. pylori hypA Zn site variant strains correlate
well with previous in vitro studies employing addition of purified HypA proteins to whole cell
extract from a ΔhypA mutant strain of H. pylori.9 Results of the HypA protein add-back studies
show a general decrease in urease activity upon addition of the zinc site variants relative to
addition of wild type HypA protein, and a generally greater effect associated with Cys mutants as
compared to His mutants.9 The urease activity of clarified lysate of H. pylori Zn site hypA variant
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strains presented here reveal two distinct phenotypes: WT-like urease activity, represented by His
mutants, and urease-deficient strains associated with Cys-mutants. The H2ase activity of these
strains closely mirror the urease activity, with the His variants exhibiting WT-like H2ase activity,
and Cys variants showing H2ase deficiency. These two classes of mutants correspond to the
Zn(Cys)4 or Zn(Cys)2(His)2 conformations, respectively. Our data indicate that, a deficient HypA
metallochaperone is deficient for both target enzymes, and that a properly constructed Zn site is
essential for Ni delivery to either target, which suggest that all Cys residues in the HypA Zn site
are important in the maturation of urease and H2ase in H. pylori. These results are consistent with
a model in which lower levels of enzyme activation are associated with the Zn(Cys)2(His)2
structural conformation, or the loss of access to the Zn(Cys)4 structure.
Among the Cys mutations, there were two levels of enzymatic activities observed: a
moderate decrease that was generally associated with ligand substitution variants (Cys  Asp);
and severe decrease in activity generally associated with loss of ligand mutations (Cys  Ala).
This trend suggests that at least part of the difference lies in coordination of the CXXC motifs. A
CysAsp mutation involves the substitution of a Cys thiolate ligand by a carboxylate. Thus, the
Cys  Asp substitution provides a mechanism to access a Zn(Cys)3Asp site that favors the wild
type-like Zn(Cys)4 conformation, which appears to preserve greater HypA function in moderately
affected mutants. Exceptions to this trend was observed for position C74, where both C74A and
C74D resulted in severe deficiency in enzymatic activities (see below for additional discussion).
Another exception was observed in the C77A variant, which was severely deficient in urease
activity but only moderately affected in H2ase activity, indicating its potential role in
differentiating the activation between the two Ni-dependent enzymes.
Acid survival studies of Zn site hypA variant strains corroborated that mutation of the His
residues did not affect acid survival. However, although most Cys mutations of hypA resulted in
lower urease activities, only three (C91A, C94A, and C74D) were shown to be acid sensitive
under the experimental conditions used in this study. This discrepancy suggests that WT-like
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urease activity is not required for acid survival under the conditions used in this study (30 minutes
at pH 2.3 and with 5mM urea supplement). Of the three Cys variants identified to be acid
sensitive, C74 occupied a unique position and phenotype (discussed in more detail below).
Interestingly, acid sensitivity was detected for the loss of Zn ligands in C91 and C94 (Cys  Ala
mutation), but not for ligand substitutions (C91D and C94D hypA variant strains had WT-like
acid survival). This suggests a positional difference in the two CXXC motifs, where the lack of
Zn coordination in the second CXXC motif (C91 and C94) is more deleterious compared to the
first CXXC motif (C74 and C77). No clear reason is apparent for the functional differences
observed for the two CXXC motifs, although it is worth noting that two of the four Cys residues
in the CXXC motifs were substituted by His at acidic pH (as previously shown by EXAFS
analysis)9 while the other two remain bound to anchor the Zn site. This pair-wise difference may
account for the functional difference noted in the two CXXC motifs, however, more structural
information is required to definitively assign the role of each CXXC motifs.
It is clear from both the enzyme activity data and acid survival data that Cys74 is a
special position among the Cys variants. It is the only position where the Cys  Asp mutation
results in a less acid viable strain than the Cys Ala mutation, and the only position where
urease activity of the Ala variant is higher than the Asp variant. The NMR structure of GSHypA
shows that the Zn site is formed by a loop that begins with Cys74 and ends with Cys94. However,
the terminal Cys residues in the loop differ in that Cys94 is flanked by a His residue and Cys74 is
not. The lack of an alternative ligand (in the form of a flanking His residue) could make Cys74
mutations a more vulnerable position, particularly if it plays an anchoring role, the loss of which
may result in a more severe phenotype due to destabilization of the entire structural zinc site.
Altering the HypA structural zinc site by point mutations also severely affects urease and
H2ase maturation and acid survival of H. pylori. These findings suggest that protein structural
dynamics, reflected in the HypA Zn site structure, may result in subtle alterations of the overall
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HypA fold, ultimately leading to a gradient in urease and H2ase enzymatic activities that varies
with cellular pH and Ni availability.
3.3.2

N-terminal amine of the HypA Ni site
Protein and cell-based studies of the N-terminal insertion variant, L2*-HypA, lead to the

conclusion that proper Ni-binding by HypA is critical for its function as a Ni-chaperone in the
urease maturation pathway. Proper Ni-binding requires the unmodified MHE-motif at the Nterminus of HypA (likely by coordinating the N-terminal amine). Deficiency in urease activity
and acid survival of the L2*-hypA mutant strain of H. pylori does not appear to result from
interruption of protein-protein interactions with the urease maturation pathway, as the apparent
affinities of WT-HypA and L2*-HypA binding to WT-UreE dimer were found to be similar
(3.2.2.7). Instead, the apparent affinity of L2*-HypA for Ni(II) ions was found to be reduced by
at least 20-fold compared to WT-HypA (3.2.2.7). This “loss of Ni-binding affinity” mechanism to
account for the observed loss of function in urease maturation is corroborated by the structural
changes found for the Ni-binding site in L2*-HypA (discussed below).
The identification of the proper Ni-binding site in HypA has been controversial. From
multiple sequence analysis to mutagenesis studies, Ni bound to HypA at the conserved Nterminal MHE-motif, involving His2 as one of the ligands.4, 7, 10 However, the geometry of the Nibinding site and the identity of the other Ni ligands from this Ni metallochaperone were not clear.
Our lab previously identified the unmodified WT-HypA as having a six-coordinate site involving
exclusively N/O-donor ligands that include 1 – 2 imidazoles.8, 9 Xia et. al., working with the Nterminal extended GSHypA that contained the intact MHE sequence (resulting from a 2-residue
overhang from cleavage of an N-terminal affinity tag) proposed a four-coordinate planar site
involving the His2 side-chain and three additional backbone amides from His2, Glu3, and Asp40
(depicted in Figure 3.13C).10 In the studies presented here, the unmodified WT-HypA protein is
consistent with the six-coordinate site with one His imidazole and where the scattering attributed
to a putative second histidine is now attributed to chelate ring formation involving backbone
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amide coordination (depicted in Figure 3.13A). The N-terminal extension variant protein, L2*HypA, bound Ni at the same locus as WT-HypA, but having lost two N/O-donor protein ligands
it adopted a pyramidal five-coordinate geometry with the additional ligand being a Brcontributed from the buffer system (depicted in Figure 3.13B). The direct comparison between
the Ni sites in unmodified WT-HypA and the variant protein with an N-terminal extension (L2*HypA) demonstrated that the N-terminal amine of HypA is clearly involved in Ni binding.
The L2*-HypA Ni site structure described here is also consistent with the data from the
N-terminally modified GSHypA protein (PDB: 2KDX), which was proposed to have a fourcoordinate (planar) Ni site based on the fact that it is diamagnetic (lack of paramagnetic linebroadening) and on chemical shift perturbations observed by 1H15N-HSQC experiments upon
Ni(II) titration into a sample that identified four ligands.10 In the case of the L2*-HypA Ni(II)
complex, the same set of ligands that were proposed in the 2KDX structure could be used to
describe the best-fit for the Ni site with the addition of a Br- in the axial position from the buffer
system (depicted in Figure 3.13B). While the NMR experiment clearly establishes that the Ni(II)
site is diamagnetic in GSHypA, it does not establish a four-coordinate planar geometry because
the technique is blind to non-protein ligands. Despite the five-coordinate pyramidal geometry,
Ni(II) binding to the L2*-HypA protein variant results in a diamagnetic low-spin Ni(II) site. In
determining the ligands involved in Ni binding, Xia et al. would not have been able to determine
the involvement of non-protein ligands in coordinating the Ni site using NMR and therefore
concluded that the N-terminally modified GSHypA Ni site is planar in geometry.10 Xia et al. also
concluded that all other conserved Glu, Asp, and His residues are quite far away from the Nterminus of the protein in the 2KDX structure and therefore are unlikely to be involved in
formation of the six-coordinate Ni site in WT-HypA.10 However, the proximity of Glu3 and
Asp40 was established in their experiments through backbone amide binding in forming the
planar Ni site.10 Having established the N-terminal amine as one of the ligands in WT-HypA, in
addition to the His2 side chain and backbone amide, the missing three ligands are proposed to be
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the sidechains of Glu3 and Asp40 as well as an additional backbone amide residue (most likely
from Glu3). This proposed Ni site structure for WT-HypA is depicted in Figure 3.13A. The
binding of Glu3 and Asp40 sidechains and neutral amides would result in a charge neutral
complex. The use of the N-terminal amine, and both the sidechain and backbone amides of His2
and Glu3 would firmly establish the rigidly conserved MHE-motif for Ni binding in HypA.
One crystallographically characterized example of the HypA Ni-binding site is available
from the T. kodakarensis KOD1 (PDB ID: 5AUN and 5AUO) in a complex with the ATPbinding form of HypB from the same organism in two distinct nucleotide-bound forms (ATP and
ADP analogs).45 Each Ni site features HypA in planar four-coordinate geometry with ligands
comprised of the N-terminal amine, the backbone amide of His2, and the sidechains of His2 and
His98 (His79 in H. pylori HypA), the latter of which is pushed into the Ni-binding site by HypB
binding close to the HypA Zn site.45 Since the H. pylori HypA Zn-binding region is much more
compact compared to the T. kodakarensis site (see multiple sequence alignment in Figure 3.1), it
is unlikely that the His residues in the Zn site would ever be able to coordinate the distant Ni site.
Additionally, H79A and H95A hypA variant strains did not exhibit deficiencies in acid survival,
urease activity, or H2ase activity; which would be expected if one of the His residues at the H.
pylori HypA Zn site was involved in Ni-coordination, either alone or as part of a functional
protein complex.
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Figure 3.13: Summary of proposed HypA Ni site structures
Proposed Ni site structures for WT-HypA (A) and L2*-HypA (B) based on the analysis of XAS
data. The Ni site structure for GSHypA (C) as proposed by Xia et. al. from NMR studies (PDB
ID: 2KDX) of the N-terminal extension variant.10 N-terminus of the SH3 mutant domain of cSRC tyrosine kinase (PDB ID: 4OMO) solved by x-ray diffraction,46 demonstrating the Ni-bound
ATCUN motif in a protein.
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The planar, and therefore diamagnetic, T. kodakarensis HypA Ni site resembles other
classic N-terminal Ni-binding motifs. Use of the N-terminal amine as a metal ligand is unusual in
metalloproteins, but more common in Ni and Cu proteins. Coordination of Ni(II) in the Nterminus of proteins and peptides has been most extensively studied in the classic amino terminal
Cu(II) and Ni(II) (ATCUN)-motifs. The ATCUN-motif was first described in albumin, which is
amongst the major transporters of Cu(II) and Ni(II) in serum.47 The motif has since been
described in several other peptides such as human protamine 2, histatin 5, heuromedin C, and
hepcidin, of which the physiological evidence of Cu(II) and Ni(II) binding has yet to be
confirmed.47, 48 Additionally, small molecule mimics and protein/peptide engineering studies have
shown that ATCUN-motifs are associated with DNA-cleavage activities.47, 49, 50 Despite the high
stability and tight binding of the ATCUN metal site [Kd ~1 pM for Cu(II) and 150 nM for Ni(II)],
the ATCUN metal site structure has yet to be crystallized in albumin and is presumed to contain
multiple conformations even in crystals.48 Instead, most of the structural information on ATCUN
motifs has been derived from small molecule and oligopeptide mimics, 48-51 although a highresolution crystal structure of the Ni-bound ATCUN motif (depicted in Figure 3.13D) at the Nterminus of a protein is available for SH3 mutant domain of c-SRC tyrosine kinase from G. gallus
(PDB ID 4OMO).46 The classic ATCUN-motif has a strictly conserved His-residue in the third
position and binds metals using the N-terminal amine, backbone amide N-donors from the second
and third amino acid, and the His-imidazole sidechain, forming two chelate rings, one 5membered and one 6-membered, with the metal in a distorted four-coordinate planar geometry.47,
48, 50

This stable planar structure excluded sidechain coordination from the first two amino acids

of the motif.48
Despite binding Ni(II) at the N-terminus, the WT-HypA Ni site structure is distinct from
the classic ATCUN-motif in several ways. Like the ATCUN-motif, Ni(II) binds to HypA with the
N-terminal three-residue motif (MHE-) through the N-terminal amine and likely the backbone
amides of His2 and Glu3 as well as the imidazole sidechain of His2. However, Ni-coordination to
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the MHE-motif forces one of these N/O-donor ligands into an axial position (as depicted in
Figure 3.13A), instead of favoring the rigid planar structure found in the classic Ni-ATCUN site.
The axial coordination of an N/O-donor, such as His imidazole, may favor a high-spin
configuration, which also favors a 6-coordinate Ni(II) site, instead of the planar four-coordinate
low-spin Ni-ATCUN structure. Like the ATCUN-motif, the HypA MHE-motif is associated with
known Ni-transporter activity, although with a much more modest Kd (~ 1 μM, vide supra),
which allows for more appropriate Ni metallochaperone activity inside the cell. With the L2*HypA variant, the conserved His2 residue is shifted to the third position (MLHE-) to more closely
resemble the classic ATCUN motif.
Despite having a more ATCUN-like metal binding motif, the L2*-HypA variant did not
exhibit the tight Ni(II) binding that is associated with the ATCUN complexes like albumin, 48
although albumin Ni-binding has not been measured under similar conditions. The reason for the
decreased affinity is not clear; one possibility lies with the difference in protein structure. In
HypA proteins, the N-terminus is associated with a helical structure that would be perturbed by
Ni binding, effectively lowering the affinity relative to the unstructured N-termini in albumin
structures.48 Another possibility is that the protonation state of the amide N-donors is important.
If one or more amides is left protonated in the L2*HypA structure, this would decrease Ni affinity
and enhance the binding of an additional anion, such as Br- or Cl-. In any case, the L2*-HypA Ni
site is low-spin, like the Ni-ATCUN site, indicating that it can adopt a similar planar coordination
of the four protein ligands. In five-coordinate Ni(II) complexes, the relative ligand field of the
ligands in the basal plane vs. the axial ligand determines the spin-state. Addition of a Br- ligand, a
weak field ligand, leads to a pyramidal geometry, but retains the low-spin configuration.
In addition to the ATCUN-motif, there are several examples of proteins that bind Ni(II)
at the N-terminus, specifically coordinating the N-terminal amine. One such example is the Nterminal high affinity site in E. coli HypB (absent in H. pylori HypB), which binds Ni(II) through
a CXXCGC motif at the N-terminus, coordinating the N-terminal amine and the three S-Cys in a
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planar geometry.52 Another such example is S. coelicolor nickel superoxide dismutase (NiSOD),
which binds Ni(II) through the N-terminal amine of His1, the backbone amide of Cys2, and the
sidechains of Cys2 and Cys6, with the sidechain imidazole of His1 also bound in the Ni(III)
state.37,

53, 54

Both the E. coli HypB N-terminal motif and NiSOD Ni binding sites have been

referred to as “ATCUN-like” in literature due to the binding of the N-terminal amine and planar
geometry.35, 37, 52 Another example of Ni-binding at the N-terminus can be found in E. coli RcnR,
a Ni(II)-/Co(II)-responsive transcriptional regulator, which binds Ni(II) with the N-terminal
amine of Ser2 (Met1 is cleaved in E. coli) in a 6-coordinate site, where there is no evidence of
backbone amide binding thus far.12 Thus, Ni(II) binding at the N-terminal amine has been found
in proteins with vastly different functions and metal coordination: metal transporters/chaperones
(e.g., albumin (planar)48 and HypA (6-coordinate)), both redox-active and inactive enzymes (e.g.,
NiSOD (planar/pyramidal)37 and EcHypB N-terminal Ni-motif (planar)52), and a metal-responsive
transcriptional regulator (RcnR (6-coordinate)12), demonstrating the N-terminal amine is a
common and important ligand for Ni(II)-binding in biology overall.
One mechanism for controlling cellular urease activity in H. pylori is through modulation
of urease maturation via nickel insertion into apo-urease.42, 55, 56 Apo-urease is produced in large
quantities (10% of all synthesized protein44) but remains largely in the apo form.38, 42 Increases in
enzyme activity are correlated with Ni available in the media.42, 55, 56 Beyond Ni availability, acid
conditions also strongly enhance urease activity, but urease transcription is only marginally
increased.57,

58

Thus, nickelation of the apo-protein is employed to boost urease activity under

acidic conditions.42 With respect to the accessory proteins involved in Ni incorporation, the roles
of the hydrogenase proteins HypA and HypB and the urease protein UreE are quite distinct. Both
the Ni-binding deficient hypA H2A mutant4, 7 and the nucleotide-binding deficient hypB K59A
mutant59 were reported to lack urease activity, but this defect could be complemented by Ni
supplementation in the media, consistent with their roles in Ni(II) transport and delivery, and
implying that under high Ni concentration some Ni is available to UreE. In contrast, Ni
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supplementation could not rescue the urease-deficient phenotype in either the ΔureE mutant4 or
the ureG K14A mutant (nucleotide-binding deficient UreG).59 Hence urease maturation
specifically requires the urease cascade, but not HypA and HypB when excess Ni is present.
With Ni-binding to WT-HypA having only a modest Ni-binding affinity at (Kd ~1 μM)
(vide supra) and H. pylori having a full cascade of urease maturation accessory proteins
UreEFGH,60 why would the full maturation of urease require the hydrogenase maturation
accessory proteins HypA and HypB? Specifically, why is HypA Ni-binding necessary for Ni
transport and delivery to the urease maturation pathway? One possibility is that HypA and HypB
provide an additional pathway for Ni incorporation that is triggered under acidic conditions that
supplements a low basal level provided by H. pylori UreE alone. In fact, H. pylori appears to
restrict Ni incorporation into urease by UreEFGH by lowering in the Ni-binding properties of
UreE. The poor Ni-sequestration ability of H. pylori UreE compared to homologues (such as K.
aerogenes UreE, which has a poly-His tail) has been studied.61 Incorporation of a poly-His tail
into H. pylori UreE has been shown to increase the Ni-sequestration ability and the urease activity
in the absence of HypA or HypB proteins.61 Under acidic conditions, HypA and HypB could
provide a higher level of Ni incorporation into UreE by 1) increasing the local concentration of Ni
by formation of a complex with HypA and HypB, or 2) by simply enhancing the affinity of UreE
for Ni in a complex with HypA and HypB. The former mechanism is suggested by the known
HypA-UreE complex formation,3, 4 and by protein structural changes that accompany changes in
the Zn site structure at pH 6.3.8, 9 The latter mechanism is supported by the increase in Ni affinity
that occurs in the HypA and HypB complex in T. kodakaraensis.45
These prior studies along with our own study point to the role of the hydrogenase
maturation accessory protein HypA in the acquisition and delivery of Ni to the urease maturation
pathway under non-abundant Ni conditions (without Ni supplementation). Instead of enhancing
the Ni-sequestration ability of the urease cascade, HypA is recruited from the hydrogenase
maturation pathway to sequester Ni for the urease maturation pathway; in doing so they assert a
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higher level of control over Ni availability to the urease maturation pathway. Due to the high
level of Apo-urease synthesized under both acidic and neutral conditions44, the higher level of Ni
control could hypothetically be employed to finely tune the urease activity of H. pylori to prevent
an alkaline internal pH or depletion of urea in the cytoplasm under neutral conditions. However,
this fine-tuning mechanism would impose acid sensitivity to the strains where the ability of HypA
to bind Ni is impaired as is the case in the H2A hypA strain4, 7 and the L2* hypA strain.
3.4

Methods

3.4.1

H. pylori growth conditions
Growth of G27 background strains of H. pylori were performed at the Merrell Lab, part

of the Department of Microbiology and Immunology at the Uniformed Services University of
Health Sciences, Bethesda, MD. All H. pylori strains were maintained at -80°C in brain heart
infusion broth (Becton Dickinson) supplemented with 10% fetal bovine serum (FBS) and 20%
glycerol and were cultivated on horse blood agar (HBA) medium containing 4% Columbia agar
base (Neogen Corp), 5% defibrinated horse blood (HemoStat Laboratories, Dixon, CA), 0.2% βcyclodextrin (Sigma), 10 μg/mL of vancomycin (Amresco), 2.5 U/mL of polymyxin B (Sigma), 5
μg/mL of trimethoprim (Sigma), and 5 μg/mL of amphotericin B (Amresco). Where required, 5%
sucrose was added to HBA for selection of sucrose sensitive strains. Liquid growth of H. pylori
was performed in Brucella broth (Neogen Corp) with 10% FBS and 10μg/mL of vancomycin. All
H. pylori cultures were grown under microaerobic conditions (5% O2, 10% CO2, and 85% N2) at
37°C with 100rpm shaking for liquid cultures. H. pylori strain G27 was used for all
experiments15. Escherichia coli Top10 cells were either grown on LB agar or in LB liquid
medium with shaking at 225rpm. Kanamycin (25μg/mL) and ampicillin (100μg/mL) were used
for bacterial selection.
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Table 3.3: List of primers in this study
Primers
Sequence (5’-3’)

Reference

HypA_Up_F

CCGCTTTGATTCAGATGGGGTG

This study

HypA_Up_R*

TCTAGAAGCTTGCGATCGCTCGAGACTCTAAAAGTCTCAAACGCGCTC

This study

HypA_Dn_F*

CTCGAGCGATCGCAAGCTTCTAGAGAATCTTTGGTGTGTAAAGACGC

This study

HypA_Dn_R

GCAAAACGCTGCGGTATTGC

This study

Kan_SacB_F*

GTGGGCTCGAGCCCGGGCGAACCATTTGAGGTGA

This study

Kan_SacB_R*

GCGCGTCTAGATATAAGCCCATTTTCATGC

This study

HypA_Confirm_F GGCTAACGAGCGTGGATAAG

This study

HypA_Confirm_R GCACTCACTAAAATCGTGGGC

This study

HypA_seq_F

CTAAAGCGGTAACCACATCCG

This study

L2_F

GGGGCTAATTTAAAGATTAAGGTTTAGTATGCTCCATGAATACTCGGTCG

This study

PhypA_R

GCGTTCAATTCTTCTTGCATCGGTTTTTATTCCGCTAACATTTCTAAAGAC

This study

HypA2_Up_F

GCGATTGAGCAAAACGGC

This study

HypA2_Up_R

ACTAAACCTTAATCTTTAAATTAGCCCC

This study

HypA2_Dn_F

AAACCGATGCAAGAAGAATTGAACGC

This study

HypA2_Dn_R

GGTTTTGGACTTGATAGAGCTTG

This study

HypA_L2*_F

CTCCATGAATACTCGGTCGTTTC

This study

HypA_L2*_R2

CGAGTATTCATGGAGCATATGTATATCTCC

HypA_C74A_F

GGTTGAATTAGAAGCCAAGGATTGTTCGCATGTTTTTAAGCCTAACGCG

9

HypA_C74A_R

CGCGTTAGGCTTAAAAACATGCGAACAATCCTTGGCTTCTAATTCAACC

9

HypA_C74D_F

GGTTGAATTAGAAGACAAGGATTGTTCGCATGTTTTTAAGCCTAACGCG

9

HypA_C74D_R

CGCGTTAGGCTTAAAAACATGCGAACAATCCTTGTCTTCTAATTCAACC

9

HypA_C77A_F

GAATTAGAATGCAAGGATGCTTCGCATGTTTTTAAGCCTAACGCGC

9

HypA_C77A_R

GCGCGTTAGGCTTAAAAACATGCGAAGCATCCTTGCATTCTAATT

9

HypA_C77D_F

GAATTAGAATGCAAGGATGATTCGCATGTTTTTAAGCCTAACGCGC

9

HypA_C77D_R

GCGCGTAGGCTTAAAAACATGCGAATCATCCTTGCATTCTAATTC

9

HypA_H79A_F

GCAAGGATTGTTCGGCTGTTTTTAAGCCTAACGCGCTAG

9

HypA_H79A_R

GTTAGGCTTAAAAACAGCCGAACAC

HypA_C91A_F

GCGCTAGATTATGGGGTGGCTGAGAAATGCCACAGC

9

HypA_C91A_R

GCTGTGGCATTTCTCAGCCACCCCATAATCTAGCGC

9

HypA_C91D_F

CGCCGTAGATTATGGGGTGGATGAGAAATGCCACAGC

9

HypA_C91D_R

GCTGTGGCACTTTCTCATCCACCCCATAATCTAGCGCG

9

HypA_C94A_F

GGTGTGTGAGAAAGCCCACAGCAAG

HypA_C94A_R

AACATTCTTGCTGTGGGCTTTCTCAC

HypA_C94D_F

GGGGTGTGTGAGAAAGACCACAGCAAGAATGTTATTATCAC

9

HypA_C94D_R

GTGATAATAACATTCTTGCTGTGGTCTTTCTCACACACCCC

9

HypA_H95A_F

GTGTGTGAGAAATGCGCCAGCAAGAATGTTATTATC

9

This study
, This study
, This study
, This study
, This study
, This study
, This study
, This study
, This study
, This study
This study
, This study
, This study
, This study
, This study
This study
This study
, This study
, This study
, This study

*Restriction enzyme sites are italicized (XhoI or XbaI)
Underline denotes nucleotide changes made to the pJI110 (wild type hypA) plasmid
Table combined from previous publications [Johnson, et. al. Metallomics, 7, 674-682 (2015) [11]
reproduced with permission of The Royal Society of Chemistry, and [Hu, et. al. Biochemistry, 56, 11051115 (2017) [14], copy right 2017 American Chemical Society.
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Table 3.4: List of plasmids and H. pylori strains in this study
Strains

Description

DSM1

G27 WT

DSM43

G27 ΔureB Kan

Reference
62
R

63

, This study

R

S

DSM1283

G27 hypA::kan-sacB Kan Suc

This study

DSM1295

G27 hypA restorant

This study

DSM1296

G27 hypA C74A

This study

DSM1297

G27 hypA C94D

This study

DSM1298

G27 hypA C91A

This study

DSM1299

G27 hypA C91D

This study

DSM1300

G27 hypA H95A

This study

DSM1301

G27 hypA C74D

This study

DSM1363

G27 hypA C77A

This study

DSM1364

G27 hypA C77D

This study

DSM1365

G27 hypA H79A

This study

DSM1366

G27 hypA C94A

This study

DSM1475

G27 hypA L2*

This study

Plasmids

Description

Reference

pDSM3

pKSF-II

64

pDSM32

pEJ22

63

pJI110

pET22b(+) vector with hypA WT coding sequence

8, 9

pET22b-HypA(C74A)

pET22b(+) vector with hypA C74A coding sequence

This study

pET22b-HypA(C74D)

pET22b(+) vector with hypA C74D coding sequence

This study

pET22b-HypA(C77A)

pET22b(+) vector with hypA C77A coding sequence

This study

pET22b-HypA(C77D)

pET22b(+) vector with hypA C77D coding sequence

This study

pET22b-HypA(H79A)

pET22b(+) vector with hypA H95A coding sequence

This study

pET22b-HypA(C91A)

pET22b(+) vector with hypA C91A coding sequence

This study

pET22b-HypA(C91D)

pET22b(+) vector with hypA C91D coding sequence

This study

pET22b-HypA(C94A)

pET22b(+) vector with hypA C94A coding sequence

This study

pET22b-HypA(C94D)

pET22b(+) vector with hypA C94D coding sequence

This study

pET22b-HypA(H95A)

pET22b(+) vector with hypA H95A coding sequence

This study

, This study

pET22b-hypA(L2*)
pET22b(+) vector with hypA L2* coding sequence
This study
Table combined from previous publications [Johnson, et. al. Metallomics, 7, 674-682 (2015) [11]
reproduced with permission of The Royal Society of Chemistry, and [Hu, et. al. Biochemistry, 56, 11051115 (2017) [14], copy right 2017 American Chemical Society.
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3.4.2

Mutant hypA Construction
Construction of H. pylori hypA strains were performed at the Merrell Lab, part of the

Department of Microbiology and Immunology at the Uniformed Services University of Health
Sciences, Bethesda, MD. H. pylori G27 genomic DNA was used as the template for mutant
construct development. A hypA mutant strain containing a kan-sacB cassette insertion was
constructed as follows. The HypA_Up_F and HypA_Up_R primers (Table 3.3) were used to
amplify a 556-base pair segment of DNA that spanned 398 base pairs upstream of hypA
(HPG27_832) and 158 base pairs into the hypA coding region. Additionally, the HypA_Dn_F and
HypA_Dn_R primers (Table 3.3) were used to amplify a 532-base pair region that began at
nucleotide position 160 of hypA and spanned 337 base pairs downstream of the hypA stop codon.
The HypA_Up_R and HypA_Dn_F primers were designed to contain identical flanking
sequences, which contained XhoI and XbaI restriction enzyme sites. Thus, the upstream and
downstream amplicons were next fused together utilizing splicing by overlap extension (SOE)
PCR65. The resulting spliced product was cloned into the pGEM-T easy vector (Promega) and
transformed into E. coli Top10 cells. The kan-sacB cassette64, which confers resistance to
kanamycin and sensitivity to sucrose, was amplified from pKSF-II64 using primers Kan_SacB_F
and Kan_SacB_R, which were designed to incorporate a XhoI and XbaI restriction site,
respectively. The resulting fragment was digested with XhoI and XbaI and was then inserted
between the spliced hypA fragments that had been similarly digested. The resulting construct was
then transformed into H. pylori G27 and transformants were selected on HBA plates containing
kanamycin. Successful insertion of the kan-sacB cassette into the hypA gene was confirmed by
PCR and sequencing using the HypA_Confirm_F/R and HypA_seq_F/R primers, respectively.
The resulting mutant strain was named DSM1283.
3.4.3

Site-directed mutagenesis
Site-directed mutagenesis constructed within pET-22b(+) vectors for the purpose of

protein overexpression were performed at the Maroney Lab, part of the Department of Chemistry
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and Program of Molecular and Cellular Biology at the University of Massachusetts Amherst,
Amherst, MA. Mutagenesis performed within the G27 H. pylori genome were performed at the
Merrell Lab, part of the Department of Microbiology and Immunology at the Uniformed Services
University of Health Sciences, Bethesda, MD.
Mutations of the cysteines in the HypA CXXC motifs (Cys71, Cys74, Cys91 and Cys94)
to alanine or aspartic acid and the flanking histidines (His79 and His95) to alanine were
constructed by polymerase chain reaction (PCR) using the PJI110 plasmid (wild type hypA
sequence carried on the pET-22b(+) vector, Table 3.4) as a template.66 The PJI110 plasmid was
transformed into NovaBlue (Novagen) competent cells and then re-isolated using the Axyprep
Plasmid MiniPrep Kit (Axygen) and used as the DNA template in all subsequent PCR reactions.
PCR primers were designed to incorporate the desired mutations and are listed in Table 3.3.
Reactions were carried out in 50μL volumes using 1ng of template DNA and 2.5ng or 2μM of
each primer per reaction. Successful PCR amplifications were confirmed by 0.8% agarose gel
electrophoresis, and then methylated PJI110 template was digested with 20 units of DpnI (New
England Biolabs) for 1 hour at 37C. The resulting PCR mixture was transformed into NovaBlue
competent cells. Single colonies were selected and grown to saturation in 5mL liquid cultures of
LB-Miller (Fisher Scientific) media supplemented with ampicillin at 37C. Cells were pelleted by
centrifugation at 6,000 g for 5 minutes and plasmids were isolated using the Axyprep Plasmid
MiniPrep Kit. Successful mutations were confirmed by plasmid sequencing (GENEWIZ, Inc.)
and listed in Table 3.4
The L2* mutation was also constructed on the PJI1108 plasmid background using two
rounds of sequential polymerase chain reactions (PCR) with the Q5 High-Fidelity DNA
polymerase (New England Biolabs). In the first round of PCR, 0.5μM of HypA_L2*_F primer
(Table 3.3) was used to amplify the forward strand of the template DNA containing the L2*
mutation. The second primer, HypA_L2*_R2 (Table 3.3), was added to the product of the first
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round of PCR mixture for a second round of PCR to amplify the complimentary strand of the
DNA template. The presence of linear double stranded PCR product was confirmed by 0.8%
agarose gel electrophoresis. The resulting mixture was digested with DpnI (New England
Biolabs) for 1 h at 37˚C to remove methylated PJI110 plasmid DNA, and then ligated for 30 min
at 25˚C using T4 ligase (New England Biolabs). The resulting reaction mixture was transformed
into NovaBlue (Novagen) competent cells and multiple single colonies were isolated from LBAgar plates supplemented with 100 μg/mL ampicillin (Amp) and then amplified in liquid
cultures. The mutated plasmid DNA from three separate single colonies were purified using the
GeneJET plasmid DNA miniprep kit (Thermos Scientific) and then sequenced (Genwiz) to
confirm the presence of the L2* mutation and successful creation of the pET22b-hypA(L2*)
plasmid (Table 3.4) for this study.
We utilized the wild-type or mutant HypA pET-22b (+) plasmids, which each contained
the entire HypA coding region, to move the mutant constructs of interest into the H. pylori
chromosome. Each of the constructs was individually transformed into DSM1283, and double
crossover events in which the kan-sacB cassette was replaced by the mutagenized hypA gene
carried on the pET-22b (+) vector were selected for based on sucrose resistance. Sucrose resistant
transformants were screened for kanamycin sensitivity and proper integration of the hypA
construct was confirmed by PCR and sequencing using the HypA_Confirm_F/R and
HypA_seq_F/R primers, respectively. In total, H. pylori mutant strains were made that contained
the following hypA mutations (Table 3.4): C74A (DSM1296), C74D (DSM1301), C77A
(DSM1363), C77D (DSM1364), H79A (DSM1365), C91A (DSM1298), C91D (DSM1299),
C94A (DSM1366), C94D (DSM1297), and H95A (DSM1300). In addition, a hypA-restorant
(hypA-R; DSM1295) in which the kan-sacB cassette was replaced by the wild type hypA gene
was also created in order to control for any defects that may have resulted due to genetic
manipulation.

90

The L2*-hypA mutant, which contains a leucine insertion in between the methionine and
histidine in the conserved MHE nickel binding motif, was constructed in a similar fashion with
slight modifications.11 Briefly, the hypA gene containing the L2* mutation was initially PCR
amplified from the pET22b-hypA(L2*) vector with the L2_F and PhypA_R primers (Table 3.3),
which were each designed to have extensions to be used in subsequent splicing by overlap
extension (SOE) reactions.67 To increase the likelihood of recombination events before and after
the 2nd amino acid position of L2*-hypA, a 442 base pair upstream DNA fragment and a 451
base pair downstream DNA fragment were added to either end of the mutated hypA amplicon
using SOE PCR.67 Wild type H. pylori G27 (DSM1) genomic DNA was used as template to PCR
amplify the upstream and downstream regions using the HypA2_Up_F / HypA2_Up_R and
HypA2_Dn_F / HypA2_Dn_R primer pairs, respectively. These products were then spliced to the
L2*-hypA fragment by SOE reaction. The resulting “upstream-L2*-hypA-downstream” SOE
construct was then transformed into the interrupted hypA mutant (DSM1283). Replacement of the
kan-sacB cassette in DSM1283 with the mutated hypA gene was selected for by plating on HBA
agar containing 5% sucrose. Sucrose resistant colonies were subsequently screened for
kanamycin sensitivity. Proper integration of the mutated hypA gene was confirmed by PCR and
sequencing using the HypA_Confirm_F and HypA_Confirm_R primers and HypA_seq_F and
HypA_seq_R primers. The newly created L2*-hypA strain was named DSM1475 (Table 3.3).
3.4.4

Acid resistance testing
Acid survival of G27 background strains of H. pylori were performed at the Merrell Lab,

part of the Department of Microbiology and Immunology at the Uniformed Services University
of Health Sciences, Bethesda, MD. Each of the ten hypA Zn site H. pylori mutants were tested for
acid resistance. Additionally, the wild type H. pylori strain, the hypA::kan-sacB mutant, and the
hypA restorant were included as controls. Furthermore, a urease-deficient mutant of H. pylori
(DSM43) in which the kanamycin resistance cassette replaced the ureB subunit was used as a
positive control for acid sensitivity; DSM43 was created by transforming wild type H. pylori with
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vector pEJ22 as previously described.17 Assays were conducted as follows: 20mL liquid cultures
of H. pylori were inoculated to an optical density (600nm) of 0.05 from overnight liquid grown
bacterial cells and then allowed to grow for approximately 19 hours. 1mL aliquots were removed
from the culture and pelleted by centrifugation. The supernatants were removed and the bacterial
pellet was re-suspended in 1mL of phosphate buffered saline (PBS) at pH 6 or 2.3, with or
without supplementation with 5mM urea. Immediately after the bacterial pellets were resuspended, an aliquot was removed, serially diluted in Brucella broth and plated on HBA plates
to determine colony forming units (CFU) per milliliter. The cultures were then incubated in
1.5mL capped tubes for 1 hour at 37°C. At this point, a second aliquot was removed from the
cultures, immediately serially diluted, and plated to determine CFU/mL as described above.
Percent survival after 1-hour incubation in the various PBS solutions was determined for each
bacterial strain. At least three biological replicates were performed for each strain.
Additionally, the L2*-hypA mutant (DSM1475), Wild type G27 (DSM1), the interrupted
hypA mutant (DSM1283), the hypA restorant (DSM1295), and urease-deficient mutant of H.
pylori (DSM43) was tested for acid survival as described above. At least three biological
replicates were performed for each strain. Furthermore, to ensure reproducibility, a second,
biologically independent L2* hypA mutant was created in H. pylori G27 in an identical fashion as
described above and tested for acid viability also. Similar phenotypes were found for each
independently derived strain.
3.4.5

Urease activity
Urease activities were determined for each of the ten hypA Zn site variants, the wild type

H. pylori strain, the hypA::kan-sacB mutant, and the hypA restorant strain. For each strain, 8mL
liquid cultures of H. pylori were inoculated to an optical density (600nm) of 0.05 from overnight
liquid grown bacterial cells and then allowed to grow for approximately 22 hours. At that point,
1mL aliquots were removed from the culture and pelleted by centrifugation (~108 cells). The
supernatants were removed and the bacterial pellets were stored at -20C until ready for urease
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assays. The frozen cells were thawed and then re-suspended in 750μL of ice-cold HEPES buffer
(pH 7.0), 1mM phenylmethylsulfonyl fluoride (PMSF) (MP Biomedicals, LLC), and 1X protease
inhibitor cocktail (Sigma-Aldrich) and then lysed by sonication at 70% power for 6 pulses (2second each) on ice. Lysate was centrifuged at 15,000-g for 10 minutes to remove insoluble
fractions from soluble whole cell extracts. Soluble whole cell extracts were kept at 4C for up to
one month and insoluble fractions were stored at -20C. Total protein concentration in soluble
whole cell extract was assessed by Bradford Assay using the Coomassie Protein Assay Kit
(Thermo Scientific).
Urease activities for each strain were determined using a modified phenol-hypochlorite
method to assay the amount of ammonia released in the soluble whole cell extract of H. pylori
lysate in the presence of urea68, 69_ENREF_24. For each strain, 5μL of whole cell extract was
added to 245μL of urease reaction buffer (50mM HEPES, 25mM Urea, pH 7.0), and incubated at
37C for 20 minutes to allow for ammonia production. The reaction was quenched with the
sequential addition of 375μL of phenol-hypochlorite buffer A (100mM phenol, 167.8μM sodium
nitroprusside) and then the addition of 375μL of phenol-hypochlorite buffer B (125mM NaOH,
0.044% NaClO); samples were mixed with quick vortexing after the addition of each buffer. The
assay mixture was incubated at 37C for 30 minutes to allow for color development (the
conversion of ammonia to indophenol) and the absorbance was evaluated at 625nm. Assays were
performed alongside a standard curve created using known amounts of ammonium chloride (0.24
– 500nmol) in place of whole cell extract.
The urease activity of ΔureB strain was set as background and subtracted from the
activity of each hypA Zn site variant and corresponding control strains. After background
subtraction, the relative urease activity (% hypA-R) of the hypA Zn site variants and
corresponding control strains were normalized to the hypA-restorant (hypA-R; DSM1295) H.
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pylori as 100%. All experiments were performed in triplicate with two independently grown
cultures.
The urease activities of the L2*-hypA mutant (DSM1475) and corresponding control
strains: Wild type G27 (DSM1), the interrupted hypA mutant (DSM1283), the hypA restorant
(DSM1295), and the urease-deficient mutant ΔureB (DSM43) was performed as a separate group
as described above and then normalized using an alternate method. The total protein
concentration of whole cell extracts was determined by Bradford assays using the Pierce
Coomassie Protein Assay Kit (ThermoFisher Scientific). The specific urease activity was
determined by calculating the nmol of ammonia produced per μg of total protein in each whole
cell extract. Relative specific activity (%WT) of the L2*-hypA strain and corresponding control
strains were determined by normalizing the specific activity against wild type as 100%. All
experiments were performed in triplicates with two independently grown cultures, each
displaying similar relative specific activity.
3.4.6

Hydrogenase activity

H2ase activities for hypA Zn site variant strains, L2*-hypA variant strains, and accompanying
controls were performed as described in CHAPTER 2, Section 2.4.3.
3.4.7

Protein overexpression and purification
Sequence-confirmed PJI110 or pET22b-hypA(L2*) plasmid was transformed into

DL41(DE3)pLysS70 competent cells and then plated on LB-Agar plates supplemented with Amp
and chloramphenicol (Cam), and stored at 4 ˚C and used for protein overexpression for up to one
month. A single colony from the plate was transferred to 150 mL of 25 g/L sterilized liquid LB
Miller media (LabExpress) supplemented with Amp and Cam and grown at 37 ˚C with shaking
(200 rpm) until saturation (>6 h). The culture was scaled up to 2 L of sterilized liquid LB media
supplemented with Amp by inoculation with 20 mL of the saturated culture followed by growth
at 37 ˚C and 200 rpm until the OD600 was ~0.6 (approximately 3.5 h). The cells were then induced
to overexpress protein by the addition of 0.8 mM of isopropyl β-D-1-thiogalactopyranoside
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(IPTG) (Carbosynth Limited) for 3 h. The culture was then harvested by centrifugation at 5,500 x
g for 8 min and then resuspended in Buffer QA (20 mM Tris, 1 mM TCEP, pH 7.2) at a final
volume of 10 mL per liter of culture grown. A final concentration of 1 mM phenylmethylsulfonyl
fluoride (PMSF) protease inhibitor was added to the resuspended culture and then stored at -80 ˚C
for up to one year.
Cells were thawed in a 37 ˚C water bath, and were lysed upon one freeze-thaw cycle due
to the expression of T7 lysozyme from the pLysS plasmid from the cell line. Upon thawing, 2
mM of PMSF was added to the cell lysate and then genomic DNA from the lysate was clarified
by the addition of 20 μL of 10 mg/mL DNase I (Worthington) per liter of cell culture followed by
digestion for 30 min at 37 ˚C in a water bath. The lysate was clarified by centrifugation at 15,000
x g for 30 min, and the soluble protein was separated from the pellet and then filtered through a
0.22 μm membrane filter prior to purification.
An AKTA FPLC (GE Healthcare) was used to purify HypA protein from clarified cell
lysate using a three-column protocol. In the first step, clarified lysate from 3 L of cell culture was
combined and then diluted to 50 mL using Buffer QA. This was applied to a Q Sepharose Fast
Flow (GE Healthcare) column (12 mL geometric column volume) that had been washed with
Buffer QB (20 mM Tris, 1 M NaCl, 1 mM TCEP, pH 7.2) and then equilibrated with Buffer QA.
The column was washed with four column volumes of 3% Buffer QB, and then the bound protein
was eluted using a linear gradient of 3 – 30% Buffer QB over 10 column volumes, with the HypA
protein eluting off the column at 15 – 23% Buffer QB. The remaining bound protein was
removed by an additional 5 column volumes of 100% Buffer QB prior to re-equilibrating the
column for more purification. Fractions from the Q Sepharose column that contain HypA protein
were identified by 16% SDS-PAGE, and then pooled together for further purification.
Two additional columns were used to concentrate and then purify the HypA protein. The
fractions from the Q Sepharose column that contained HypA were diluted to 50 mL (~3 times

95

dilution) with Buffer QA, and then applied onto a pre-packed 1 mL HiTrap QXL column (GE
Healthcare) pre-washed with Buffer QB and then equilibrated with Buffer QA. The column was
washed with 5 column volumes of 7% Buffer QB to remove loosely bound protein, and then
HypA and other proteins were eluted in a single 3 mL fraction with 50% Buffer QB. The
concentrated HypA proteins were further purified by using the HiLoad 16/60 Superdex 75 Prep
Grade (GE Healthcare) gel filtration column (120 mL geometric column volume) pre-equilibrated
with Buffer GF (20 mM HEPES, 200 mM NaCl, 1 mM TCEP, pH 7.2). HypA separates from
other cellular proteins in a resolved peak centered around 95 mL. The purity of the HypA protein
was confirmed by 16% SDS-PAGE and quantified using the Odyssey CLx Imaging System (LICOR). Only protein samples with greater than 90% purity were used for experiments. The
expressions of the desired HypA proteins were confirmed by LC-MS using an Agilent 1100
HPLC with a BioBasic-8 column (Thermo Scientific) and a QSTAR XL MS/MS system (Applied
Biosystems). The theoretical mass of WT-HypA protein is 13202.2 Da and the experimental mass
was determined to be 13202.03 Da. The theoretical mass of L2*-HypA protein is 13315.3 Da and
the experimental mass was determined to be 13315.21 Da.
The concentration of HypA proteins in buffer was determined by the absorption at 280
nm using and extinction coefficient of 3250 M-1 cm-1 per monomer (previously determined by
amino acid analysis as 6500 M-1 cm-1 per dimer23) using a Agilent/HP 8453 UV-Vis
spectrophotometer. The metal content of purified HypA proteins was analyzed by ICP-OES and
confirmed to contain approximately one zinc per protein for both WT- and L2*-HypA.
3.4.8

XAS sample preparation and data collection
Nickel complexes of HypA for XAS were prepared in Buffer XBr (20 mM HEPES, 200

mM NaBr, 1 mM TCEP, pH 7.2) or Buffer GF unless otherwise noted. For samples prepared in
Buffer XBr, purified HypA proteins (>90% pure by SDS-PAGE) were diluted to between 100 –
250 μM in concentration (1.5 – 4 mL in volume) and then rapidly buffer exchanged into Buffer
XBr using two consecutive 10 mL Zeba Spin Desalting columns with 7-kDa MWCO (Thermo
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Fisher Scientific) and pre-equilibrated with Buffer XBr. The concentration of the HypA protein in
Buffer XBr was measured again to account for any sample loss or dilution.
The metal content of a 10 mM Ni(OAc)2 stock solution was confirmed by ICP-OES and
then used for reconstituting the HypA protein in the desired buffer. A total of two molarequivalents of Ni(OAc)2 from the stock was added to the HypA protein in four aliquots at room
temperature, allowing for 15 – 20 min equilibration between additions and an additional 30 min
after the final metal addition to allow for proper metal binding. Chelex 100 (sodium form, Sigma)
resin was added to the Ni-HypA complex at equal volume to the protein and gently agitated at
room temperature for 45 min to remove any unbound Ni(II) ions from solution. The Ni-HypA
complex was removed from the resin either by pipette or by filtration through a 0.22 μm
membrane filter. The resulting Ni-HypA complex was concentrated using Amicon Ultra-0.5 mL
3-kDa MWCO (EMD Millipore) at 10,000 x g to 1 – 3 mM. The exact concentration of the HypA
protein in the concentrated Ni-HypA complex was determined by absorption at 280 nm after
treating with 15 mM EDTA for 10 min at 60˚C. The final metal content of the Ni-HypA complex
was measured by ICP-OES and used to calculate the final Ni:Zn:HypA ratios, which were
1.1:1.0:1 for WT-HypA in Buffer XBr; 0.63:1.2:1 for WT-HypA in Buffer GF; 0.8:1.4:1 for L2*HypA in both Buffer XBr and Buffer GF. The Ni content of the final flow through from Ni-HypA
centrifugal concentrating was analyzed by ICP-OES and determined to be at least 500-folds less
than the concentration of Ni in the Ni-HypA complex in each sample. The Ni-HypA complexes
were mixed with sterile 80% glycerol to a final glycerol concentration of 11 – 15% as a glassing
agent. The samples were loaded into Kapton-taped polycarbonate sample holders and then rapidly
frozen in liquid nitrogen and then stored at -80˚C until ready for XAS data collection.
XAS at the Ni and Zn K-edges of WT- and L2*-HypA in Buffer XBr were collected at
the National Synchrotron Light Source (NSLS) of the Brookhaven National Labs using the
dedicated ring conditions and optics at beamline X3B. Ni and Zn K-edges of WT-HypA in Buffer
GF were collected at the Stanford Synchrotron Radiation Lightsource (SSRL) at the SLAC
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National Accelerator Laboratory using the dedicated ring conditions and optics at beamline 7-3.
For XAS collected at NSLS, data were collected on frozen samples in kapton-taped
polycarbonate holders immobilized in an aluminum sample clamp under vacuum and cooled to
~40 K with a helium displex cryostat. XAS was collected under ring conditions of 2.8 GeV and
120 – 300 mA with a sagittally focused Si (111) double crystal monochromator. X-ray
fluorescence was collected with a 31-element Ge fluorescence detector (Canberra) with a 3 μm Z1 filter installed between the detector and the sample to minimize scattering.
For XAS data collected at SSRL, frozen samples in kapton-taped polycarbonate holders
were immobilized by aluminum prongs and cooled to ~10 K using a liquid helium cryostat. XAS
was collected under ring conditions of 3 GeV and 450 – 500 mA with a Si (220) double-crystal
monochromator. X-ray fluorescence data were collected with a 30-element Ge detector
(Canberra) with a 3 μm Z-1 filter and Soller slits installed between the detector and the sample to
minimize scattering.
X-ray fluorescence data for Ni and Zn K-edges of WT- and L2*-HypA were collected
concurrently with the relevant metal foil in transmission mode for energy calibration. X-ray
Absorption Near Edge Structure (XANES) data were collected from -200 to +200 eV relative to
the metal K-edge, and Extended X-ray Absorption Fine Structure (EXAFS) were collected to 15k
above the K-edge.
3.4.9

XAS data reduction and analysis
XAS data processing and normalization were performed using the Sixpack71 software

package for the Ni K-edge and the Athena program (part of the Demeter72 suite of XAS analysis
software package) for the Zn K-edge spectra. The data are an average of 8 – 10 scans at the Ni Kedges and 5 – 8 scans at the Zn K-edges. Fluorescence channels from each scan were visually
scrutinized and bad channels were deleted. K-edge energy calibrations were performed for each
scan by assigning the first inflection point in the first-derivative spectra of the metal foils to
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8331.6 eV for Ni and 9660.7 eV for Zn. Additional energy alignments were performed for Zn Kedge spectra by aligning each subsequent scan of the Zn foil to the first scan using the auto align
feature of Athena to correct for apparent monochromator slipping. The fluorescence channels
from all scans were averaged, and the averaged spectra were normalized using the AUTOBK73
algorithm. The normalization and background correction routine involved setting the K-edge
energy (E0) to 8340 eV for Ni and 9670 eV for Zn with a Rbkg of 1 and a k-weight of 3, and then
normalizing the edge step to 1 between the pre-edge and post-edge. A linear or Gaussian function
was used for fitting the pre-edge range of -200 to -50 eV and quadratic functions were used for
fitting the post-edge range of -50 to +860 eV relative to E0. The data were converted to k-space
1

using the relationship 𝑘 =

2𝑚 (𝐸−𝐸 ) 2
[ 𝑒 2 0],
ℏ

where 𝑚𝑒 is the mass of the election and ℏ is Plank’s

constant divided by 2π. The EXAFS data were extracted by setting a polynomial spline with 7 – 8
knots between the k range of 2 – 14 Å-1, resulting in χ(k) data. The χ(k) data for Ni K-edge data
or the normalized and background corrected spectra for Zn K-edge data were exported for further
analysis and fitting using the Artemis program (part of Demeter72).
The XANES region of the Ni spectra were analysis for pre-edge peak areas using
EXAFs12374 as previously described.12 Briefly, the baseline of the spectra were fitted with cubic
function with the edge jump fitted to a 75% Gaussian and 25% Lorenzian function. Transitions
occurring prior to the edge jump (~8 eV below E0) were taken as the 1s3d transition and fitted
with a Gaussian function with the area under the curve taken as the pre-edge peak area.
Additionally, 1s  4pz transitions were observed in some spectra but were not fitted accurately
due to overlap with the rising edge.
EXAFS analysis were performed using the Artemis72 software, which employs the
IFEFFIT75 engine to fit scattering paths to the conventional EXAFS equation (below) using phase
and amplitude parameters generated by FEFF676:
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𝜒(𝑘) = ∑𝑗

𝑁𝑗 𝑓𝑗 (𝑘)𝑒

−2𝑘2 𝜎2
𝑗

𝑘𝑟𝑗2

sin[2𝑘𝑟𝑗 + 𝛿𝑗 (𝑘)]

Eq. 3.1

With respect to the neighbor scattering atom, f(k) is the scattering amplitude, and δ(k) is the
phase-shift; r is the distance σ2 is the mean-square disorder of the distance; N is the coordination
number.
All data sets were fitted in r-space, where the χ(k) data were Fourier-transformed using
the Hanning window function for k range of 2 – 14 Å-1. For each model, an amplitude correction
factor (S02) set to 0.9 and a single value of E0 was used, with the adjustable parameter of ΔE0 at an
initial value of 0 eV. A systematic combination of Ni-N/O, Ni-S, and Ni-Br scattering paths at
distances (reff) between 1.8 and 2.3 Å were fitted to the data for approximation of the first
coordination sphere. For each shell of scattering paths in a fit model, separate sets adjustable
parameters: Δreff and σ2 were used, with initial guess values of 0 Å and 0.003 Å2 respectively.
The r-space data were fit to models built using a bottom-up approach that involved
systematic combinations of integer numbers of N- and S-donor ligands, as well as possible Br- or
Cl- ligation from the buffer. A total of up to seven ligands were fitted in the r = 1 – 2.5 Å range
(roughly the first coordination sphere) using these combinations. The best fits from the first
coordination combinations were then further refined by adding scattering atoms in the second and
third coordination spheres that are ordered by metal-ligand bonds, and fit using multiplescattering parameters to arrive at the best statistical (based on the R-factor, reduced 2, and 2)
and scientifically sound fits. The best fits for the Ni site of HypA in XBr buffer were selected
from an accumulation of 298 and 426 individual fits for WT and L2* respectively. The best fits
for the Ni site of L2*-HypA in Buffer GF (NaCl) were selected from 309 individual fits.
Multiple-scattering ligands include His imidazoles and five-membered chelate rings that
form when two adjacent backbone amide N-donors are ligated from the protein (BBAm).
Multiple-scattering paths for imidazoles and BBAm five-membered chelate rings were calculated
from coordinates obtained from high resolution protein crystal structures (less than 1.4 Å) from
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the protein data bank (PDB). For each Ni-imidazole or Ni-BBAm FEFF calculation, scattering
paths with amplitude ratio greater than 15% were used for fitting. Calculated multiple-scattering
paths from either imidazole or BBAm shared the same adjustable distance (Δreff) and disorder (σ2)
parameters, effectively treating the entire multiple-scattering scaffold as a rigid entity where all
the atoms move together as a unit. Due to this rigid treatment of fitting His-imidazole ligands, a
change in angle of Ni-imidazole binding may cause dramatic changes in the disorder parameter
(σ2) associated with the scattering scaffold. To compensate for this, metal-imidazole scattering is
fitted using FEFF paths calculated for imidazole binding at two different tilt angles (α) with
respect to the absorbing metal. Ni-imidazole with tilt angles of 0˚ and 7˚ were obtained from PDB
ID 1Q5Y,36 as depicted in Figure 3.6, and Zn-imidazole at α=2˚ and α=8˚ originated from PDB
ID 1Q0E.77 With ordered atoms at three bonds away from the absorber, metal-imidazole
scattering have characteristic intensities visible at ~4Å in the non-phase corrected r-space data,
which is absent from multiple scattering from bidentate backbone amide binding (see Figure 3.6).
Therefore, a separate FEFF calculation was performed to generate multiple scatting paths for
bidentate binding of backbone amides from the polypeptide chain to the Ni absorbing atom (NiBBAm) using coordinates originated from PDB ID 1T6U37 (Figure 3.7). The number of Hisimidazoles bound to the absorbing metal atom is increased by integer numbers using the same
bottom-up approach to improve the final fitting model. The Ni-BBAm multiple scattering
scaffold was used to replace of two Ni-N/O ligands in select fits to improve/refine the final fitting
model.
To evaluate goodness of fit between different fitting models, IFEFFIT minimizes three
different fit parameters: R-factor, χ2, and Reduced χ2. The R-factor evaluates the misfit relative to
the data size and is defined as:
2

𝑅=

2

∑𝑁
𝑖=1{[𝑅𝑒(𝜒𝑑𝑎𝑡𝑎 (𝑟𝑖 )−𝜒𝑚𝑜𝑑𝑒𝑙 (𝑟𝑖 ))] +[𝐼𝑚(𝜒𝑑𝑎𝑡𝑎 (𝑟𝑖 )−𝜒𝑚𝑜𝑑𝑒𝑙 (𝑟𝑖 ))] }
2

2

∑𝑁
𝑖=1{[𝑅𝑒(𝜒𝑑𝑎𝑡𝑎 𝑖 (𝑟𝑖 ))] +[𝐼𝑚(𝜒𝑑𝑎𝑡𝑎 (𝑟𝑖 ))] }
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Eq. 3.2

Where 𝜒(𝑟𝑖 )is the Fourier-transformed EXAFS data or model function, Re( ) is the real, and Im( )
is the imaginary parts of the EXAFS Fourier transform. The R-factor is directly proportional to
the statistical parameter χ2 and related to the Reduced χ2, which are defined as:
𝜒2 =

𝑁𝑖𝑑𝑝
𝑁𝑝𝑡 𝜀2

2

2

∑𝑁
𝑖=1 {[𝑅𝑒(𝜒𝑑𝑎𝑡𝑎 (𝑟𝑖 ) − 𝜒𝑚𝑜𝑑𝑒𝑙 (𝑟𝑖 ))] + [𝐼𝑚(𝜒𝑑𝑎𝑡𝑎 (𝑟𝑖 ) − 𝜒𝑚𝑜𝑑𝑒𝑙 (𝑟𝑖 ))] }
𝑅𝑒𝑑𝑢𝑐𝑒𝑑 𝜒 2 =

𝜒2
𝑁𝑖𝑑𝑝 −𝑁𝑣𝑎𝑟

𝑁𝑖𝑑𝑝 is the number of independent data points defined as 𝑁𝑖𝑑𝑝 ≅

Eq. 3.3
Eq. 3.4

(2Δ𝑟Δ𝑘)⁄
𝜋, with Δr as the

fitting range in r-space, Δk is the fitting range in k-space. 𝑁𝑝𝑡 is the number point in the fitting
range, 𝜀 is the estimated uncertainty of the data, and 𝑁𝑣𝑎𝑟 is the number of adjustable parameters
in the model. R-factor and Reduced χ2 were both considered in comparing different models fit to
the same χ(r) data. Whereas increasing the number of adjustable parameters would generally
improve the R-factor, the Reduced χ2 would go through a minimum and then increase indicating
the model is overfitting the data.75
3.4.10 Isothermal titration calorimetry (ITC)
ITC was used to measure the heat released by Ni-binding to HypA proteins, and the
protein-protein interactions between HypA and UreE using the Auto-ITC200 (Microcal/Malvern).
The instrument has a cell volume of 200 μL and a syringe volume of 40 μL, which were filled by
robotic arms from plates stored at 4˚C prior to the start of the experiment. All titrations were
performed in Buffer GF (20 mM HEPES, 200 mM NaCl, 1 mM TCEP, pH 7.2) at 25˚C with the
reference cell filled with Buffer GF. All purified proteins (WT- and L2*-HypA and WT-UreE)
used for titrations were confirmed to be greater than 90% pure by SDS-PAGE. Concentrated
proteins were rapidly buffer exchanged into Buffer GF using 0.5 mL Zeba Spin Desalting
columns with 7-kDa MWCO pre-equilibrated with Buffer GF and then diluted to the appropriate
concentration as needed for titration immediately before ITC experiments. The Zn:HypA ratios
were confirmed by ICP-OES to be between 0.8 – 1.0 in all proteins used for ITC, and metal:WT-
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UreE ratio were confirmed to be less than 0.05 (Ni or Zn) in all ITC experiments. For Ni to HypA
titrations, NiCl2 was dissolved in MilliQ water from a 500-mM stock solution and then diluted
into Buffer GF at the appropriate concentrations for ITC experiments (~1.5 – 2.5 mM). The exact
concentrations of Ni in Buffer GF used for titrations were confirmed by ICP-OES and used for
fitting the data.
For each ITC experiment, 20 injections were made from the syringe into the cell and the
change in heat was monitored by the instrument. The initial injection contained only 0.4 μL and
was used to minimize the equilibration artifacts sometimes observed with the first injection and
was not included in fitting the data. All subsequent injections at 2.0 μL each were used for fitting
the titration curve in each experiment. For Ni titration into WT-HypA, the spacing between
injections were set to 1,500 sec due to initial observations of a slow return to baseline. For Ni
titration into L2*-HypA the spacing between injections were reduced to 600 sec. For WT-HypA
or L2*-HypA titrations into WT-UreE dimer, the spacing between injections were further reduced
to 240 sec. Experimental titrations were accompanied by corresponding reference/control
titrations of the titrants (either Ni or HypA protein) into Buffer GF in the cell, the resulting heats
of which were used to establish the corresponding baseline corrections used for fitting the ΔH
data. Experimental titrations were performed at least twice using separately prepared proteins and
each produced similar result.
The resulting data were fitted using the MicroCal analysis module in Origin7.0. First, the
heat released from titration experiments were baseline corrected and then integrated to produce
the corresponding ΔH curve. The ΔH curve for each experiment was corrected by subtracting the
average ΔH from the reference titration. The ΔH curve was fitted with the OneSite model to find
the apparent Ka (multiple fitting models were attempted for each set of experimental data and in
each case the OneSite model produced the best 2 value). The apparent Kd values reported are the
inverse of the Ka values obtained from each fit.
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3.4.11 UV-Vis absorption for Ni-HypA titration
For Ni-titration into Apo-ZnHypA protein monitored by UV-Vis, a series of samples
were prepared with equal concentration of HypA protein (~50 μM) and varying concentrations of
Ni (400 – 1 μM) in Buffer UV (20 mM HEPES, 200 mM NaCl, pH 7.2). First, concentrated ApoZnWT-HypA and L2*-HypA were rapidly desalted into Buffer UV and the Zn:HypA ratio were
confirmed by ICP-OES to be 0.8 in each sample. Proteins were diluted to ~50-70 μM using
Buffer UV and then equal volumes were distributed to separate 1.7-mL centrifuge tubes. The
NiCl2 used for the experiment was diluted to 10 mM in Buffer UV (from a 500-mM stock in
water), with the actual concentration of the Ni confirmed by ICP-OES. Decreasing concentrations
of Ni in Buffer UV were serially diluted (2:3 and 1:1) from the 10-mM stock. For WT-HypA, 5
μL of the serially diluted NiCl2 solution was added to 115 μL of ~50 μM producing a 12-point
dilution series with the final Ni concentration ranging from 400 μM to 1.10 μM. For L2*-HypA,
30 μL of the serially diluted NiCl2 solution was added to 90 μL of ~70 μM of protein 15-point
dilution series with Ni concentration ranging from 2.4mM to 1.48 μM (Ni-L2*-HypA samples
beyond 271 μM precipitated prior to data collection). Equal volumes of Buffer UV alone were
added to each respective HypA aliquot to produce the Apo-ZnHypA background in each series.
From this, the final concentration of WT- and L2*-HypA in the Ni-titration series were
determined to be 49.1 μM and 51.9 μM respectively. All samples were gently agitated at room
temperature for one hour prior to UV-Vis measurement using an Agilent/HP 8453 UV-Vis
spectrophotometer. The respective Apo-ZnHypA spectra of the of WT- and L2*- were subtracted
from each of the spectra in the Ni-HypA titration series producing the difference spectra with Nidependent increases in absorption observed at 269 nm and 244 nm, respectively. These Δabsorbance for Ni-WT- and Ni-L2*-HypA were graphed against the concentrations of Ni in each
dilution series to produce the titration curve. The titration curve was fitted with the quadratic from
of the mass action function using the following equation:
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𝑓(𝑀) = 𝑃𝑓𝑟𝑒𝑒 +

𝑃𝑀−𝑃𝑓𝑟𝑒𝑒
2

∗ (𝑃 + 𝑀 + 𝐾𝑑 − √(𝑃 + 𝑀 + 𝐾𝑑 )2 − 4 ∗ 𝑃 ∗ 𝑀)

Eq. 3.5

with the adjustable parameters of M as the concentration of Ni, Pfree is the fraction of ApoZnHypA, PM is the fraction of Ni-ZnHypA, and P is the concentration of total HypA (which is
constant and fixed to 49.1 and 51.9 μM for WT and L2*-HypA respectively). Leaving the
apparent dissociation constant, Kd, as the only unknown in the equations.
3.4.12 Magnetic susceptibility
Magnetic susceptibility of the Ni binding site in WT-HypA and L2* protein was assessed
by Evans method with slight modification from previously described.8 All samples and standards
were prepared in a D2O buffer containing 20 mM HEPES, 200 mM NaCl, 1mM TCEP, pD 7.1,
filtered (0.22 μm membrane). NiCl2 in buffer was used as a paramagnetic standard and
K2Ni(CN)4 in buffer was used as a diamagnetic standard to determine the effective magnetic
moment (μeff) from 1mM of paramagnetic Ni(II). Protein samples were prepared by buffer
exchanging the WT- or L2*- Apo-ZnHypA protein into the D2O buffer. Metallation of proteins
were performed as described in the XAS sample preparation (Section 3.4.8) using NiCl2 stocks
dissolved in D2O buffer, and then concentrated to 1.14 mM and 1.28mM respectively for NiZnWT-HypA and Ni-ZnL2*-HypA. The metal concentrations of Standards and proteins samples
were confirmed by metal analysis using ICP-OES. The final Ni:Zn:HypA ratios for Ni-ZnWTHypA was 0.97:0.7:1, and for Ni-ZnL2*-HypA was 1.05:0.75:1.
Evans method was performed by collecting 1H NMR on samples concurrently with the
reference D2O buffer on a Bruker Avance III 400 instrument. The standards or samples were
placed in NMR tubes with a coaxial insert (Wilmad-LabGlass) filled with the reference D2O
buffer. Separation in the HDO peak (in Hz) was used to confirm the presence of a paramagnetic
metal site (where a single HDO peak was observed for diamagnetic samples) and to calculate the
μeff in each sample. Diamagnetic corrections of ligands in protein samples were determined from
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WT- and L2*-Apo-ZnHypA samples. The following equations were used to calculate the
paramagnetic properties of Ni sites in WT-Ni-ZnHypA:
𝜒𝑔 =

−3 Δ𝜈
4 𝜋 𝜈0 𝑚

+ 𝜒0

Eq. 3.6

𝜒𝑀 = 𝜒𝑔 𝑀

Eq. 3.7

∗
𝜒𝑀
= 𝜒𝑀 − ∑ 𝜒𝐿

Eq. 3.8

∗
𝜇𝑒𝑓𝑓 = 2.83 √𝜒𝑀
𝑇

Eq. 3.9

Given χg is the mass susceptibility of the metal ion, Δν is the peak separation (Hz); ν0 is the
frequency of the spectrometer (Hz); m is the concentration of the sample (g/mL); χ0 is the mass
susceptibility of solvent (csg); M is the compound molecular weight (g/mol); χM* is the molar
susceptibility of the metal ion; χL is diamagnetic correction for ligands; μeff is the effective
magnetic moment; T is the absolute temperature (K).
3.4.13 Circular dichroism
Circular Dichroism (CD) spectroscopy of purified HypA proteins was performed on a
Jasco J-715 spectropolarimeter. All spectra were taken of 20μM purified HypA proteins (> 90 %)
loaded into quartz cuvettes with a 1mm path length in buffer with 10mM Tris, 100mM NaCl,
1mM TCEP, pH 7.2. Ni-bound protein was prepared using the same method as described for
XAS sample preparation and the Ni:Zn:HypA ratio for WT was 1.0:0.74:1.0; and for L2* was
0.75:0.94:1.0. An average of four scans were taken of each sample at 20 ˚C with scan speeds of
20nm/min and step size of 2nm. Spectra of buffer alone were also taken using the same scan
parameters using the same cuvette and then subtracted from the protein spectra to produce the
final figure as shown in Figure 3.4.
3.4.14 Size Exclusion Chromatography/Multi-Angle Light Scattering (SEC-MALS)
SEC-MALS was performed using a combination of an Agilent HPLC running a Superdex
75 10/300GL (GE Healthcare Life Sciences) attached to the DAWN HELEOS II (Wyatt
Technology) and the Optilab T-rEX (Wyatt Technology). Experiments were performed at 25 ˚C,
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with the system was equilibrated with Buffer GF (20 mM HEPES, 200 mM NaCl, 1mM TCEP,
pH 7.2) at 0.2 mL/min and then purified HypA protein was injected at 100 μL of 98 μM for L2*HypA and 100 μL of 120 μM for WT-HypA. Proteins eluting off the column were monitored by
UV absorbance (280 nm) on the HPLC, and for multi-angle (16 angles ranging from 13 – 157.8˚)
light scattering with the DAWN HELEOS II at 664nm, as well as for RI with the Optilab T-tEX
at 658 nm. Peak data were processed using the Astra 6 software package (Wyatt) with lightscattering peaks fitted with the Zimm model with a dn/dc value of 0.185 ml/g (typically
recommended value for a range of proteins by Wyatt manual) to deduce the absolute mass of the
peak. To ensure that the data processing method used was accurate in measuring the absolute
mass of the proteins, the experiment and data processing procedures were used to calculate the
mass of bovine serum albumin (expected 66.5 kDa, SEC-MALS 66.2 kDa), H. pylori HypB
(expected 27.2 kDa, SEC-MALS 27.1 kDa), and H. pylori UreE dimer (expected 38.8 kDa, SECMALS 39.7 kDa), all of which were accurate in calculating the molecular weight of the peak.
Additionally, the same LC method was used to calculate the elution volume of known
molecular weight standards (Sigma) for gel filtration chromatography using blue dextran (void
volume), albumin (66 kDa), carbonic anhydrase (29 kDa), cytochrome C (12.4 kDa), and
aprotinin (6.5 kDa). The elution volumes of each protein standard were used to construct a
calibration curve for protein molecular weights, by which HypA protein was measured. Using
this traditional calibration curve for size exclusion chromatography obtained from retention times
of molecular weight standards WT- and L2*-HypA was calculated to have an apparently
molecular weight of 21.7 and 22.7 kDa (data not shown), which is consistent with a dimeric
quaternary structure. However, MALS analysis calculates the mass of HypA WT and L2* to be
13.01 ± 0.007 and 13.37 ± 0.021 kDa respectively (Figure 3.4), which is consistent with
monomeric HypA. Additional SEC-MALS experiments of other proteins including BSA, H.

107

pylori HypB, and UreE confirms that MALS analysis correctly calculates the molecular weights
of globular proteins (data not shown).

3.4.15 Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES)
Metal analysis was performed on protein samples and metal solutions using a PerkinElmer Optima DV4300 ICP-OES instrument. The instrument was blanked with MilliQ water and
then calibrated with 0.1 – 10.0 ppm standards of Ni, Cu, and Zn diluted from known ICP
analytical standards (Sigma) in MilliQ water to ensure linearity and consistency in response.
Metal solutions samples were prepared by diluting the stock solution to an expected metal content
between 1.0 – 3.0 ppm with a known amount of MilliQ water. The ratio of the actual metal
content of the sample to the expected metal content multiplied by the expected metal
concentration and dilution factor is taken as the actual concentration of the stock solution. Protein
samples were prepared by first accurately measuring the protein concentration, and then diluting
the sample to an expected metal content of 0.5 – 1.0 ppm metal (assuming 1:1 binding of proteinto-metal) with a known amount of MilliQ water. The ratio of the actual metal content of the
protein sample to the expected metal content of the sample is taken as the metal:protein ratio.
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CHAPTER 4
NICKEL- AND PH-DEPENDENT INTERACTIONS REVEAL THAT HYPA AND UREE2
ACT AS CO-METALLOCHAPERONES IN NICKEL-DELIVERY TO HELICOBACTER
PYLORI UREASE
This chapter will be submitted for publication: Hu, H. Q. and Maroney, M. J. (2017) Nickel- and
pH-dependent interactions reveal that HypA and UreE2 act as co-metallochaperones in nickeldelivery to Helicobacter pylori urease. ACS Chemical Biology.
4.1

Introduction
Helicobacter pylori is a successful human pathogen that colonizes the stomach and

causes chronic gastritis, ulcers, and cancers.1, 2 Despite thriving in the niche environment of the
acidic stomach, H. pylori is a neutrophilic bacterium. One of the adaptations that allow for
successful colonization in the acidic stomach is the ability to rapidly increase urease activity upon
acid shock.3 Urease catalyzes the hydrolysis of urea to carbamate (spontaneously hydrolyzing to
ammonia and carbon dioxide) and ammonia, which neutralizes the intracellular pH of the
bacterium in acidic environments.4 Acid readiness is ensured by a plentiful supply of apo-urease
protein, which accounts for 7 – 10% of the total nascent proteins synthesized by H. pylori at both
neutral and acidic pH conditions.5 Activation of urease involves the assembly of the complex dinickel active sites, which requires the accessory proteins UreEFGH as well as hydrogenaseassociated accessory proteins HypA and HypB in H. pylori.6,

7

The function of the accessory

proteins in urease maturation has been extensively studied and reviewed for H. pylori and other
organisms.6
Of these accessory proteins, UreE, has been identified as a Ni-metallochaperone
responsible for acquiring and specifically delivering Ni2+ for urease activation.6 H. pylori UreE is
a homodimer (UreE2), where a six-coordinate Ni site is formed at the dimer interface using a
labile C-terminal motif.8 The interfacial UreE2 site has a relatively high-affinity for Ni2+ with an
apparent dissociation constant (Kd) of 0.15 ± 0.01 μM, as measured by isothermal titration
calorimetry (ITC).9 However, purified UreE2 has been known to demonstrate disorder and/or
partial degradation at the C-terminal Ni-binding motif,8, 10, 11 which may reduce the ability of H.
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pylori UreE2 to sequester Ni. Additionally, UreE in H. pylori lacks a His-rich tail commonly
found in other known UreE proteins12 resulting in a lower Ni-binding capacity of one Ni2+ per
dimer8-10, 12 compared to up to six Ni2+ per dimer in K. aerogenes UreE2.6, 13, 14 Appending Hisrich tails derived from homologues to the H. pylori UreE protein sequence increases the Nibinding capacity of the protein variants and the urease activities of corresponding H. pylori
isostrains.

12

Where other UreE homologues have evolved superior Ni-sequestration ability, H.

pylori UreE seems obviously lacking.
Urease activity in H. pylori also requires another known Ni-metallochaperone, HypA,15
which is typically associated with the maturation of the Ni-containing enzyme, NiFehydrogenase.16 Interruption of the hypA gene 11, 15, 17 or diminishing its Ni-binding ability by sitedirected mutagenesis

11, 18

have been known to abolish urease activity and acid survival of the

cells. WT-like urease activity in hypA-interruption strains of H. pylori can be restored by Nisupplementation in the growth media,15 but cannot rescue ureE-interruption strains.19 These
phenotypes suggest that while both HypA and UreE2 are involved in delivery of Ni2+ to H. pylori
apo-urease, Ni2+ insertion specifically requires UreE2, potentially due to protein-protein
interactions with downstream urease accessory proteins in a maturation complex, as observed in
other bacterial strains.6
Purified HypA protein has been shown to interact with UreE2, forming a stable complex
that can outcompete complex formation with UreG,20 an accessory protein in the urease
maturation cascade that is characterized as a GTPase.21-23 In contrast, alternate studies using Nterminally modified HypA (where cleavage of an affinity tag left a Gly-Ser overhang at the Nterminal Ni-binding motif; henceforth referred to as GSHypA) found that the GSHypA-UreE2
complex dissociates in favor of a UreG2-UreE2 complex in the presence of Mg and GTP.24
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Figure 4.1: Model of Ni-transfer paths between H. pylori HypA and UreE2.
Possible paths (steps labeled in red) of Ni-transfer between HypA and UreE2 in the urease
maturation process culminating with delivery of Ni to the urease maturation complex (PDB ID
4HI021). Gray squiggles surrounding Ni represents the available Ni within the cell that are loosely
coordinated by proteins, peptides, or small molecules. Paths marked with a red X have submicromolar apparent dissociation constants (Kd), indicating the complex is unlikely to dissociate.
H. pylori HypA has been extensively characterized and has been found to be a
monomeric protein that contains a structural Zn-site, as well as a Ni-binding site with moderate
affinity (Kd ~1 μM).11,

25-27

The Ni-binding to HypA is approximately one order of magnitude

weaker than that of UreE2, and with both proteins serving the same function of Ni2+ acquisition
and delivery, the requirement of HypA in H. pylori urease maturation seems redundant and
confounding. The disparity in the Ni-binding affinities between HypA and UreE2 led to a current
model in the literature24 that suggests that HypA first acquires Ni2+, possibly by direct interaction
with the Ni importer, (Figure 4.1, path 1C), and then transfers it to UreE2 (Figure 4.1, path 1D)
through protein-protein interactions.19, 24 Subsequently, HypA dissociates (Figure 4.1, path 1F)
from the complex leaving Ni-UreE2 to interact with UreG (Figure 4.1, path 2B) in delivering Ni2+
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to apo-urease.24 However, early in vitro and in vivo attempts to show Ni-transfer between HypA
and UreE2 yielded ambiguous results.19 Ni-transfer from GSHypA to UreE has been demonstrated
using a Ni-specific cross-linking dye after SDS-PAGE separation of the two proteins,28 however
other N-terminally modified HypA variants (H2A and M1_H2insL, hereafter known as
L2*HypA) have been known to abrogate or weaken Ni-binding.11, 18 Additionally, separation of
the tightly bound Ni-GSHypA-UreE2 complex requires denaturing conditions28 or additional
cofactors (such as Mg, GTP, and UreG2).24
As a mechanism accounting for the HypA-requirement in H. pylori urease maturation, the
HypA Ni2+ acquisition and handoff to UreE2 is unsatisfactory in two respects. First, the in vitro
studies of the HypA-UreE2 interaction reported thus far have been performed under neutral pH
conditions, which may miss key aspects of the mechanism of Ni-delivery for urease maturation
that are critical for the survival of H. pylori under acid shock (with internal pH ~ 6.3).29-31 Second,
the studies performed thus far at neutral pH indicate that the HypA-UreE2 complex is stable with
or without Ni2+, which renders spontaneous HypA dissociation from the complex unlikely. Even
with UreE2 binding more tightly to Ni2+ than HypA, the strong protein-protein interaction would
hamper the hand-off mode of Ni-transfer that is a feature of the current model. The goal of the
studies presented here is to elucidate the role(s) of HypA in Ni2+ delivery to the urease maturation
pathway in H. pylori, and specifically to add studies performed under conditions that mimic acid
shock (i.e., at pH 6.3).
4.2

Results

4.2.1

Apo--ZnHypA-UreE2 interactions are not altered by acid shock conditions
Although H. pylori has a specific Ni-chaperone for urease, UreE2, the full activation of

urease requires another Ni-chaperone, HypA.15 One possible mechanism is that the HypA-UreE2
interaction (Figure 4.1, Path 1A and 1D) is enhanced by acidic pH, recruiting HypA to the urease
maturation pathway through protein-protein interactions under acidic shock conditions. To assess
the pH effects on the interaction between apo-ZnHypA or Ni-ZnHypA with UreE2, size exclusion
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chromatography in tandem with multi-angle light-scattering (SEC-MALS) and ITC titrations
were performed under neutral (pH 7.2) conditions and conditions that approximate acid shock
(pH 6.3). 29-31
Prior studies of the N-terminally modified GSHypA and UreE2 mixture by SEC and
Static Light Scattering performed only at pH 7.2 indicated the formation of a stable complex of
GSHypA-UreE2 with a mass of 51 kDa.28 To confirm that this complex remains stable under acid
shock conditions, SEC-MALS was used to determine the masses of peaks resolved from a
mixture containing a three-fold excess of apo-ZnHypA to apo-UreE2 at both pH 7.2 and 6.3. Two
peaks were clearly resolved for the mixture at both pH conditions with elution volumes of 7.2 –
7.3 and 8.5 – 8.7 mL (APPENDIX 3, Figure A3.1). The peak at 8.5 – 8.7 mL overlaps with the
peak for isolated apo-ZnHypA, has a molecular mass of 13 kDa, and is therefore attributable to
the excess apo-ZnHypA protein in the mixture. The peak at 7.2 – 7.3 mL has a molecular mass of
51 kDa, which is distinct from either apo-ZnHypA or apo-UreE2 alone (with elution volume at
7.6 – 7.8 mL and a mass of 38 kDa), and match the mass of the previously characterized
GSHypA-UreE2 complex.28 This peak is therefore assigned to a HypA-UreE2 complex.
The formation of the apo-ZnHypA-UreE2 complex was also by assessed by the titration
of apo-ZnHypA into apo-UreE2 and measured by ITC. Single isotherm binding curves were
detected at both pH 7.2 and 6.3 (Figure 4.2, left) and best fitted by OneSite models with apparent
dissociation constant (Kd) values of 0.90 ± 0.44 μM and 1.2 ± 0.3 μM, respectively (Table 4.1).
These Kd values corroborate prior ITC studies of GSHypA binding to apo-UreE2 performed at
neutral pH, and the low-affinity binding event detected by bio-layer interferometry (BLI) at
similar pH.20,

28

The change in pH from 7.2 to 6.3 did not affect the overall binding of apo-

ZnHypA to apo-UreE2, suggesting that acid shock conditions do not alter the interaction between
these proteins in the absence of Ni.
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Figure 4.2: ITC isotherms of HypA binding to UreE2.

ITC binding isotherms resulting from the titration of apo-ZnHypA (open squares) into
apo-UreE2 and Ni-ZnHypA (half-filled squares) into apo-UreE2, with cartoon
representations of each titration shown above the curves. Titrations were performed at pH
7.2 (blue) and 6.3 (green). Data are shown in colored symbols and fits in black lines.
Titration curves were graphed to the same y-scale for visual comparison. Data were fitted
to OneSite or TwoSites models as described in the text. See method Section 4.5.3 for
detail fitting procedures and APPENDIX 3, Figure A3.2 for raw ITC thermograms.
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Table 4.1: Summary of HypA titration into UreE2
pH 7.2
Binding Partners
K d (M)
N (Sites)
Apo-ZnHypA
Ni-ZnHypA

K d (M)
ITC

(9.0 ± 4.4) x 10-7

1.4 ± 0.2

(1.2 ± 0.3) x 10-6

1.4 ± 0.1

(1.8 ± 0.1) x 10-7

1.1 ± 0.1

(3.6 ± 3.0) x 10-7

1.0 ± 0.1

-10

Apo-ZnHypA

pH 6.3
N (Sites)

(6.4 ± 4.0) x 10

0.50 ± 0.09

(2.7 ± 0.5) x 10-6

1:1

-10

(6.4 ± 2.5) x 10
∆ Fluorescence (NHS640-UreE2)

(1.8 ± 0.2) x 10-6

0.52 ± 0.06
1:1

Ni-ZnHypA* (2.0 ± 0.9) x 10-8
1:1
(H) 1.4 ± 0.6
(4.5 ± 2.6) x 10-9
Results were the average of three or more independent titrations. ITC data fitted with Microcal
analysis for One- or TwoSites models. ∆ Fluorescence binding fitted with mass action function
assuming 1:1 binding; or with the Hill Equation with Hill coefficient (H) as indicated. See
method Sections 4.5.3 and 4.5.4 for fitting detail.
* = Measured in Ni-saturating conditions (with 1 μM Ni2+ in the buffer)

Fluorescence intensity change was used to further address apo-ZnHypA-UreE2 binding.
Primary amines in purified recombinant apo-UreE2 were labeled with a fluorophore (NHS640UreE2) and then mixed with increasing concentrations of apo-ZnHypA, and the fluorescence of
each mixture was then measured using a NanoTemper NT.115. Fluorescence intensity increases
from apo-ZnHypA titration into apo-NHS640-UreE2 were fitted to a modified mass action
function, assuming a single binding site, to obtain Kd values of 2.7 ± 0.5 μM at pH 7.2 and 1.8 ±
0.2 μM at pH 6.3 (Figure 4.3 left panels and Table 4.1). These fluorescence binding results
corroborate the ITC results and support a single observable binding event between apo-ZnHypA
and apo-UreE2 (Table 4.1). Protein-protein interactions between apo-ZnHypA and apo-UreE2
remain the same at pH 7.2 and 6.3, indicating pH-dependent changes in the protein interactions is
unlikely to contribute to enhanced urease activity under acid shock conditions in vivo in the
absence of Ni.
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Figure 4.3: Fluorescence binding curve of HypA to NHS640-UreE2
Titration were performed at pH 7.2 (blue) and 6.3 (green). Cartoon representations of each
titration are shown above the binding curves, where fluorophores are represented as yellow stars.
Apo-ZnHypA titrations into NHS640-UreE2 (open squares) were performed in buffer without Ni,
and Ni-ZnHypA titration into NHS-640-UreE2 (filled squares) were performed with 1 μM Ni2+ in
the buffer. Fluorescence data (colored symbols) were fitted (black lines) with the mass action
function for the binding of apo-ZnHypA to NHS640-UreE2 at both pH, and for Ni-ZnHypA
binding to NHS640-UreE2 at pH 7.2, assuming 1:1 binding. A Hill Equation was used to fit the
Ni-ZnHypA binding to NHS640-UreE2 at pH 6.3. See method Section 4.5.4 for fit details.
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4.2.2

Low pH not favor Ni2+ binding to HypA over UreE2
Another possible mechanism for requiring HypA in H. pylori urease maturation is that

under acid shock conditions, Ni2+ binding to HypA (Figure 4.1 path 1C) may be favored over
UreE2 (Figure 4.1 path 1E). Prior studies have established that Ni binds to UreE2 approximately
one order of magnitude tighter than HypA at neutral pH,9, 26, 28 but Ni2+ binding to UreE2 has not
been studied at conditions resembling acid shock. Using identical buffers, the Ni2+ binding to
HypA and UreE2 under neutral (pH 7.2) or acid shock (pH 6.3) conditions were compared. NiCl2
was dissolved in buffers at pH 7.2 or 6.3, and then titrated into either apo-UreE2 or apo-ZnHypA
in the same buffer, monitoring the heat of binding using ITC. A single isotherm was observed for
Ni2+ binding to either apo-ZnHypA or apo-UreE2, and the data were best fit by OneSite models,
as summarized in Table 4.2, with example data and fits shown in Figure 4.4.
The moderate change of expected cytoplasmic pH of H. pylori under neutral (pH 7.2) and
acid shock (pH 6.3) conditions did not significantly alter the Ni2+ binding of either UreE2 or
HypA individually. At both pH conditions tested, UreE bound to Ni2+ at least one order of
magnitude tighter than HypA. The Kd for Ni2+ binding to UreE2 were best fit to 67 ± 15 nM at pH
7.2 and 53 ± 25 nM at pH 6.3, which are indistinguishable values and within the range of
previously reported values measured at pH 7.9 Apo-ZnHypA bound Ni2+ with more moderate
affinities (Kd = 0.97 ± 0.26 μM at pH 7.2; 1.6 ± 0.8 μM at pH 6.3) that are also indistinguishable
in both neutral and acidic conditions, and in agreement with prior reports.11, 26
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Figure 4.4: ITC binding isotherms of Ni2+ titration into proteins
Titration of Ni2+ into HypA (circles), UreE2 (squares), and HypA-UreE2 complex (diamonds)
with data in color and fits in black lines. Titrations were performed at pH 7.2 (blue) and 6.3
(green) and isotherms were graphed to the same y-scale for visual comparison. With insets
showing properly scaled isotherms for Ni2+ binding to HypA. Ni2+ binding to HypA or UreE2
were fitted with OneSite models, and Ni2+ binding to the HypA-UreE2 complex were fitted to
TwoSites models (see text and Section 4.5.3 for detail fitting procedures and APPENDIX 3,
Figure A3.2 for raw ITC thermograms).
The ITC data also reveal that the capacity for Ni-binding was reduced in UreE2 (Table
4.2). UreE2 was found to bind less than one Ni2+ per dimer with the number of sites (N) fitted to
0.71 ± 0.12 at pH 7.2, and 0.56 ± 0.01 at pH 6.3. As previously reported, the C-terminal motif
(close to the Ni-binding site) of purified H. pylori UreE degrades slowly over time,8, 9, 11 which
affects the number of sites available for Ni-binding. However, the N values determined in our fits
are consistent with approximately one Ni-site per UreE dimer and is consistent with previously
reported crystal structures8, 10 and Ni K-edge X-ray absorption spectroscopy data.8
Apo-ZnHypA bound one Ni2+ per monomer, as expected, with N fitted to 0.94 ± 0.4 and
0.92 ± 0.21 at pH 7.2 and 6.3, respectively. This result contradicts a previous report of HypA
binding one Ni2+ per monomer at pH 7.2 and one Ni2+ per dimer at pH 6.3.26 This discrepancy
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could be attributed to buffer system differences, where the presence of reducing agents in the
buffer used in these studies prevented sulfur oxidation, and therefore better maintained the native
Zn-bound state of HypA, or possibly due to the use of re-folded protein in the prior studies.
Table 4.2: Summary of ITC results from Ni titration into HypA and UreE
pH 7.2
pH 6.3
Binding Partners
K d (M)
N (Sites)
K d (M)
N (Sites)
Apo,Zn-HypA
Apo-UreE2
*HypA-UreE2

(9.7 ± 2.6) x 10-7
-8

(6.7 ± 1.5) x 10

-7

(2.9 ± 2.3) x 10

0.94 ± 0.04

(1.6 ± 0.8) x 10-6

0.92 ± 0.21

0.71 ± 0.12

-8

0.56 ± 0.01

-7

0.37 ± 0.04

1.2 ± 0.1

(5.3 ± 2.5) x 10
(7.2 ± 2.1) x 10

0.54 ± 0.05
0.52 ± 0.01
(1.9 ± 1.6) x 10-10
(3.1 ± 1.9) x 10-9
Results represent the average and standard deviation from three or more independent titrations
unless otherwise noted. See Section 4.5.3 for fit details.
* = Result represent the average and range from two independent titrations

4.2.3

Ni2+ binding to HypA-UreE2 complex is enhanced at neutral and acid shock pH
Our results indicate that Ni2+ binding to HypA was not favored over UreE2 under acidic

conditions, ruling out pH-dependent changes in the Ni affinities of the two metallochaperones as
a possible mechanism for the HypA-requirement in H. pylori urease maturation. However, since
HypA and UreE2 are known to form a tight complex,11, 19 the interaction of Ni2+ with the complex
(Figure 4.1, path 1B) may be drastically different as compared to each protein individually
(Figure 4.1, paths 1C and 1E). ITC was used to measure the Ni2+ binding to the HypA-UreE2
complex under neutral (pH 7.2) and acid shock (pH 6.3) conditions to assess whether Ni-binding
is enhanced in the preformed protein complex. The formation of the HypA-UreE2 complex under
the conditions used in these titrations was confirmed by protein-protein titrations and SEC-MALS
(see Table 4.1, and Figure 4.2 and Figure 4.3 left panels, and APPENDIX 3 Figure A3.1). Two
distinct isotherms were observed in the titration of Ni2+ into the HypA-UreE2 complex at both pH
7.2 and 6.3, and were best fitted to models that featured two independent sites (Figure 4.4 middle
panels, Table 4.2). Fits for a single binding site produced statistically and visually poor fits for the
data (APPENDIX 3, Figure A3.3).
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At neutral pH, Ni2+ binding to the preformed HypA-UreE2 complex was best fitted to two
binding events. The lower affinity binding event (Kd2 = 0.29 ± 0.23 μM and N2 = 1.2 ± 0.1 sites)
feature a Kd value in-between that of Ni2+ binding to HypA and UreE2 individually. The higher
affinity binding event (Kd1 = 0.19 ± 0.16 nM and N1 = 0.54 ± 0.05 sites) feature a Kd value that is
almost three orders of magnitude tighter than Ni2+ binding to UreE2 (Figure 4.4, Table 4.2).
Under acidic conditions, the two isotherms for Ni2+ binding to the HypA-UreE2 complex were
also modeled with two binding events [Kd1 = 3.1 ± 1.9 nM (N1 = 0.52 ± 0.01 sites) and Kd2 = 0.72
± 0.21 μM (N2 = 0.37 ± 0.4 sites)]. The higher affinity binding is one order of magnitude tighter
than Ni2+ binding to UreE2, and the lower affinity binding features a Kd value similar to the Ni2+
binding to HypA (Figure 4.4 and Table 4.2). Thus, in contrast to the situation at neutral pH, Ni2+
binding to the preformed HypA-UreE complex under acid shock conditions is only slightly
enhanced relative to Ni2+ binding to the two isolated proteins.
Although HypA has only a moderate affinity towards Ni2+ (~1 μM, see Table 4.2), it
appears to play a crucial role in the high affinity Ni-binding event observed in the apo-ZnHypAUreE2 complex. Disruption of the native Ni-binding site in HypA by site-directed mutagenesis
was used to investigate the contribution of HypA to the high-affinity (Kd1 ~ 0.2 – 3 nM, Table
4.2) binding events observed in Ni2+ titration into the ZnHypA-UreE2 complex. A previously
characterized HypA variant, L2*HypA, was shown to bind Ni2+ at a lowered affinity (Kd ~ 20 –
60 μM) compared to WT-HypA (Kd ~ 1 μM) without affecting the binding affinity to UreE2.11
Indeed, the L2*HypA closely resembles the GSHypA variant in Ni-binding affinity (Kd ~ 14
μM),28 Ni-site structure, and magnetic properties.11,
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Ni2+ titration of the ZnL2*HypA-UreE2

complex was measured by ITC (APPENDIX 3, Figure A3.4). A single isotherm was observed at
pH 7.2 (Kd = 17 ± 2 nM and N = 0.49 ± 0.002 sites) and pH 6.3 (Kd = 27 ± 5 nM and N = 0.48 ±
0.003 sites), with affinities that are similar to Ni2+ binding to apo-UreE2 alone (Figure 4.4, Table
4.2). The higher affinity binding event observed in the Ni titration into ZnWTHypA-UreE2 (Kd ~
0.2 – 3 nM, see Table 4.2) is absent. Thus, the loss of this higher affinity binding event upon the
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disruption of the native HypA Ni-binding site suggests that the Ni-binding ligands in HypA are
essential for forming a high affinity site in the HypA-UreE2 complex.
4.2.4

Ni-ZnHypA enhances protein interactions under both neutral and acid shock pH
ITC was used to monitor the interaction between HypA and UreE2 when Ni-ZnHypA was

titrated into apo-UreE2 under neutral (pH 7.2) and acid shock (pH 6.3) conditions (Figure 4.1,
path 1D). The results are consistent with a series of complex interactions that are reflected in at
least two distinct isotherms under both neutral and acidic conditions. TwoSites models were used
to fit the titrations at both pH values and reveal two binding events (Figure 4.2, right). The tighter
binding events were best fitted with Kd values of 0.64 ± 0.40 nM (N = 0.50 ± 0.09 sites) at pH
7.2, and 0.64 ± 0.25 nM (N = 0.52 ± 0.06 sites) at pH 6.3, both of which are three orders of
magnitude tighter than the binding of the two apo-proteins observed in the absence of Ni2+ (Table
4.1). These Kd values are in the same order of magnitude as the high affinity binding events
observed in the titration of Ni into the ZnHypA-UreE2 complex, although it is unclear whether the
same binding events precipitated these observed isotherms. The lower affinity events were best
fitted with Kd values of 0.18 ± 0.01 μM (N = 1.1 ± 0.1 sites) at pH 7.2, and 0.36 ± 0.30 μM (N =
1.0 ± 0.1) sites at pH 6.3 (Table 4.1), which are within the range of Ni2+ binding to apo-UreE2
(Table 4.2). The tighter binding events (with Kd values in the sub-nM to low-nM range) are only
observed in the presence of both Ni and the HypA-UreE2 complex (i.e., in the titrations of NiZnHypA into apo-UreE2; or in the titrations of Ni2+ into the apo-ZnHypA-UreE2 complexes). This
suggests that the tight interactions are due to the formation of a new Ni-binding site formed by
the ZnHypA-UreE2 complex that was absent in the individual proteins.
4.2.5

High-affinity interaction between HypA and UreE2 persists with Ni-bound UreE2
ITC detects all the processes that result in heat change during a titration, including any

metal binding/unbinding and changes to protein conformation. Thus, to simplify the processes
observed in the titration of Ni-ZnHypA into apo-UreE2, the titration was repeated under
saturating Ni2+ conditions using fluorescence change as a detection method. The fluorescence
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change of Ni-NHS640-UreE2 was measured upon titration with unlabeled Ni-ZnHypA under both
neutral (pH 7.2) and acid shock (pH 6.3) conditions in the presence of excess Ni2+ (1 μM) in the
buffer (Figure 4.3 and Table 4.1). In this approach, the signal is derived exclusively from
fluorophores bound to the surface of Ni-NHS640-UreE2 at nM concentration, where the UreE2
Ni-binding site is saturated. The release or rebinding of Ni2+ or rearrangements in HypA is not
detectible by this method unless the process directly affects the surface of the Ni-NHS640-UreE2.
This experimental design allowed for the detected signals to be unambiguously assigned to
protein-protein interactions in the presence of Ni.
The Ni-NHS640-UreE2 fluorescence intensities decrease with increasing concentration of
Ni-ZnHypA, which is opposite to the effect observed for the apo-ZnHypA interaction with apoNHS640-UreE2 (Figure 4.3). The reversal of the fluorescence intensity changes in response to
increasing concentrations of HypA indicates that interactions that occur in the Ni-bound proteins
are distinct from the binding events in the apo-proteins. One possible mechanism for the NiZnHypA-dependent decrease in fluorescence is the release and/or rebinding of Ni to the NiNHS640-UreE2.
The changes in fluorescence intensities were plotted against the concentration of NiZnHypA and to generate binding curves. At pH 7.2, the binding of Ni-ZnHypA to Ni-NHS640UreE2 was fitted to a modified mass action function, assuming a single binding site, resulting in
Kd of 20 ± 9 nM. The binding at pH 6.3 was best fitted with the Hill’s equation resulting in Kd of
4.5 ± 2.6 nM with Hill coefficient (H) of 1.4 ± 0.6, suggesting cooperativity in binding. These Kd
values are at least two orders of magnitude tighter than the apo-protein interactions measured by
fluorescence at both pH values (Kd ~ 2 μM). These observations unambiguously establish that a
HypA-UreE2 complex occurs under saturating Ni2+ conditions, and that the affinity between NiZnHypA and Ni-UreE2 was increased under both neutral and acid shock conditions. Further, the
complex is about 10-fold tighter under acid shock conditions. These enhanced interactions
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provide a possible mechanism for increased Ni delivery to apo-urease under acid shock
conditions, and suggest a more involved role for HypA beyond the handing off Ni2+ to UreE2.
4.2.6

Ni2+ and apo-ZnHypA does not dissociates from the Ni-ZnHypA-UreE2 complex in

size exclusion chromatography
To assess the stability of the HypA-UreE2 complex with Ni bound, particularly its ability
to retain Ni2+ ions under dilute conditions, the SEC-MALS experiment described above for the
interaction of apo-ZnHypA and apo-UreE2 was repeated using Ni-ZnHypA.
A three-fold excess of Ni-ZnHypA was mixed with apo-UreE2 under neutral (pH 7.2) and
acidic (pH 6.3) conditions, and then separated and analyzed by SEC-MALS. The results shown in
Figure 4.5 are essentially identical to those obtained using apo-ZnHypA (APPENDIX 3, Figure
A3.1), and featured two resolved peaks at similar elution volumes. The first peak centered at
elution volumes of 7.1 – 7.3 mL corresponds to a molecular mass of 51 kDa at both pH 7.2 and
6.3, and is assigned to the stable complex of ZnHypA-UreE2, with or without Ni2+ bound. A
second smaller peak eluted at 8.5 – 8.7 mL and overlaps with the peak of HypA alone. This
smaller peak has a molecular mass of 13 kDa both pH values, and is assigned to the excess HypA
separated from the mixture, with or without Ni2+ bound.
To assess whether metals remain bound to the resolved protein peaks, each peak was
collected and analyzed for metal content using inductively coupled plasma optical emission
spectroscopy (ICP-OES). Since properly folded HypA contains a structural Zn-site,17,

25, 26, 32

comparing the Ni:Zn ratio of each peak is a convenient way to accurately assess the Ni retention
and stoichiometry compared with the amount of HypA in the sample. The 51 kDa HypA-UreE2
complex contained 0.36 ± 0.06 μM Ni with a Ni:Zn ratio of 1.07 at pH 7.2; and had a 0.10 ± 0.05
μM Ni concentration with a Ni:Zn ratio of 1.33 at pH 6.3. These results show that Ni is retained
in the protein complex and this complex is stable at sub-micromolar concentrations (Figure 4.1,
Path 1B). The peak corresponding to excess Ni-ZnHypA contained 0.72 ± 0.05 μM Ni with a
Ni:Zn ratio of 0.85 at pH 7.2; and contained 0.38 ± 0.03 μM Ni with a Ni:Zn ratio of 0.98 at pH
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6.3, demonstrating that Ni-ZnHypA also retains Ni under these conditions at close to 1:1 ratios
(Figure 4.1, Path 1F). Together these data indicate that the Ni-ZnHypA-UreE2 complex is stable
at sub-micromolar concentrations, suggesting that this complex is unlikely to dissociate within
the cell without other disruptions.

Figure 4.5: SEC-MALS analyses of Ni-ZnHypA-UreE2 complexes
Chromatographs of Ni-ZnHypA (gray lines), UreE2 (cyan lines), and a 3:1 mixture of NiZnHypA with UreE2 at pH 7.2 (blue line, upper panel) and at pH 6.3 (green line, lower panel)
separated by SEC. The deconvoluted molecular masses from MALS analyses are graphed on the
center of each peak. See Section 4.5.5 for detailed analysis method. Cartoon representation of the
individual proteins and complexes are shown below each set of peaks.
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4.2.7

Binding to HypA slows the degradation of UreE
One potential role of HypA in ensuring proper Ni-delivery to the urease maturation

pathway in H. pylori is to stabilize UreE2. The C-terminal domain of H. pylori UreE protein has
been known to be disordered or degrade over time producing two distinct bands on SDS-PAGE
(APPENDIX 3, Figure A3.5).8, 10, 11 LC-MS analysis of partially degraded UreE protein identified
the full-length protein at 19407.3 Da (theoretical mass = 19407.5 Da) and a major degradation
product at 18504.4 Da corresponding to UreE with eight residues missing from the C-terminus
(theoretical mass = 18504.5 Da) producing a UreE∆163-170 fragment. A similar H. pylori UreE
variant, UreE∆158-170, has been shown to lose the ability to interact with the N-terminally
modified GSHypA,28 indicating the C-terminal domain of UreE is critical for interaction with
HypA. We hypothesize that the tight complex formed between native ZnHypA-UreE2 both in the
absence and presence of Ni (Figure 4.2 and Figure 4.3, Table 4.1) may stabilize the disordered Cterminus of UreE2, therefore slowing its degradation. To test this hypothesis, the stability of
purified UreE2 was monitored in the presence and absence of ZnHypA, with and without of Ni 2+,
at pH 7.2 and 6.3.

Figure 4.6: SDS-PAGE of time-dependent UreE degradation
Degradation of the UreE at room temperature was monitored at pH 7.2 (left) and 6.3 (right), in
the presence and absence of one molar equivalent of ZnHypA and two molar equivalents of Ni 2+
as indicated at the bottom of the gel. The molecular weight positions of HypA and UreE
[separated into full-length peptide (UreE) and degraded peptide (UreE∆163-170)] are marked
with arrows.

132

At pH 7.2 and in the absence of Ni, the presence of UreE∆163-170 fragment increases
proportionally to the disappearance of full-length UreE between 0 – 5 days at 20˚C (Figure 4.6
left, lanes 1 – 3). Addition of Ni2+ to UreE slightly enhances the appearance of the degraded
fragment (Figure 4.6, left, lanes 10 – 12). Whereas addition of ZnHypA in the absence (Figure
4.6, lanes left 4 – 6) and presence (Figure 4.6 left, lanes 7 – 9) of Ni2+ reduced the appearance of
the degraded fragment in the same time frame. Complex formation with ZnHypA also reduced
the degradation of UreE under acid shock conditions (pH 6.3), however the effects were less
prominent as the ZnHypA protein also degraded over the 3 – 5-day period (Figure 4.6 right, lanes
4 – 6 and 8 – 10). These observations demonstrate that formation of the ZnHypA-UreE2 complex
protected the of the labile UreE C-terminal domain from degradation and therefore enhances
urease maturation by ensuring the availability of full-length UreE.
4.3

Discussion
Understanding the mechanism of urease maturation in H. pylori is of interest both

because of the unique adaptations that carefully control urease activity, and the health issues
posed by the pervasiveness of the pathogen infecting the mucous layer of the stomach.1, 2, 33 One
of these adaptations encompasses the conundrum of the HypA-requirement for urease maturation,
despite the presence of the urease-specific Ni-metallochaperone: UreE2.15, 34 Using a biophysical
approach, the studies presented above address the role of pH in the relevant Ni-protein and
protein-protein interactions, and extend current knowledge to include studies that mimic acid
shock conditions.
Several hypothetical mechanisms might account for why HypA is needed to achieve full
urease activation in H. pylori.11, 12, 15, 17-19, 28 As the requirement for higher urease activity is most
acute under acidic shock, the demand for Ni-insertion into urease would also increase at low pH.
Changes in the Ni-binding affinities of the isolated proteins at low pH (Figure 4.1, Paths 1C and
1E) were ruled out by titrations conducted at both pH 7.2 and 6.3, the estimate of the internal pH
of H. pylori under neutral or acid shock conditions (Table 4.2).29-31
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Under neutral pH conditions, H. pylori HypA and UreE dimers are known to form a
stable complex both as apo-proteins11, 20 and in the presence of metals,20, 24 raising the possibility
that nickel availability for urease maturation is significantly improved in the HypA-UreE2
complex compared to UreE2 alone. Improvements in Ni-binding could occur via enhanced Ni
interaction with the preformed HypA-UreE2 complex (Figure 4.1, Path 1B) compared to either
protein individually or by enhancing protein-protein complex formation in the presence of Ni2+
(Figure 4.1, Path 1D), particularly at low pH. The results of our studies shown above establish
that while Ni2+ binding to the pre-formed ZnHypA-UreE2 complex (Figure 4.1, Path 1B) is
significantly enhanced relative to UreE2 alone at neutral pH, it is only slightly increased at pH 6.3
(Table 4.2). Thus, enhancing the Ni-binding in HypA-UreE2 (Figure 4.1, Path 1B) would not be a
likely mechanism for increasing Ni delivery to urease under acid shock conditions.
Enhancing the HypA and UreE2 protein-protein interactions (Figure 4.1, Paths 1A and
1D) under acid shock conditions can also improve Ni delivery to the urease maturation pathway.
This was addressed by examining the interaction of apo-ZnHypA and Ni-ZnHypA with UreE2 as
a function of pH. The results establish that a single binding event with Kd ~ 1 - 2 μM accounts for
the formation of the apo-ZnHypA-UreE2 complex (Table 4.1), which is stable and has the same
protein stoichiometry at both pH values (APPENDIX 3, Figure A3.1). However, use of NiZnHypA in the titrations reveals a more complicated binding process that is characterized by at
least two binding events, one high-affinity event with Kd ~ 0.6 nM that is not observed in the
titration using apo-ZnHypA and not pH-dependent, and a lower affinity binding event with low
μM Kd that is also not pH-dependent and is similar to the binding of apo-ZnHypA to apo-UreE2
(Table 4.1). Thus, the enhanced interaction between Ni-ZnHypA and UreE2 (Figure 4.1, Path 1D)
is a major pathway for potentially increasing Ni delivery to the urease maturation pathway.
Prior studies of the HypA-UreE2 interaction at neutral pH with biolayer interferometry
(BLI) and surface plasmon resonance (SPR) demonstrated the presence of two binding events
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(with reported dissociation constants of 5.4 nM and 1.1 μM), which were attributed to initial
binding at higher affinity followed by a conformational change at lower affinity.20 The Kd values
reported above (Table 4.1) generally agree with the lower-affinity binding event observed in prior
SPR and BLI studies,20 but the previously reported high-affinity site was not detected using the
apo-proteins. Addition of Ni2+ or Zn2+ ions to the binding studies did not affect the binding of
HypA and UreE in the BLI and SPR studies,20 but use of Ni-ZnHypA in the titrations presented
above resulted in the observation of a high-affinity binding event by ITC with nM affinity
(similar to the high-affinity binding event observed by BLI and SPR). This high-affinity binding
event is clearly associated with the presence of Ni2+ by the studies presented here. Both the BLI
and SPR experiments feature tethering of HypA to a surface, which given its small size (13 kDa)
and complexity (binding Zn, Ni, and protein partners), could alter its interaction with UreE2.
Prior studies of interactions between HypA and UreE2 were also performed using the Nterminally modified GSHypA.28 In contrast to the current study, ITC measurements of GSHypA
interaction with UreE2 produced single isotherms (Kd ~ 1 μM), regardless of metal loading of
GSHypA (apo, Zn-bound, or Ni-Zn-bound) or the metal loading of UreE2 (apo, Zn-bound, or Nibound).28 The high-affinity binding events (Kd ~ 0.6 nM) that were observed in the current studies
between (Ni-ZnHypA and apo-UreE2) and in previous BLI and SPR studies (between tetheredHypA and UreE2 in the presence and absence of metals)20 were absent in the GSHypA studies.28
These observations point to a loss of function in the N-terminally modified GSHypA in Nibinding, which also interferes with the Ni-site formation in the HypA-UreE2 complex. This was
confirmed by the missing high-affinity binding event when Ni was titrated into the ZnL2*HypAUreE2 complex (APPENDIX 3, Figure A3.4).
In our ITC studies of Ni-ZnHypA binding to apo-UreE2, both isotherms observed were
distinct from the apo-ZnHypA interaction with UreE2 (Figure 4.2) and therefore cannot be
definitively attributed to the same interactions. The isotherms observed for Ni-ZnHypA
interactions with apo-UreE2 could be the results of combinations of multiple events with distinct
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heat changes. Some possible interaction events include Ni transfer to UreE2 from HypA, and/or
the dissociation of HypA from Ni-UreE2 after Ni-transfer, and/or Ni-enhanced HypA-UreE2
interaction (thermodynamically distinct from the interactions in apo-forms), and/or Ni site and
protein rearrangements in one or both protein partners.
The number of potential mechanistic steps, each with unknown thermodynamic
parameters, render the unambiguous assignments of the isotherms to specific events improbable.
However, the complexities of the Ni-ZnHypA interaction with apo-UreE2 were partially clarified
by probing some of the possible events that may be involved. To remove transfer of Ni 2+ from
HypA to UreE2 from the process, titrations were carried out under conditions where both the
HypA and UreE2 Ni-binding sites are saturated with Ni2+. Since HypA has been hypothesized to
bind and then transfer Ni2+ to UreE2,24,

28

one anticipated outcome was that the HypA-UreE2

complex would not form with Ni-UreE2, or that the protein-protein affinities would be reduced.
However, titration yielded an unexpected outcome: compared to apo protein-protein interactions
with Kd ~ 2 μM at both pH, the affinity of the HypA-UreE2 complex is markedly enhanced under
saturating Ni2+ concentrations with Kd = 20 ± 9 nM at pH 7.2, and Kd = 4.5 ± 2.9 nM at pH 6.3
(Figure 4.3 and Table 4.1). The pH dependency indicates that the complex is about 10-fold tighter
under acidic conditions. In addition, SEC-MALS showed that the complex stoichiometry under
these conditions (1 HypA: 1 UreE2) was not affected by pH (Figure 4.5). The complex was
separated chromatographically and analyzed for Ni and Zn content, which showed that NiZnHypA-UreE2 contained a Ni:Zn ration of 1.1:1 at pH 7.2, and 1.3:1 at pH 6.3. The results are
consistent with the formation of a HypA-UreE2 protein complex containing a single tight Nibinding site, since the Ni content is equal to the Zn content of the HypA protein present in the
complex.
A long-standing hypothesis in the field proposes that HypA acquires and then delivers
Ni2+ to UreE2 (Figure 4.1, path 1C and 1D).19, 24 Prior in vitro and in vivo experiments performed
to elucidate Ni-transfer from HypA to UreE2 yielded ambiguous results indicating that UreE2 was
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able to acquire Ni2+ directly as well as from HypA.19 Transfer of Ni from GSHypA to UreE2 was
demonstrated with Ni-specific cross-linking and then forcibly separating the protein complex
under denaturing conditions, in support of the hypothesis that HypA transfers Ni2+ to UreE2,
which has the tighter Ni-binding affinity of the two isolated proteins.28 This hypothesis suggests
that Ni-UreE2 may no longer interact with apo-ZnHypA following the transfer, or that the
interaction would weaken significantly (Figure 4.1 Path 1F). However, the Ni-ZnHypA-UreE2
complex remains intact in SEC at sub-micromolar concentrations, indicating that neither Ni2+ or
ZnHypA are likely dissociates from this tight complex (Figure 4.5) without further disruptions.
The results presented here are more consistent with an alternative mechanism wherein a
tight protein complex is formed between Ni-ZnHypA and UreE2 (Kd ~ low nM, Figure 4.1 path
1D) that has higher affinity than the complex formation between apo-ZnHypA and UreE2 (Kd ~ 1
μM, Figure 4.1 path 1A). This complex creates a single novel Ni-binding site with higher affinity
(Kd ~ 0.2 – 3 nM, Figure 4.1 path 1B) than either Ni2+ binding to HypA (Kd ~ 1 μM, Figure 4.1
path 1C) or UreE2 (Kd ~ 60 nM, Figure 4.1 path 1E) individually. This mechanism explains the
observation of a high-affinity binding event observed in the titration of Ni-ZnHypA into UreE2
shown here (Figure 4.2 and Figure 4.3, Table 4.1), and possibly also those observed by BLI and
SPR.20 The fact that the Ni-ZnHypA-UreE2 complex contains a new tight Ni-binding site, rather
than the weaker Ni-binding sites associated with the isolated protein, suggests that it is located at
an interface and is composed of ligands from both proteins in the complex. The shared Ni-ligands
hypothesis is supported by the loss of the high affinity Ni binding event when the native HypA
Ni-site in the complex is was altered by substituting with the L2*-HypA variant (APPENDIX 3,
Figure A3.4). The formation of the complex also reduced the hydrolysis of the UreE peptides in
the complex (Figure 4.6), thereby increasing the stability of the Ni delivery system and providing
another mechanism for control of Ni incorporation into UreE. The fact that the Ni-ZnHypAUreE2 complex formation is enhanced at pH 6.3 (Figure 4.3) provides a possible mechanism for
increased Ni delivery to the urease maturation pathway under acid shock conditions.
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Prior studies in BLI experiments demonstrated that HypA outcompetes UreG (urease
accessory protein with GTP hydrolysis activity) for binding to UreE2.20 In contrast, size exclusion
chromatography of protein mixtures found that formation of the UreE2-UreG2 complex was
favored over GSHypA-UreE2 in the presence of GTP and Mg2+.24 The same study also found that
GTP-hydrolysis by UreG was significantly enhanced by the presence of the Ni-GSHypA-UreE2
or Ni-UreE2, but to a lesser degree with either Ni-GSHypA or Ni2+.24 Taken together, the
disruption of the tight Ni-ZnHypA-UreE2 complex likely requires Ni- and GTP-induced
dimerization of UreG, which favors GTP-hydrolysis.21 The requirement of GTP-bound UreG2 for
disrupting the Ni-ZnHypA-UreE2 complex likely enhances the fidelity of Ni delivery to the
urease maturation pathway. In this way, the results of this study, along with previous studies,19, 20,
24

indicate that HypA and UreE2 act as co-metallochaperone that form the Ni-ZnHypA-UreE2

complex, offering both tight Ni-coordination and fidelity of release, for Ni delivery to apo-urease
in H. pylori.
4.4

Conclusions
The results presented here suggest that a ZnHypA-UreE2 complex acts as an enhanced

Ni-metallochaperone for delivering Ni2+ to the urease maturation pathway in H. pylori. Unlike
UreE in other urease-containing organisms, the short C-terminal Ni-binding motif in H. pylori
UreE has a lower Ni-binding capacity12 and tends to be degraded.8-11 With Ni2+ binding at the
dimer interface in Ni-UreE2, even the degradation/instability of the C-terminal Ni-binding motif
in just one subunit in the UreE2 would hamper its ability to retain Ni2+. Given the high level of
expression of apo-urease in H. pylori at both neutral and low pH, the low Ni-binding capacity in
H. pylori UreE2 may be an additional mechanism for preventing over-activation of urease at
neutral pH. The formation of the HypA-UreE2 complex stabilizes and slows the degradation of
the C-terminal domain of UreE proteins. This level of control would require a Nimetallochaperone enhancer, such as HypA, for UreE2 under acid-shock conditions. Indeed, acidinduced up-regulation of hypA has been previously reported.30, 35 The current studies demonstrate

138

that HypA binding to UreE2 enhances the affinity, capacity, and retention of Ni2+ in the complex.
This complex does not dissociate at sub-micromolar concentrations, as HypA dissociation was
previously shown to require GTP-bound UreG2 or denaturing conditions.24,

28

This mechanism

ensures delivery of Ni2+ to the urease maturation cascade, and resolves the HypA-requirement in
H. pylori urease maturation by establishing its role as a co-metallochaperone in Ni-delivery to
apo-urease.
4.5

Methods

4.5.1

Protein overexpression, purification, and preparation
Untagged WT-HypA and L2*-HypA proteins were overexpressed in E. coli strain DL41

(DE3) pLysS transformed with the PJI110 plasmid, and then purified using ion exchange and size
exclusion columns as previously described.11
Overexpression of the untagged WT-UreE2 proteins was achieved from E. coli expression
cell lines transformed with the pET15b::HpureE plasmid9, generously donated from Professor
Stephano Ciurli’s lab (Univ. of Bologna). The pET15b::HpureE plasmid was first amplified and
the open-reading frame was confirmed to match the reported H. pylori G27 UreE protein
sequence (GenBank Accession: Number ABM16833) prior to transformation into DL41 (DE3)
pLysS or BL21 (DE3) pLysS cell lines. Transformed cells were plated on LB-agar plates
supplemented with a final concentration of 100 μg/mL of ampicillin (Amp) and 34 μg/mL of
chloramphenicol (Cam) and were used for overexpression within one month of transformation. A
single colony selected from the transformed plate was used to inoculate small scale (50 – 150
mL) aliquots of sterile liquid LB culture media supplemented with Amp and Cam and grown at
37 ˚C with shaking (200 rpm) until saturation (> 6 hours). A 1:100 dilution of the small saturated
culture was scaled to a large (1 or 2 L) culture using sterile liquid LB culture supplemented with
only Amp and then grown at 37˚C with shaking until the OD600 reached ~0.6 (approximately 3
hours). Protein overexpression was induced by addition of isopropyl β-D-1-thiogalactopyranoside
(IPTG) to a final concentration of 0.4 mM and then dropping the temperature to 25˚ C for 5
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hours. Cells were separated from residual media by centrifugation at 5,500 x g for 8 minutes and
then resuspended in SP A Buffer (20 mM HEPES, 1 mM TCEP, pH 7.2) and then
phenylmethylsulfonyl fluoride (PMSF) and SigmaFast EDTA-free protease inhibitor cocktail
(Sigma) was added to the resuspended cells to a final concentration of 1mM prior to freezing and
storage at -80 ˚C.
Cells were thawed in a 30˚C water bath and were lysed upon thawing. PMSF was added
to the lysate to 2 mM final concentration. The genomic DNA in the cell lysate was cleared by
digestion with 20 μL of 10 mg/mL DNase I (Worthington) per liter of culture for 30 minutes in a
30˚C water bath. The insoluble fraction was removed from the lysate by centrifugation at 15,000
x g for 30 minutes. The soluble clarified lysate from 2 L of cells was diluted to 50 mL with SP A
Buffer for purification using an AKTA FPLC system (Amersham Biosciences/GE Healthcare
Life Sciences) equipped with a packed column (9 mL column volume) of SP Sepharose HighPerformance resin (GE Healthcare Life Sciences). The SP Sepharose column was first preconditioned with 3 column volumes of SP A Buffer, followed by 3 column volumes of SP B
Buffer (20 mM HEPES, 1 M NaCl, 1 mM TCEP, pH 7.2), and then washed with SP A buffer
until the conductance was stabilized. The clarified diluted lysate is applied to the SP Sepharose
column at 3 mL/min, following which nonspecifically bound proteins were washed off with 5
column volumes of 5% SP B Buffer. The bound proteins were eluted using a linear gradient of SP
B Buffer from 5 – 60% over 10 column volumes. UreE2 protein typically elutes off the column
between 17 – 27% SP B Buffer. Fractions collected from SP Sepharose columns were separated
on 16% SDS-PAGE to confirm the presence of UreE2 protein.
Fractions containing UreE2 were further purified using a 120-mL column volume HiLoad
Superdex 75 16/60 column (GE Healthcare Life Sciences) pre-equilibrated with GF Buffer (20
mM HEPES, 200 mM NaCl, 1mM TCEP, pH 7.2). Combined fractions from SP Sepharose were
loaded onto the HiLoad Superdex 75 at no more than 3 mL (5 – 10 mg/mL) per column and all
fractions were collected and analyzed using 16% SDS-PAGE, with UreE2 typically coming off
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the column starting at 81 mL after injection. Fractions were assessed for purity and were reloaded onto the HiLoad Superdex75 column for additional purification as needed. Pure fractions
were pooled and then concentrated using a Vivaspin 20 (Sartorius) centrifugal concentrator with a
10-kDa MWCO. Purity and quality of the protein was reassessed by 16% SDS-PAGE
(APPENDIX 3, Figure A3.5) and quantified using the Odyssey CLx Imaging System (LI-COR),
with only fractions at >90% purity used for experiments. The actual mass of the purified protein
was confirmed by ESI Mass Spec to be 19408.84 Da (theoretical mass of 19407.5).
Purified proteins were concentrated to 0.2 – 1.2 mM and then flash frozen with liquid N2
and stored at -80 ˚C (for up to one year) and were rapidly thawed in a room temperature water
bath as needed for experiments. All protein samples used for experiments were prepared by
rapidly buffer exchanging concentrated protein using 0.5 mL Zeba Spin Desalting Columns with
a 7-kDa MWCO pre-equilibrated with the desired buffer at Ph 7.2 or 6.3 as needed. Protein
concentration as well as metal analysis were remeasured to account for any protein loss prior to
final dilution of the proteins into to the appropriate concentration for experiments. For all
experiments involving Ni-ZnHypA, the apo-ZnHypA protein was first reconstituted with two
molar equivalents of Ni2+ with excess Ni2+ removed by Chelex 100 resin11 prior to desalting into
appropriate buffers for experiments. All samples of Ni-ZnHypA proteins used in experiments
contain 0.8 – 1.1 Zn and 0.9 – 1.0 Ni per HypA. Each batch of UreE2 used in experiments was
confirmed to be less than 2% metal loaded (Ni or Zn) as measured by ICP-OES (see below).
4.5.2

Inductively coupled plasma-optical emission spectroscopy (ICP-OES)
ICP-OES was used to analyze the metal content (Ni, Cu, and Zn) of protein and metal

solutions with sample preparation and method as previously described (3.4.15).11 Analyses of the
metal concentrations of the HypA-UreE2 complexes were also performed using ICP-OES, where
peak fraction collected from SEC-MALS (vide infra) was directly analyzed without further
dilution.
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4.5.3

Isothermal titration calorimetry (ITC)

ITC measurements of Ni-protein and protein-protein interactions were performed as previously
described11 using an Auto-ITC200 (MicroCal) with slight modifications. ITC experiments were
performed in GF Buffer or NTP Buffer (20mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM
MgCl2, 1 mM TCEP) with the final pH adjusted to 7.2 or 6.3 and then filtered through a 0.22 μm
membrane. No changes were observed in isotherms obtained from experiments performed in
either GF Buffer or NTP Buffer (APPENDIX 3, Figure A3.6).
All proteins used in ITC experiments were prepared as described (vide supra). All Ni2+
solutions used for titration into protein or protein complexes were diluted from a stock of 500
mM NiCl2 (in MilliQ water) into the same buffer as the protein solutions in the cell. The metal
concentrations of each metal in the appropriate buffer solution used in ITC experiments were
confirmed by ICP-OES.
ITC titrations were performed at 25˚C with the reference cell filled with the same buffer
as the experiment. Each titration curve was the result of one injection of 0.4 μL, followed by 19
injections of 2.0 μL from the syringe into the cell with 150 – 600 seconds between each injection,
depending on the baseline. For each set of interactions, the heat of dilution was established by
injecting the appropriate buffer into the cell filled with the same protein or protein complexes.
The results from ITC titrations were fitted with the MicroCal ITC Analysis Module in
Origin 7.0. Raw ITC data was first baseline corrected and then integrated to produce the initial
∆H curve, from which the averaged ∆H from the heat of dilutions from buffer injections was
subtracted to produce the final ∆H curve for each titration. The first injection (0.4 μL) was
excluded from use in fitting as appropriate (it is typically used to eliminate equilibration
artifacts). The remaining data points were fitted to OneSite and/or TwoSites models to produce
the best χ2 values and visually appropriate fits. The inverses of the fitted K values were taken as
the apparent dissociation constants (Kd) values. The reported Kd values and associated errors
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reported were the averages and standard deviations of three or more independent ITC titrations
(unless otherwise noted) for each interaction.
4.5.4

Fluorescence protein-protein interaction

Fluorescence measurements of protein-protein interactions were performed in MST Buffer (20
mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2, 1mM TCEP, and 0.02% Tween 20) at
pH 7.2 or 6.3 for Apo-ZnHypA titrations into UreE2, and with an additional 1 μM NiCl2 added
for Ni-ZnHypA titrations into UreE2. HypA protein samples were prepared as described in the
Protein overexpression, purification, and preparation section (vide supra). Purified UreE2 was
labeled with the amine reactive Monolith Protein Labeling Kit Red-NHS (MO-L001,
NanoTemper Technologies) by reacting a solution of a 3:1 dye:protein ratio for 30 minutes in the
dark. Excess dye was removed using a 0.5 mL Zeba Spin Desalting Column with a 7-kDa
MWCO that was pre-equilibrated with MST buffer at pH 7.2 or 6.3. Protein concentrations and
dye:protein ratios were re-evaluated using UV-Vis (with protein absorbance at 260nm and dye
absorbance at 650nm) after dye removal to account for protein loss in the column. The resulting
NHS640-UreE2 protein sample was rapidly frozen with liquid N2 in small aliquots and stored at 80˚C and used for experiments within one year. Both HypA and NHS640-UreE2 proteins were
centrifuged at 15,000 x g for 15 minutes to pellet potential aggregates prior to dilution to the
appropriate concentration for protein-protein titration experiments.
Titration samples of HypA into NHS640-UreE2 were prepared by serial dilution of the
HypA protein into the appropriate MST Buffer and then adding equal volumes of NHS640-UreE
to each HypA sample. The resulting titration series contains 16 samples with a constant
concentration of fluorescently labeled NHS640-UreE2 (15 – 17 nM) and increasing
concentrations of HypA from sub-nM to μM range. The protein samples were loaded into
Monolith NT.115 premium coated capillaries (MO-K005, NanoTemper Technologies) and the
fluorescence of each tube was measured using the Monolith NT.115 Nano-Green/Red instrument
at 50 – 100% LED power for 5 seconds. In each titration series, the initial fluorescence of
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NHS640-UreE2 changed by 10% or more with increasing concentrations of HypA. The raw
fluorescence counts collected for each data point in the titration curve was plotted against the
concentration of HypA and then fitted using the NanoTemper MO.Affinity Analysis software
(MO-S001A). A modified version of the mass action function was used to fit each titration curve:
𝐹(𝐿) = 𝑈𝑛𝑏𝑜𝑢𝑛𝑑 +

(𝐵𝑜𝑢𝑛𝑑 −𝑈𝑛𝑏𝑙𝑢𝑛𝑑)
2

∗ (𝑇𝑎𝑟𝑔𝑒𝑡𝐶𝑜𝑛𝑐 + 𝐿 + 𝐾𝑑 −

√(𝑇𝑎𝑟𝑔𝑒𝑡𝐶𝑜𝑛𝑐 + 𝐿 + 𝐾𝑑 )2 − 4 ∗ 𝑇𝑎𝑟𝑔𝑒𝑡𝐶𝑜𝑛𝑐 ∗ 𝐿)

Eq. 4.1

Fits were also performed for each set of data using the Hill’s Equation:
𝐹(𝐿) = 𝑈𝑛𝑏𝑜𝑢𝑛𝑑 + (

(𝐵𝑜𝑢𝑛𝑑−𝑈𝑛𝑏𝑜𝑢𝑛𝑑)
𝐾
1+( 𝑑 )

𝐻

)

Eq. 4.2

𝐿

where L is the variable concentration of HypA, Unbound is the concentration of free UreE2, and
Bound is the concentration of the HypA-UreE2 complex, TargetConc is the concentration of total
UreE2, Kd is the apparent dissociation constant of the HypA-UreE2 complex, and H is the Hill
coefficient. In each case the total UreE2 concentration (TargetConc) is known and set as a
constant for fitting. In each case, best χ2 values and visually appropriate fits were reported. The
reported Kd values and associated errors for each set of interactions were the averages and
standard deviations from three or more independent titrations.
To rule out the possibilities of that the observed HypA-dependent fluorescence change
was caused by pipetting errors, protein aggregation, or NHS640-UreE2 sticking to the tubing at
high- and low- HypA concentrations, SD tests were performed for each titration. The SD tests
involves removal of potential aggregates from select samples by centrifugation, followed by
reducing and denaturing the samples with SD-mix (8% SDS, 80mM DTT) and heat to disrupt all
interactions with the fluorescently labeled molecule. The resulting samples should have the same
fluorescent signal for high and low concentrations of the non-fluorescent ligands in the titration
series. SD tests were performed for samples containing the highest and lowest concentration of
HypA in the HypA-NHS640-UreE2 titration series. These samples were centrifuged for 15
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minutes at 15,000 x g to pellet any protein aggregates, and then a 10 μL aliquot of each sample
was removed and mixed with 10 μL of SD-mix and then heated at 90 ˚C for 5 minutes. The SDtreated samples were cooled to room temperature and then loaded into Monolith NT.115 standard
coated capillaries (MO-K002, NanoTemper Technologies) and the fluorescence of the SD-treated
samples were measured alongside the corresponding native samples. The results show similar
levels of fluorescence in SD-treated samples with high- and low-HypA concentrations, and 10%
or more change in fluorescence in the corresponding native samples (APPENDIX 3, Figure
A3.7). These results confirmed that the HypA-dependent fluorescence changes in NHS640-UreE2
were the results of HypA-UreE2 interactions and not a result of pipetting errors, protein
aggregation, or protein sticking to tubing.
4.5.5

Size exclusion chromatography with multi-angle light scattering (SEC-MALS)
SEC-MALS was performed using a modified version of a previously described method.11

The instrument setup consisted of a combination of an Agilent HPLC running a TSKgel
G2000SWxL column (Tosoh Bioscience) attached to the DAWN HELEOS II light scattering
detector (Wyatt Technology) and the Optilab T-rEX refractometer (Wyatt Technology).
Experiments were performed at 25 ˚C, with the system was equilibrated with NTP Buffer at pH
7.2 or 6.3 at 0.5 mL/min. Individual proteins were prepared as described in the protein
overexpression, purification, and preparation method section (vide supra). An injection volume of
50 μL was used for all samples analyzed, with the protein concentration at 75 μM for Apo- or NiZnHypA individually, 25 μM for UreE2 individually, and 75 μM of Apo- or Ni-ZnHypA
combined with 25 μM UreE2 for protein complexes. Proteins eluting off the column were
monitored by multiple channels on the instrument including: UV at 280nm, light-scattering at 664
nm with multiple angled (13 – 157.8˚) detectors, and refractive index at 658 nm. Each
chromatograph was processed using the Astra 6 software package (Wyatt Technology) as
previously described.11 The system and data processing method was calibrated by measuring the
absolute mass of bovine serum albumin (expected 66.5 kDa, SEC-MALS 64.9 kDa) to ensure
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accurate mass determination. Peaks from injections of protein complexes were manually collected
following the last module (Optilab T-rEX) in the instrument set-up according to the changes in
refractive index measurement with each collected peak range from 0.5 – 0.9 mL in total volume
depending on the broadness of the peak. Collected peak samples were analyzed with ICP-OES to
deduce the metal content of individual HypA and HypA-UreE2 complexes.
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CHAPTER 5
CONCLUSIONS AND FUTURE DIRECTIONS
5.1

Discussions and conclusions
The abundant use of the Ni-dependent enzyme, urease, is one of the major adaptations that

allow the human pathogen Helicobacter pylori to colonize the acidic human stomach,1-4 ensuring
the rapid activation of enzyme upon acid stress by insertion of Ni into the urease active site.5 In
addition to the urease-specific accessory proteins UreEFGH, the full activation of urease also
required the accessory proteins HypA and HypB, which are associated with Ni insertion into the
NiFe-hydrogenase (H2ase).5, 6 Thus, the accessory proteins HypA and HypB are pivotal for the
maturation of Ni-dependent enzymes within H. pylori.
While the role of HypB (discussed in APPENDIX 1) in urease maturation remain
uncertain,7-9 the link between the Ni-metallochaperone HypA and the urease maturation pathway
was established through its direct interaction with the urease-specific Ni-metallochaperone,
UreE2.10-13 The small HypA protein (13 kDa) contains two conserved metal sites, the structural Zn
site involving two CXXC motifs, as well as the Ni site using the N-terminal MHE-motif.14-18 The
work presented in this dissertation seeks to further explore the role of the Ni-metallochaperone
HypA in the Ni-dependent acid adaptions of H. pylori. Our findings were summarized in the
model shown in Figure 5.1.
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Figure 5.1: Model summarizing the role of HypA in H. pylori Ni enzyme maturation.
The available Ni pool within the cells bound by proteins, peptides, or small molecules
(represented as squiggles). Ni-trafficking pathways are shown in green arrows and pathways to
other cellular processes are shown in black arrows, where thin arrows represent minor pathways.
The red X indicates the lack of a contribution for H2ase in the acid resistance mechanisms in H.
pylori. Proposed HypA Ni and Zn sites are shown in boxes.
5.1.1

Hydrogenase is not required for acid adaptation in H. pylori
The only other Ni-dependent enzyme in H. pylori, NiFe-H2ase, has been characterized as

a membrane-bound enzyme that oxidizes molecular H2 (presumably produced by intestinal flora
in the host) to protons and electrons.19,

20

H2ase has also been shown to be increase initial

colonization density in Mongolian gerbil infection models.20,

21

While this phenotype was

attributed to its use of H2 as an alternate energy source,20 its potential contribution to acid
adaptability was not addressed until our present study. A variant strain of H. pylori G27 that lack
H2ase activity was created, by deleting the hydB gene, which coded for the Ni-containing large
subunit of H2ase. H2ase and urease assays confirmed that the ∆hydB strain exhibit WT-like in
urease activity CHAPTER 2, Figure 2.2B), but does not have H2-oxidation activity (CHAPTER
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2, Figure 2.2A). In acid shock challenge, the ∆hydB strain also exhibit WT-like survival
(CHAPTER 2, Figure 2.3D), whereas the urease-deficient strain (∆ureB) did not survive the acid
challenge. These results were independently verified in the ∆hydABCDE strain in the H. pylori
26695 background (CHAPTER 2, Figure 2.4).
Our results indicate that H2ase is not part of the acid adaptive mechanism in H. pylori.
The initial boost in infection density observed in Mongolian gerbils with H2ase-active strains
were not a result of increased acid adaptations, and are more likely related to the coupling of
H2ase activity to increased activity in the H. pylori type IV secretion system (T4SS) in modifying
the host immune system.21 Since both H2ase and urease rely on the presence of HypA for Niinsertion, these two enzymes must compete for activation.
5.1.2

Proper HypA metal site structures are important for Ni-enzyme maturation and

acid survival
Previous structural characterizations of Ni-bound H. pylori HypA indicated that the Zn site
coordination is dynamic, changing from an averaged Zn(Cys)4 site at pH 7.2 to a Zn(Cys)2(His)2
site at pH 6.3 (CHAPTER 1, Figure 1.6).15 Structural changes were lost with ligand substitution
or loss of any of the Cys residues that constituted the conserved CXXC (C74, C77, C91, C94)
motifs, or the loss of either of the flanking His residues (H79 or H95) (CHAPTER 3, Figure
3.1).16 The endogenous hypA gene in H. pylori was replaced with the coding sequences for the
HypA Zn site variants. These hypA Zn site variant strains were then tested for acid survival, as
well as H2ase and urease activities.18 Our results show that the non-conserved His residues are
generally not important for acid survival or enzymatic activities (CHAPTER 3, Figure 3.3).18 The
conserved Cys residues are generally important for enzymatic activities, but only the C74D,
C91A, and C94A variant strains were deficient in acid survival (CHAPTER 3, Figure 3.2 Figure
3.3)18 These results indicate that although mutation of any Cys residues in the CXXC motifs
resulted in the same averaged structure at the Zn site [Zn(Cys)2(His)2], certain positions in the
CXXC motifs are more significant than others in enzyme maturation.18 Taken together, our
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studies suggest that the proper Zn site coordination in HypA is required for efficient maturation
of urease and H2ase, and that the residues that are important for the maturation of urease are also
important for H2ase. Additionally, full urease activation is not necessary for short term acid
survival (1 hour at pH 2.3, with 5 mM urea supplement).18
The Ni coordination to the N-terminal amine of HypA was also established and its effects
were investigated. The L2*-HypA variant was created, wherein an Leu residue was inserted
between the conserved Met1 and His2 residue, thereby extending the N-terminal amine one
residue further away from the known Ni-binding site. Structural and magnetic property studies
show that the L2*-HypA variant is five-coordinate and diamagnetic, having lost two N/O-ligands
(presumably contributed by the protein), one of which was replaced by a buffer anion as
compared to WT (CHAPTER 3, Table 3.1 and Figure 3.7), which is six-coordinate and
paramagnetic.17 This change in coordination and magnetic properties in L2* is similar to a
previously characterized N-terminal extension variant GSHypA (Gly-Ser overhang at the Nterminus leftover from cleavage of an affinity tag).14 H. pylori strains expressing the L2*-HypA
protein are also deficient in acid survival, and lack H2ase and urease activities (CHAPTER 3,
Figure 3.8 and Figure 3.9).17 This phenotypic deficiency is best explained by a decrease in Nibinding affinity by one order of magnitude compared to WT-HypA (CHAPTER 3, Table 3.2, and
Figure 3.11 and Figure 3.12).17 While the affinity of the protein-protein interactions between apoZnHypA and apo-UreE2 (CHAPTER 3, Table 3.2 and Figure 3.10) were unaffected by the L2*
mutation.17
5.1.3

HypA and UreE2 act as co-metallochaperone in delivering Ni for urease maturation
HypA has been hypothesized to hand-off Ni to UreE2 in the urease maturation pathway,13

enabling Ni-UreE2 to deliver Ni to the rest of the maturation complex: UreH-UreG2-UreF2UreH.22 However, the HypA-UreE2 complex does not appear to dissociate without either
denaturation13 or the presence of UreG2 (along with Mg2+ and GTP),23 indicating a more involved
role than the Ni hand-off mechanism. We systematically investigated the interaction of Ni with

153

HypA, UreE2, and the HypA-UreE2 complex (CHAPTER 4, Table 4.2, and Figure 4.4), as well as
the protein-protein interactions between HypA and UreE2 with and without Ni (CHAPTER 4,
Table 4.1, and Figure 4.2 and Figure 4.3), at pH conditions that simulate the internal pH of H.
pylori at neutral (pH 7.2) and under acid shock (pH 6.3) conditions. We found a new Ni-binding
site was formed in the HypA-UreE2 complex that is tighter than Ni-binding to either protein
individually (CHAPTER 4, Figure 4.4). Contrary to the prediction of a Ni hand-off mechanism
from HypA to UreE2, Ni-ZnHypA interactions with Ni-UreE2 persisted and are enhanced
compared to the interactions of the two apo-proteins (CHAPTER 4, Figure 4.3). Moreover, the
Ni-ZnHypA-UreE2 complex is stable at sub-micromolar concentrations (CHAPTER 4, Figure
4.5), with neither Ni or apo-ZnHypA dissociating from the complex, as expected from a simple
Ni hand-off mechanism. Our results indicate that HypA and UreE2 form a tight complex, which
act as co-metallochaperones in Ni delivery to the urease maturation pathway. In prior studies, the
dissociation of the GSHypA-UreE2 complex was promoted by the presence of UreG2 (along with
Mg2+ and GTP),23 which would ensure the fidelity in Ni delivery to the urease maturation
pathway.
5.2

Future Directions

The role of HypA as a co-metallochaperone along with UreE2 in Ni delivery, as well as the
importance of the unmodified metal sites within HypA, in the activation of urease confirmed that
Ni delivery involving HypA is an essential part of the post-translational regulation of urease
activation in H. pylori. With the abundance of apo-urease produced at both neutral and acidic
pH,4 the multi-level regulation of its activity is essential for the survival and adaptability of the
cell in the host stomach.24 Alternately, H. pylori may divert Ni to the H2ase maturation pathway.
Based on infection studies in Mongolian gerbil models, elevation of H2ase activity is associated
with more virulent infections (increase initial infection density; and prolong inflammation and
host cell transformation in cagA-positive strains).20, 21 Understanding the underlying mechanisms
of diverging Ni co-factors between H2ase and urease may lead to better treatments and/or more
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effective eradications of particularly virulent strains if H. pylori. The future directions suggested
here pertain to additional layers in the regulation of urease and H2ase activities within H. pylori
by controlling Ni availability.
5.2.1

UreE2 stability as a mechanism for controlling urease activity
Ni supplementation in the growth media can restore the urease activity to ∆hypA strains

but not in ∆ureE strains of H. pylori.6 However, purified H. pylori UreE2 proteins have been
documented to be degraded at the C-terminal motif,17, 25, 26 which resulted in loss of interaction
with HypA and potential loss of Ni-binding.13 Formation of the HypA-UreE2 complex have been
shown to stabilized UreE2 (CHAPTER 4, Figure 4.6) and slow the degradation at both neutral and
acidic pH, in the presence and absence of Ni. This observation led us to the hypothesis that the
C-terminal degradation of UreE2 is part of the mechanism for controlling the activity of urease.
To further test this hypothesis, the stability of the UreE peptide(s) should be tested in vivo.
One of the most unambiguous ways to test the stability of the UreE peptide is through
Western blotting of the whole cell lysate. The full-length and C-terminally degraded UreE
peptides separate into discrete bands in 16% SDS-PAGE (CHAPTER 4, Figure 4.6) in relatively
dilute conditions. Therefore, SDS-PAGE can be used to separate these peptides in whole cell
lysate. H. pylori cells grown at neutral and acidic pH should be compared for the relative
abundance and ratio of full-length versus C-terminally degraded UreE peptide. Since the hypA
gene is transcriptionally upregulated in acid stress, it is expected that the HypA protein levels
would be increased under acidic growth conditions. Therefore, the ratio of full-length UreE
peptide to C-terminally degraded peptide is expected to be greater in cultures grown under acid
conditions compared to those grown under neutral conditions. Western Blots of an invariable
cellular protein, UreB, and HypA proteins should also be conducted as a control for loading, as
well as confirming the expected increase in UreB and HypA levels under acidic growth. AntiUreE,27 anti-HypA,10 and anti-UreB7 antibodies were previously described from work in the
Maier lab (University of Georgia, Athens, GA).
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To confirm the role of HypA in stabilizing the UreE peptide, a variant strain of H. pylori
should be constructed that constitutively overexpresses (OX) the WT-HypA or Ni-binding
deficient variant of HypA (such as L2*-HypA). Additional controls would include the hypA::kansacB strain, which do not express a functional HypA peptide. All cells should be grown at the
same pH conditions (neutral) and in media with a consistent and known concentration of Ni. The
ratio of full-length to C-terminally degraded UreE peptides in the hypA-OX strains is expected to
be higher than WT (G27 parental) strain, and the hypA::kan-sacB strain is expected to have the
lowest full-length UreE2. It is unclear whether the strain overexpressing the L2*-HypA protein
would protect UreE from degradation, although it is expected to, since N-terminally modified
HypA (GSHypA13 and L2*-HypA17) persisted in forming tight complexes with UreE2. Thus far
the protection of UreE by complex formation with HypA does not appear to be Ni-dependent
(CHAPTER 4, Figure 4.6), although Ni-dependence should be reevaluated within the cell. The
urease activity assays of these strains should be tested to confirm the expected increase in urease
activity in strains overexpressing the WT-HypA protein.
5.2.2

High affinity Ni-binding site in the HypA-UreE2 complex
We observe a tight binding event (Kd ~ 0.2 – 3 nM) in the titration of Ni into the

preformed apo-ZnHypA-UreE2 complex that was not observed in the binding of Ni to either
proteins individually (CHAPTER 4, Table 4.2). This binding event was not observed in the
titration of Ni into the L2*-HypA-UreE2 complex, where the Ni site in HypA was disrupted. The
interaction of Ni-ZnHypA with apo-UreE2 also produced a tight binding event (Kd ~ 0.6 nM) that
was absent from the interaction of the apo-proteins (CHAPTER 4, Table 4.1). These events point
to the formation of a unique high-affinity Ni-binding site within the ZnHypA-UreE2 complex that
involves ligands from both proteins (i.e. at an interfacial site).
The structural characterization of this potential new Ni site would further support the role
of HypA and UreE2 as co-metallochaperones in Ni-delivery. XAS studies of the Ni sites in Ni-
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ZnHypA15-17 and Ni-UreE228 indicate that these proteins each form six-coordinate complexes with
Ni, containing all N/O ligands. XAS characterizations of the Ni-ZnHypA-UreE2 complex
compared to the Ni complex with either protein should reveal whether this new high-affinity site
is unique. The Ni-ZnHypA-UreE2 Ni K-edge is expected to be different from Ni-complex with
either protein alone (Figure 5.2).

Figure 5.2: XAS Ni K-edge overlay of Ni-UreE2 and Ni-ZnHypA.
Comparison of published Ni K-edge XANES (top) and EXAFS (bottom) spectra [k3-weighted
unfiltered EXAFS data (left) and Fourier-transformed data (right)] for Ni-complexes with H.
pylori UreE228 and HypA17.
We expect that the ligands from each protein contribute to the formation of the new Ni
site within the Ni-ZnHypA-UreE2 complex. This hypothesis was supported by the loss of the
high-affinity binding site when Ni was titrated into the ZnL2*HypA-UreE2 complex, resulting in
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a single binding event (Kd ~ 20 nM) with affinities similar to Ni binding to UreE2 (Kd ~ 60 nM)
alone (APPENDIX 3, Figure A3.4). Additionally, replacing the endogenous hypA gene with L2*hypA resulted in loss of urease activity (CHAPTER3, Figure 3.9) and acid survival (CHAPTER 3,
Figure 3.8) in H. pylori cultures, indicating that the N-terminal amine plays a crucial role in the
urease maturation pathway. Comparison of the Ni K-edges of the Ni-ZnWTHypA-UreE2 and the
Ni-ZnL2*HypA-UreE2 complexes will definitively reveal whether the N-terminal amine is a
ligand in the new Ni-ZnHypA-UreE2 complex. Additionally, comparison of the Ni K-edge of the
Ni-ZnL2*HypA-UreE2 complex with the Ni-UreE2 will definitively reveal whether the loss of the
N-terminal amine as a potential ligand prevents the formation of the high-affinity Ni site formed
by the HypA-UreE2 complex.
The Ni site within the Ni-ZnHypA-UreE2 complex may also be explored using variant
proteins of UreE2, such as H102K and H152A. The H152A variant was previously characterized
to have lower affinity for Ni compared to WT-UreE2, whereas the H102K variant did not bind
Ni.26,

28

The Ni titration into ZnHypA-UreE2 with either of these two variants would reveal

whether one or both of these ligands are involved in the formation of the new Ni site.
Additionally, biophysical characterizations of the interaction between the HypA protein with
these two UreE2 variants would reveal the role of each potential ligand.
In addition to these biophysical and spectroscopic studies of the Ni-ZnHypA-UreE2
complex, efforts to crystalize the complex should be attempted. The crystal structures of UreE2
had already been solved.25, 28 Although the Ni-binding domain of the protein has been disordered
due to degradation of the UreE2 C-terminal domain,25,

28

mutagenesis and XAS were used to

confirm the side-chain of His152 as a Ni-binding ligand.28 We have found that formation of the
ZnHypA-UreE2 complex with or without Ni can slow the degradation process of the UreE2
protein (CHAPTER 4, Figure 4.6). This finding indicated that co-crystallization of these two
proteins may prove to be a valuable tool for gaining structural information. Firstly, co-expression
of the HypA and UreE proteins in E. coli could be accomplished using the pETDuet vectors
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(EMD Millipore). The purified HypA-UreE2 complexes from these cells should therefore have
minimal degradation in the C-terminal domain of UreE. Since the crystallization conditions for
UreE2 has already been published,25, 28 the same conditions should be used to attempt to crystalize
the HypA-UreE2 complex. Success in crystallizing this complex, especially with Ni-bound, will
provide validation of the biochemical data as well as a wealth of information regarding the urease
maturation process.
5.2.3

Role of HypB in Ni-enzyme maturation
Although both hypA and hypB are required for the maturation of H2ase and urease in H.

pylori,6 the role of HypB remain uncertain. Similar to the requirement of HypA, the HypBrequirement for maturation of H. pylori urease is only necessary when Ni is abundant.6 HypB is
small GTPase in the G3E family and part of the SIMIBI class of P-loop NTPases.29, 30 Studies
involving the GTPase-deficient K59A-hypB strain of H. pylori indicate that the GTP-turnover
activity in HypB is more important for H2ase activation than urease (discussed in APPENDIX 1).7
The GTPase activity of the protein has been notoriously sluggish in vitro, leading to hypotheses
that additional cofactors are required to boost its activity.7,

29-31

Recently, potassium (100 mM

KCl) was shown to boost the GTPase activity of HypB by one order of magnitude, whereas
excessive (200 μM) Ni and Zn was found to reduce this activity.30 Although our own studies
along with others in literature31 support that lower concentrations of Ni (5 μM) does not
negatively affect the GTPase activity of HypB, and the addition of 5 μM of Ni along with
stoichiometric concentrations of HypA improves the GTP turnover rate (APPENDIX 1, Table
A1.2 and Figure A1.9).
One hypothesis that may explain this phenomenon is that HypB interacts with HypA and
the Ni-storage proteins within the cells (Figure 5.1), where the presence of both HypA and Ni
stimulates the GTPase turnover in HypB to release Ni for the urease maturation pathway. This
hypothesis is supported by the interaction between H. pylori HypB with known Ni-storage
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proteins, Hpn and Hpn2.32 Hpn appears to be important for upregulating urease activity in Ni
abundant conditions, whereas Hpn2 appears to suppress urease activation in low Ni conditions.32,
33

Several in vitro experiments can be used to characterized the interactions between Hpn, HypA,

and HypB.
The His- and Cys-rich Hpn protein (7 kDa monomer) have been known to form large
oligomers after purification (> 500 kDa) without the presence of 500 mM of imidazole and 5 mM
of DTT.32 These large oligomers were predicted to be also present inside the cell.32 These large
oligomers prevent many traditional biochemical techniques that probe its direct interactions with
HypB. However, the Ni content of proteins can be used to directly monitor whether HypB can
release Ni from the Hpn oligomers.
First, Hpn must be purified32 and then bound to Ni with all excess Ni removed from the
buffer. A portion of the Ni-Hpn complex can be mixed with apo-HypB, and then the HypB
protein can be separated from the Ni-Hpn oligomers after an appropriate incubation period. This
could be accomplished by either using a Zeba Spin desalting column at 40 kDa MWCO or a
Vivaspin protein concentrator at 100 kDa MWCO. The separated fractions should be evaluated
by 20% SDS-PAGE to ensure proper separation of the two proteins. The recovered HypB protein
should be evaluated by ICP to determine whether it was able to extract Ni from the Ni-Hpn
complex. Alternatively, SEC can be used for separating the HypB and Ni-Hpn mixture, although
the large Ni-Hpn oligomers may negatively affect the reproducibility and longevity of the
column. The separation techniques used will concentrate or dilute the Ni content of the protein
complexes, and therefore all fractions must be meticulously collected and then assess as a
percentage of total available Ni in the system.
This experiment should be performed in the presence of buffers that promote GTPase
turnover in HypB (20 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl 2, and 1 mM
TCEP), and the experiment should be repeated at pH 7.2 and 6.3 with and without the presence of
GTP or GDP. Although bacteria two-hybrid assays did not find direct interactions between HypA
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and either Hpn or Hpn2,32 it is possible that HypA can still directly bind Ni from the Ni-Hpn
complex. Therefore, the separation techniques should also be repeated using HypA alone. Our
preliminary results indicate that the presence of HypA and Ni together can stimulate GTPturnover in HypB (APPENDIX 1, Table A1.2 and Figure A1.9). Therefore, we predict that
adding Apo-ZnHypA and apo-HypB together to the Ni-Hpn oligomers would simulate additional
release of Ni, which should be tested directly. These experiments can also be repeated with the
previously characterized GTPase-deficient HypB variant, K59A-HypB.
Systematic deletion of the hpn, hypB, and hypA genes from the H. pylori genome can be
used to assess whether the interaction between HypB and Hpn is linked to the Ni enzyme
maturation pathway. The ∆hypA and ∆hypB effects on urease and hydrogenase activities were
observed in various strain of H. pylori (43504, 26695, G27),6, 8, 17, 18 at least two of which should
be selected for additional deletion of the hpn gene. The control strains of WT, ∆hydB, and ∆ureB;
the single-gene mutants ∆hypB, K59A-hypB, and ∆hpn; and double-mutants ∆hpn-∆hypB and
∆hpn-K59A-hypB would be assessed for urease and hydrogenase activities as well as acid
survivals in the presence and absence of 5 μM of Ni added to the growth media. The ∆hpn strain
is expected not to have deleterious effects on the acid survival, urease, or H2ase activities with or
without Ni supplementation.32 The ∆hypB or K59A-∆hypB are expected to be acid sensitive,
urease- and H2ase-deficient, which is expected to be rescued to varying extents with 5 μM of Ni
added to the growth media. However, the Ni-supplementation is not expected to rescue the ∆hpn∆hypB and ∆hpn-K59A-hypB strains, in acid survival, urease or H2ase activities. These studies
should be repeated with ∆hypA and hypA-overexpression strains to assess the effect of HypA to
the system.
These same assays can be repeated alongside Hpn2 proteins and ∆hpn2 variants strains of
H. pylori. Although the Hpn2 protein properties have been extensively studied, 34 but its
interaction with HypB is less robust and dependent on the Gln-rich C-terminal region of the
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protein. Additionally, the hpn2 gene appear to negatively regulate urease activity, where the
∆hpn2 strains appear to have increased urease activities compared to WT (B128) strain.32
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APPENDIX 1
STRUCTURE, ACTIVITY, AND INTERACTIONS OF HELICOBACTER PYLORI HYPB
A1.1

Introduction
The Helicobacter pylori hypA and hypB genes are required for the maturation of NiFe-

hydrogenase (H2ase),1 and the full maturation of urease under conditions where Ni is not
supplemented in the media.1, 2 The focus of this dissertation has been on the structure, Ni-protein
and protein-protein interactions, and cellular function of the HypA protein in the maturation of
H2ase and urease. Whereas the role of HypB in enzyme maturation has remained mysterious,
despite its known function as a small GTPase.3-8

Figure A1.1: HypB crystal structures
Crystal structures of dimeric Ni-bound HypB from H. pylori (Top, PDB ID 4LPS)6 with subunits
shown in cartoon and colored in teal and light green, Ni (green) and Mg (pink) shown as spheres.
The close-up views of the Ni site at the dimer interface are shown to the right with the side chains
of potential Ni-binding residues shown as sticks. The crystal structure of Zn-bound HypB from
Methanocaldococcus jannaschii (bottom, PDB ID 2HF9)9 is also shown, where subunits are
shown in cartoon and colored in light gray and cyan, with Zn (gray) and Mg (pink) shown as
spheres. The close-up of the interfacial residues corresponding to Ni-binding site in H. pylori
HypB are shown to the right.
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HypB is small GTPase in the G3E family and part of the SIMIBI class of P-loop NTPases.6, 7 The
HypB protein is purified as a monomer and forms homodimers in the presence of Ni and
nucleotides (GTP or GDP).6-8 A crystal structure of H. pylori HypB (Figure A1.1)6 shows that Ni
binds at the dimer interface, coordinating two Cys residues (Cys106 and Cys142) from each
monomer with a His residue (His107) from each monomer close by.6 However, UV-absorption
(at 350 nm) studies of Ni titration into HypB indicate that it could bind up to one Ni per monomer
without nucleotide present, and only one Ni per dimer in the presence of nucleotide.6 A crystal
structure of the M. jannaschii HypB (PDB 2HF9)9 bound to Zn indicate an alternate metal
binding site well away from the interfacial Ni-binding site. It is unclear if oligomeric state or
metal binding affects the interaction of H. pylori HypB with other protein binding partners in the
Ni trafficking system.4, 8 Although HypA and HypB interaction have been characterized using
crosslinking studies,2 the interaction is weak (Kd ~ 60 μM by ITC).8
An active site mutant strain, K59A-hypB, was used in prior studies to investigate the role
of H. pylori HypB GTPase activity in either urease or H2ase maturations.5 These studies found
that the GTPase activity of HypB is essential for both the maturation of both urease and H 2ase in
low Ni conditions.5 However, in Ni abundant conditions (5 μM Ni supplement in growth media)
urease activity was fully recovered and H2ase activity was partially restored, despite the lack of
GTPase activity in the K59A-hypB mutant variant.5 Whereas in hypB deletion strains, 5 μM Ni
supplement in growth media fully rescued the urease activity of the strain, but not the H 2ase
activity.2 These observations indicate H. pylori HypB is also involved in Ni acquisition, like
HypA. Moreover, the GTPase activity of H. pylori HypB appears to be more important in H2ase
maturation than in urease maturation.
This appendix summarizes the work that we have done on the HypB protein to elucidate
its potential role in the maturation pathway of H2ase and urease. Most of the work performed on
HypB is based on the hypothesis of a pH-dependent prioritization of the maturation of H2ase and
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urease, which could be reflected in the preferential interactions between HypA-UreE2 or HypAHypB (Figure A1.2).

Figure A1.2: Hypothesis of pH-dependent maturation of urease and H2ase
The pH-dependent Zn site structural changes in HypA was proposed to alter its overall structure,
leading to preferential interaction with either UreE or HypB, culminating in pH- and Nidependent maturation of urease and H2ase.
A1.2

Results

A1.2.1 H. pylori HypA and HypB do not form stable complexes in SEC
H. pylori HypA and HypB interactions were initially characterized using Immunoblots
that identified a cross-linked HypA-HypB complex.2 The in vivo interactions between the two
proteins were also observed using GFP-fragment complementation assays by expression of the
two fusion proteins in E. coli.8 We initially predict that the H. pylori HypA-HypB complex could
be purified as a complex for structure and functional analyses. However, equimolar mixtures of
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apo-ZnHypA and apo-HypB produced two peaks on size exclusion chromatography (SEC) that
overlapped precisely with the two individual proteins (Figure A1.3) and no other higher
molecular weight peak that indicated a stable HypA-HypB complex. The lack of HypA-HypB
complex formation in SEC is unusual, The HypA-HypB complex (without nucleotides) from
Archaeoglobus fulgidus;10 and several high molecular weight complexes variations were observed
for HypA and the ATP-binding form of HypBAT from Thermococcus kodakarensis.11

Figure A1.3: SEC of apo-ZnHypA and apo-HypB
Superdex 75 10/300 GL column was used to separate 100 μL of protein samples: 40 μM of apoZnHypA, 40 μM of apo-HypB, or a mixture of 20 μM each of the two proteins using GF buffer
(20 mM HEPES, 200 mM NaCl, 1 mM TCEP at pH 7.2 or 6.3) as the mobile phase. SDS-PAGE
of the protein fractions (A1 and A2) collected from resolution of each mixture and the positions
of HypA and HypB are as shown on the gels.
These relatively resolved peaks of purified H. pylori HypA and HypB mixtures indicate
that it may be possible to elucidate the direction of potential Ni-transfer between the two proteins.
Therefore, the experiment was repeated at pH 7.2 with two mixtures containing equimolar
amounts of either (1) Ni-ZnHypA and apo-HypB or (2) apo-ZnHypA and Ni-HypB (Figure
A1.3). The resolution of these two mixtures resulted in chromatographs that resemble the mixture
of apo proteins, where HypA and HypB proteins are well-resolved into two peaks with minimum
overlap. Five fractions were collected from the two peaks and then SDS-PAGE was used to
analyze the protein content of each fraction, revealing that fractions A1 – A3 consisted primarily
of HypB, and fractions A4 and A5 consisted primarily of HypA (Figure A1.4).
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Figure A1.4: SEC of Ni-bound HypA and HypB mixtures
Superdex 75 10/300 GL column was used to separate 100 μL of protein samples: 40 μM of NiZnHypA, 40 μM of Ni-HypB, a mixture of 20 μM each of the Ni-ZnHypA and apo-HypB, and a
mixture of 20 μM each of the apo-ZnHypA and Ni-HypB using NTP buffer (20 mM HEPES, 100
mM NaCl,100 mM KCl, 5 mM MgCl2, 1 mM TCEP at pH 7.2 or 6.3) as the mobile phase. SDSPAGE of protein fractions collected (A1 – A5) from the two resolved mixtures as labeled on each
gel. The position of the HypA and HypB proteins are as labeled on the gel. The fractions A2
(primarily HypB) and A4 (primarily HypA) from each mixture were additionally analyzed by
ICP-OES (lane marked with *) with results shown in Table A1.1.
These most concentrated fractions (A2 and A4) from each resolved mixture was analyzed
for metal content by ICP-OES. Metal analysis was also performed on the individual proteins
before loading onto the column and the main fraction collected after the column. ICP results were
summarized in Table A1.1. The metal analyses of Ni-HypB proteins before loading onto the SEC
column and the fraction collected after indicated that the HypB protein does not retain Ni through
the SEC separation, instead it has a tendency of picking up Zn from the buffer. This observation
was unexpected but not unreasonable, given that Ni bound at the homodimer interface, where the
HypB protein was clearly separated into monomers through the SEC column resulting in the loss
of Ni. Zn-binding in HypB was presumed not to involve the Cys residues at the dimer interface
and favored the monomeric conformation,9 hence HypB was able to pick up the trace amount of
Zn within the mobile phase (< 1 ppb Zn, the limit of detection of our ICP-OES standards). In
contrast, HypA retained both Ni and Zn through the SEC column, where the ratio of Ni:Zn is
closer to one. The initial high Ni:Zn ratio of the in the Ni-ZnHypA protein was attributed to
excess Ni loosely bound to the protein despite treatment with Chelex 100 resin. The metal
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analyses of the HypA and HypB mixtures, resulted in Ni ending up with HypA, which is
explained by the results from the individual proteins. The tendency of HypB to lose Ni in SEC
may be altered by the presence of nucleotides, which were reported to stabilize the HypB dimer. 6,
8

Additionally, protein concentration may also affect the oligomeric state of HypB, as it was also

reported that higher concentrations of HypB eluted as dimers with a full equivalent of Ni added
from SEC.7
Table A1.1: ICP-OES results of SEC fractions from HypA and HypB Mixtures

Protein Samples
apo-ZnHypA
Ni-ZnHypA
apo-HypB
Ni-HypB
Ni-ZnHypA + apo-HypB
Ni-ZnHypA + apo-HypB
apo-ZnHypA + Ni-HypB
apo-ZnHypA + Ni-HypB

Before or
after SEC?
Before
After
Before
After
Before
After
Before
After
After *
After *
After *
After *

Protein Fraction
by SDS-PAGE
HypA
HypA
HypB
HypB
HypB
HypA
HypB
HypA

Ni (μM) Zn (μM)
0.78
15
0.00
1.7
33
13
0.80
1.1
0.22
0.00
0.00
0.67
18
0.00
0.00
0.23
0.00
1.1
0.65
1.1
0.00
0.81
1.3
2.2

Ni:Zn
0.05
No Ni
2.5
0.73
No Zn
No Ni
No Zn
No Ni
No Ni
0.61
No Ni
0.61

* = the same fractions collected in SEC and represented in SDS-PAGE in Figure A1.4
A1.2.2 HypB binds Ni with similar affinity compared to HypA
Next, we investigated the Ni-binding of HypB using isothermal titration chromatography
(ITC). Titrations of NiCl2 (dissolved in buffer) into apo-HypB in GF buffer (20 mM HEPES, 200
mM NaCl, 1 mM TCEP) at pH 7.2 resulted in a clear single isotherm (Figure A1.5) that was best
fitted with a Kd of 1.3 ± 0.3 μM with N of 0.44 ± 0.003 sites (from the average and standard
deviation of three independent titrations). The Kd is similar to the Ni binding to HypA (Kd ~ 1
μM), however, HypB only binds ~0.5 Ni per protein as opposed to a full Ni in HypA. The N ~ 0.5
sites is consistent with the crystal structure of H. pylori Ni-(HypB)2 (PDB 4LPS, Figure A1.1 Top
panel), indicating that Ni bound at the homodimer interface coordinating residues from each
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monomer.6 Ni binding to HypB was much weaker at pH 6.3 (Figure A1.5), with a Kd of 43 ± 8
μM and N of 0.30 ± 0.06 site (from the average and range of two independent titrations),
compared to HypA (Kd ~ 1 μM). The Kd for Ni binding to HypB as determined by ITC titrations
were consistent with those determined from UV-Vis absorption changes (Kd ~ 1.7 μM),8 but is
approximately one order of magnitude less tight than those derived from competition assays with
Mag-Fura-2 (Kd ~ 0.2 – 0.3 μM).6 However, the Mag-Fure-2 competition assays were fitted with
a model assuming one Ni binding per monomer,6 which was not observed in our ITC studies.

Figure A1.5: ITC of Ni binding to HypB
NiCl2 titrated into apo-HypB at pH 7.2 (blue) and 6.3 (green) were monitored by ITC with raw
data graphed on top panels and corresponding ∆H graphed on the bottom panels (data in color
and fits in black lines). See methods in A1.3.3for detail fitting methods.
The similarity in Kd between Ni binding to HypA and HypB suggested that the two
proteins should be able to compete for Ni. However, the SEC experiments clearly indicated that
HypA ended up with all the Ni. Since, the SEC experiments with Ni-HypB were injected at 100
μL of 40 μM (monomer) and then diluted over the column (with ~ 22 mL column volume), the
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resulting concentration of the eluted peak is likely to be low. The low concentration may have
contributed to its failure to maintain dimeric conformation/hold onto Ni. Future experiments with
SEC of HypB should be performed with higher protein concentrations.
A1.2.3 Weak interaction between HypA and HypB
A1.2.3.1

ITC

Prior reports of HypA interactions with HypB in NMR and ITC show that the two
proteins interact with relatively low affinity (Kd ~ 60 μM). Our own attempts to monitor the ITC
from HypA titrated into HypB (from two independent trials) or the reverse titration (from a single
trial) did not yield appreciable isotherms (Figure A1.6). However, when Ni-ZnHypA was titrated
into apo-HypB, a low affinity isotherm was detected, which was best fitted with a Kd of 23 ± 4
μM with N of 0.34 ± 0.04 site (from a single trial, Figure A1.6). It is unclear whether the presence
of nucleotide would improve this interaction, or the potential interaction between HypA and the
GTP/GDP-bound Ni-HypB2.

Figure A1.6: ITC of HypA-HypB interactions
ApoHypB WT titrated into apo-ZnHypA WT (left, circles) and apo-ZnHypA titrated into
apoHypB WT (middle, open triangles) did not produce clear isotherms in ITC. Ni-ZnHypA WT
titrated into apoHypB WT (right, half-filled triangles) produced an isotherm that was fitted with a
OneSite model (black line). See method Section A1.3.3 for detail fitting methods.
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A1.2.3.2

Thermophoresis

The interactions between HypA and HypB were also investigated using microscale
thermophoresis using the NanoTemper NT.115. In the first demonstration (September 2010),
HypA (purified by a previous post-doc) was labeled. Unlabeled apo-HypB was serial diluted and
then added to tubes containing constant amounts (50 nM) of fluorescently-labeled HypA, creating
a titration series, which was monitored by the NT.115. This series was repeated in the presence of
10-fold excess of Ni (as compared to HypA), following a 10-minute incubation, was also
monitored by the NT.115. The thermophoresis data from these two titrations were fitted by the
scientists from NanoTemper, accumulating in a report that indicated that apoHypB bound to
HypA with an apparent Kd of 1.8 ± 0.4 μM, and in the presence of excess Ni the Kd was improved
by approximately three-fold to 0.65 ± 0.2 μM.
A second demonstration (November 2012) from NanoTemper was performed with
fluorescently labeled HypB. Increasing concentrations of apo-ZnHypA (0.61 nM – 20 μM) was
added to a constant concentration of fluorescently-labeled HypB (100 nM) at pH 7.2, and the
thermophoresis was monitored by the NT.115. The experiment was repeated at pH 6.3, but with
lower concentrations of both proteins (constant 29.3 nM of fluorescently labeled HypB; and 0.3
nM – 10 μM of unlabeled apo-ZnHypA). The data generated were also fitted by the NanoTemper
representative, which reported an apparent Kd of 66 ± 9 nM at pH 7.2; and 0.45 ± 0.03 μM at pH
6.3. So far, both demonstrations were performed in GF buffer (20 mM HEPES, 200 mM NaCl, 1
mM TCEP, at pH 7.2 or 6.3) using standard capillaries.
The results from the NanoTemper demonstrations of HypA-HypB interactions did not
agree with the reported literature values from ITC titrations of GSHypA (N-terminally modified
HypA) into HypB (Kd ~ 60 μM).8 The binding events with high-to-moderate affinity observed in
thermophoresis was also absent from our own ITC studies of unmodified HypA interaction with
HypB, with or without Ni present (Figure A1.6).
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Figure A1.7: Summary of data analysis for thermophoresis experiments
Titration series containing serially diluted unlabeled binding partners (HypA, in most
experiments) were mixed with equal amounts of fluorescently labeled molecules (in this case,
NHS640-HypB), and loaded into capillary tubes and scanned for fluorescence using the NT.115,
which produces fluorescence Time-traces (upper panel). The thermophoresis + T-jump from each
trace was graphed against the concentration of the unlabeled molecule (HypA) to produce the
binding curve (lower panel), which was fitted with the Law of Mass Action.
Experiments with the NT.115 continued after acquiring the instrument, from which three
additional sets of data were acquired for the HypA-HypB interactions using relatively consistent
buffer and titration conditions. Primarily, apo-HypB were labeled with NHS-640, which targeted
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the free amines on the surface of the protein, and then free fluorophores were removed using a
desalting column. The labeled NHS640-HypB were diluted into the binding buffer (20 mM
HEPES, 200 mM NaCl, 1 mM TCEP, 0.02% Tween20, at pH 7.2 or 6.3) to check for fluorescent
response. Unlabeled HypA is then serially diluted and then mixed with a constant concentration
of the NHS640-HypB protein and then the fluorescence of the mixtures in the dilutions series
were read by the NT.115. These mixtures were typically excited at a consistent power, and the
fluorescence of the mixture was monitored while the IR laser is powered on and off at regular
intervals to capture the thermophoresis of the fluorescent molecules in each mixture (Figure
A1.7). The change in thermophoresis plus T-jump of each mixture was plotted to evaluate for the
occurrence of a binding event. The thermophoresis plus T-jump is defined as the accumulated
fluorescence intensities from one second of the hot/cold, where the “cold” fluorescence was taken
immediately prior to turning on the IR laser, and “hot” fluorescence was taken immediately prior
to turning off the IR laser (Figure A1.7).
Of the three sets of HypA titration into NHS640-HypB that was performed, the response
from thermophoresis was inconsistent, resulting in three vastly different Kd values from the fitted
data. Example binding curves from each set of data are shown in Figure A1.8, with the summary
of all binding data collected shown in Table A1.2. The binding of unlabeled apo-ZnHypA to
NHS640-HypB at pH 7.2 (Figure A1.8, Jun 2015) initially produced well-defined binding curves,
however, attempts to repeat this initial data failed to produce data with similar quality. Instead,
low amplitude and noisy curves were observed, including reversal of the direction of the binding
curve in one instance (Figure A1.8, Aug 2016). The corresponding Kd values from the fits of
these curves are equally unreliable. This inconsistency was also true for experiments conducted at
pH 6.3 (Table A1.2). These inconsistencies may have resulted from the fluorescent labeling of
HypB. The HypB protein have been known to form homodimers under certain conditions, and it
is unclear whether fluorescent labeling of the monomeric form would have prevented some of
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these interactions. It is also unclear whether the fluorescent labeling would interrupt interaction
with HypA.

Figure A1.8: Thermophoresis plus T-jump binding curves of HypA and NHS640-HypB
The binding of apo-ZnHypA to NHS640-HypB was inconsistent and irreproducible. The square,
triangle, and x-symbols represent three different scans of the same dilution series. Higher
concentration samples in the same dilution series were added to the Oct 2016 curve represented
as inverted triangle and yellow *.
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Table A1.2: Summary of thermophoresis data for HypA binding to NHS640-HypB

pH
6.3

7.2

[HypA] used
3.8 nM - 125 μM

NHS640HypB
(nM)
Date
40.2
6/5/15

3.8 nM - 125 μM

14.8

10/22/16 50%

40%

3.31

2.53 ± 0.88

1,2,3

Ni-ZnHypAWT 22 nM - 184 μM
Apo-ZnHypAWT 3.6 nM - 177 μM

14.8
47.5

10/22/16 50%
6/3/15
70%

80%
40%

Low
38.94

No Fit
2.37 ± 0.31

2,4

7.6 nM - 250 μM

47.5

8/26/16

100%

8.36

4.05 ± 1.21

2,3

2.7 nM - 354 μM

15.9

10/22/16 50%

40%

8.51

369 ± 56

1,2,3

13 nM - 207 μM

15.9

10/22/16 50%

80%

35.37

105 ± 19

1

Ligand
Apo-ZnHypA

Ni-ZnHypAWT

Laser MST Amplitude
Power Power (‰)
K d (μM)
70%
40%
27.99
23.4 ± 2.2

50%

Notes

Notes: 1 = no saturation; 2 = low amplitude; 3 = noisy data; 4 = apparent aggregation
The early experiments with thermophoresis (early demos from NanoTemper and Jun
2015) found that the HypA-HypB interaction may be high affinity. This was contradictory to the
ITC results, which found that H. pylori HypA and HypB interact at much lower affinities than
initially expected. This was also confirmed by other studies that no observable interactions for
HypA and HypB using Biolayer Interferometry or surface plasmon resonance.12 It also agreed
with the low affinity interaction found between the N-terminally modified GSHypA and HypB by
ITC (Kd ~ 60 μM).8
Thermophoresis is an excellent technique for observing transient interactions between
biomolecules, however, additional experiments using this technique may be best conducted with
fluorescently labeled HypA. This was utilized in the first demonstrations from NanoTemper
(September 2012) that found fluorescently-labeled HypA interactions with unlabeled HypB. This
method offers higher levels of control for the oligomeric state of the HypB used for titrations. The
HypA protein appears to be primarily monomeric in solution and would be less likely to affect the
interactions between the two proteins. Labeling of HypA under neutral conditions using the
NHS640 kit from NanoTemper would result in modification of amines of arginine and lysine
residues and should not affect the N-terminal amine. However, Ni titration into the NHS640HypA should be used as a control for the availability of the N-terminal amine for Ni-binding
since it was characterized as an essential ligand (L2*-HypA variant discussed in CHAPTER 3).
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A1.2.4 HypA and Ni enhances HypB GTPase activity
The poor GTPase activity in HypB was enhanced by addition of potassium and reducing
agents,6,

7

resulting in the NTP buffer (20 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM

MgCl2, 1 mM TCEP, at pH 7.2). Using this buffer, the activity of HypB was assayed using
malachite green method modified from previous reports.7, 13, 14 Firstly, Ni was reported to reduce
the GTPase activity of HypB in one incident,6 and to enhance it in another.8 Our own finding
suggests that moderate amount of Ni (5 μM) can slightly enhance the activity of HypB, whereas
high concentration (200 μM) reduces the GTPase activity (Figure A1.9A, Table A1.3). The
addition of an equimolar amount of HypA slightly enhances the GTPase activity at pH 6.3 but has
no affect at pH 7.2 (Figure A1.9, and Table A1.3). The addition of both HypA and low
concentrations of Ni seem to enhance the GTPase activity of HypB at both pH values (Figure
A1.9, Table A1.3).

Figure A1.9: HypB GTPase activity
Phosphate produced by 2 μM of apo-HypB (open triangle), with addition 2 μM of apo-ZnHypA
(open square), with addition of 5 μM of Ni (closed triangle), or with addition of 2 μM of apoZnHypA and 5 μM of Ni (closed square), at pH 7.2 (A, blue) and 6.3 (B, green). Phosphate
production of 2 μM of apo-HypB with addition 200 μM of Ni at pH 7.2 (closed diamond) was
also shown in panel A.
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Table A1.3: HypB GTPase Activity Summary
Conditions

pH 7.2

pH 6.3

Apo

Kcat
(x 10-3 sec-1)
0.86 ± 0.03

KM
(μM)
29 ± 3

Kcat/KM
(M-1 s-1)
30 ± 10

Kcat
(x 10-3 sec-1)
2.67 ± 0.54

KM
(μM)
249 ± 79

Kcat/KM
(M-1 s-1)
11 ± 7

+ 5 μM Ni

1.64 ± 0.12

33 ± 8

50 ± 15

3.60 ± 0.57

387 ± 88

9.3 ± 6.5

+ 200 μM Ni

0.81 ± 0.16

438 ± 140

1.9 ± 1.1

ND

ND

ND

+ HypA

0.66 ± 0.07

31 ± 7

21 ± 10

1.46 ± 0.10

23 ± 5

64 ± 21

+ HypA + 5 μM Ni 1.50 ± 0.01

25 ± 6

60 ± 22

3.24 ± 0.14

39 ± 10

83 ± 14

Measured in NTP buffer (20 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2, 1 mM
TCEP) at the indicated pH.

The addition of HypA and Ni together appear to enhance the GTP turnover of HypB by 2
– 3 folds, which is very slight. However, due to the propensity of HypB to dimerize in the
presence of Ni and nucleotide, there may be a concentration dependence to the GTPase activity of
HypB. The Kd for Ni-binding in HypB is ~ 1 μM (see above) at pH 7.2 and significantly weaker
at pH 6.3 (Kd ~ 40 μM, see above), therefore the enhancement at pH 6.3 is likely due to the
involvement of HypA, which shows little pH-dependence in Ni-binding affinity (Kd ~ 1 – 2 μM,
CHAPTER 4, Figure 4.4 and Table 4.2). The acid-enhanced of HypB GTPase activity involving
the presence of Ni and HypA suggest a potential mechanism for urease maturation under these
conditions.
A1.2.5 Ni K-edge of HypA-HypB complex
Due to the disparate structures of the Ni-HypA and Ni-HypB2 site, Ni K-edge is an attractive
method for exploring the metal site created in the complex. XAS samples were collected for a 1:1
mixture of apo-ZnHypA and Ni-HypB2 in XBr buffer (20 mM HEPES, 200 mM NaBr, 1mM
TCEP) at pH 7.2, which resulted in Ni K-edge spectra that is a combination of the Ni K-edge
spectra from each of the individual proteins (Figure A1.10A). The Least Squares Fitting module
from SIXPack was used to fit the XANES of the mixture using the individual Ni K-edge of NiZnHypA WT and Ni-HypB2 WT as component standards in the linear combination fit. The
results indicate a 69% character from the Ni-ZnHypA WT and a 30% character from the Ni-
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HypB2 WT character (Figure A1.10B). Since the Ni started off in the Ni-HypB2 WT, a change in
the XANES in the 1:1 mixture indicated that either some of the Ni have been transferred to HypA
or a new Ni site was formed that combined the characteristics of both proteins. In the opposing
experiment, where a 1:1 mixture of Ni-ZnHypA WT was combined with apo-HypB WT
(monomer), yielded similar results. The least squares fitted results indicated that the mixture
retained 65% character of the Ni-ZnHypA WT and 33% of the character from the Ni-HypB2 WT
XANES spectra (Figure A1.10C).

Figure A1.10: XANES of Ni K-edge of HypA, HypB, and HypA-HypB mixtures
Overlay of the individual Ni K-edge spectra of Ni-ZnHypA WT, Ni-HypB2, and 1:1 mixtures of
apo:Ni of the two proteins (A). The XANES of Ni-ZnHypA and Ni-HypB2 were used in linear
combination to produce least square fits for the 1:1 mixture of apo-ZnHypA + Ni-HypB2 (B), and
the 1:1 mixture of Ni-ZnHypA + apo-HypB (C).
It is still unclear whether these spectra represent a new site or an uneven mixture of the
two types of Ni sites in solution. Additionally, the physiological relevance of this mixture is
unclear, since the buffer conditions used do not favor the active conformations of HypB (does not
contain K+, Mg2+, or nucleotides). The addition of these components may favor the adaptation of
an alternate conformation for HypB or otherwise alter the Ni sites in HypB or in the distributions
of Ni in the HypA-HypB mixtures. Since the HypA and HypB mixtures separate into separate
peaks in SEC, it is possible that the Ni has distributed between the two proteins, with HypA
retaining slightly more Ni due to the 1:1 stoichiometry of binding.
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It is possible that HypB GTP-turnover cycle rely on formation and then dissociation of
the homodimer, which is aided by the presence of Ni and HypA. This type of mechanism is
favored by some members of the SIMIBI (signal recognition particle, MinD, and BioD) -type
NTP-binding proteins,15 of which HypB is also a member.16 Presuming that HypB follow a
homodimer formation/dissociation cycle in GTP-hydrolysis, which is supported by the fact that
dimer formation is favored in the presence of Ni and nucleotide,6,

8

and that HypA and Ni

stimulate GTPase activity (Figure A1.9 and Table A1.3), the role of HypA remains unclear.
HypA may act as an activator (in handing off Ni to Ni-HypB2) or an effector (in receiving Ni
from Ni-HypB2) in the GTP-hydrolysis cycle. The Ni binding affinity of the individual protein
suggests that this may be a pH-dependent phenomenon, where HypA may be more prone to
receive Ni from HypB at lower pH. With either Ni transfer mechanism, the interaction between
H. pylori HypA and HypB is likely to be transient and difficult to quantitate in vitro. A Nitransfer mechanism suggests the combined Ni site structure of the HypA-HypB complex is likely
to be short-lived and dynamic in vivo. Hence, is vitally important to first elucidate the nature of
interaction between HypA and HypB and the GTP-hydrolysis mechanism of HypB.
A1.2.6 Ni K-edge XAS of HypB
The Ni-HypB2 complex was prepared in Br buffer (20 mM HEPES, 200 mM NaBr, 1mM
TCEP) at pH 7.2, and the Ni K-edge XAS spectrum was collected at NSLS beamline X3B.
Systematic fitting was performed as previously described.17, 18 The shape of the XANES spectrum
suggested coordination of heavy atoms (such as sulfur) with a broad 1s→4p z transition (plus
shakedown) that indicated a four- or five-coordinate Ni site (Figure A1.10A).19 The Ni K-edge
EXAFS spectra were fitted using SIXpack to a best fit containing four S-Cys ligands and a single
His-imidazole ligand (Figure A1.11 and Table A1.4).
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Figure A1.11: EXAFS spectra and best fit for Ni-HypB2
Data and best fit model of the Ni K-edge EXAFS represented in k3-weighted unfiltered data (top)
and Fourier-transformed (k = 2 – 14 Å-1) data uncorrected for phase shifts (bottom) for Ni-HypB2
in 20 mM HEPES, 200 mM NaBr, 1mM TCEP (pH 7.2).
Table A1.4: EXAFS analysis of Ni-HypB2

Shell
4S

r (Å)

σ2 (x10-3 Å 2 ) ΔEo (eV)

2.19(1)

9(1)

3S
1S

2.20(1)

7(0)

2.56(4)

15(6)

1 N/O
4S

2.32(2)

1(2)

2.21(1)

9(1)

1 N/O (Imid)

2.07(1)

0(1)

4S

2.18(1)

10(1)

-12(2)

R factor
0.0713

Reduced χ 2
67.14

-11(2)

0.0376

17.03

-11(2)

0.0539

24.40

-11(1)

0.0103

8.57

Uncertainties in the fitted parameters are shown in parentheses. Unacceptable values are shown in
red and the best fit highlighted in orange. See method Section A1.3.6 for fitting method.
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A1.3

Methods

A1.3.1 Protein overexpression and purification
The HypB protein was overexpressed from the DL41 (DE3) pLysS E. coli cells transformed with
the Hp WThypB-pET22b plasmid (pET22b vector containing the WT hypB coding sequence from
H. pylori strain 26695). Single colonies were selected from freshly transformed cells grown on
LB-agar plates supplemented with 34 μg/mL chloramphenicol (Cam) and 100 μg/mL ampicillin
(Amp), and then grown in 150 mL of sterile liquid LB supplemented with Cam/Amp until
saturation (>6 hours, shaking at 200 RPM at 37 ˚C). Large scale (typically 2L in a 5L growth
flask) sterile LB media supplemented with Amp only with 1:100 (typically 20 mL) of the
saturated culture of Hp WThypB-pET22B plasmid and allow to grow at 37 ˚C shaking at 200
RPM to OD600 of ~0.8 (2.5 – 3.5 hours). Protein overexpression was induced by addition of
isopropyl β-D-1-thiogalacopyranoside (IPTG) to a final concentration of 0.8 mM, and then
dropping the temperature to 25 ˚C for three hours. Cells containing the WT HypB proteins were
pelleted by centrifugation at 5500 x g for 10 minutes, and then resuspended with 10 mL of QA
buffer (20 mM Tris, 1 mM TCEP, pH 7.2) per liter of cells. Phenylmethylsulfonyl fluoride
(PMSF) was added to the resuspended cells to a final concentration of 1 mM and mixed
thoroughly by vortexing, and then immediately stored in the -80 ˚C freezer for no more than 2
years.
Frozen cells were removed from the -80 ˚C freezer and then thawed in a 30 – 35 ˚C water
bath. Cells were lysed upon one freeze-thaw cycle due to release of lysozymes from the
expression of the included pLysS plasmid. Deoxyribonuclease I (frozen stock in 10 mg/mL with
40% glycerol) were added to the cell lysate at 10 μL per liter of cell culture along with 2 mM
(final concentration) of PMSF, and then thoroughly mixed by vortex. The cell lysates were
returned to the water bath for 30 minutes to allow for digestion of the genomic DNA in the lysate.
The digested lysate was pelleted by centrifugation at 15,000 x g to remove insoluble materials,
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and then the soluble part of the lysate was filtered through a 0.22 μm membrane filter and then
stored on ice (for no more than 3 hours) prior to column loading.
The overexpressed HypB protein was purified by a Q Sepharose column and then a
HiLoad Superdex 75 16/60 on an ÄKTA FPLC system at room temperature. The packed Q
Sepharose column (12 mL column volume) was the first step of purifying HypB protein. The
column should be freshly conditioned by first washing with three column volumes of QA buffer,
followed by three column volumes of QB buffer (20 mM Tris, 1 M NaCl, 1 mM TCEP, pH 7.2),
and then another three to five column volumes of QA buffer until the conductance of the flow
through is minimized and stabilized. All fractions should be collected for analyses by SDS-PAGE
from the onset of loading protein onto the column. The clarified lysate from 1.5 L of cell culture
was diluted with QA buffer to a final volume of 50 mL for loading onto the Q Sepharose columns
with 12 mL bed volume. The diluted clarified lysate was loaded onto the column at a flow rate
(usually 1.5 mL/min) that does not exceed an overall pressure of 0.3 MPa within the column.
After loading, the Q Sepharose column was washed with 3 – 5 column volumes of QA buffer to
remove loosely bound proteins until the conductance of the flow through is stabilized. The bound
HypB protein was eluted off the column using a 0 – 20% QB gradient, after which 3 – 4 column
volumes of 100% QB buffer was used to wash off all other proteins from the column. Although
HypB protein continue to elute at high salt concentrations beyond 20% QB, the high amount of
impurities in the higher salt fractions render the additional purification of HypB from these
fractions improbable.
All collected fractions should be evaluated using SDS-PAGE (Figure A1.12A). The
fractions containing the highest concentrations of HypB (with relatively few other contaminant
proteins) was selected for further purification on the Hiload Superdex 75 16/60 column. These
fractions were treated with ~ 20 mM EDTA overnight at 4 ˚C prior to loading onto the gel
filtration column. Using only the most concentrated fractions (as indicated on Figure A1.12A) the
fractions from the Q Sepharose columns did not need to be concentrated for the HiLoad Superdex
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75 column. Typically, 2 – 3 HiLoad Superdex 75 columns should be run per each Q Sepharose
column with no more than 3.5 mL loaded per column, which was pre-equilibrated with 3 column
volumes of GF buffer (20 mM HEPES, 200 mM NaCl, 1 mM TCEP, pH 7.2). Pure HypB eluted
from the HiLoad Superdex 75 16/60 column between 78 – 90 mL after injection. Collected
fractions were evaluated by SDS-PAGE (Figure A1.12B) to evaluate purity. Only proteins with
>90% pure were used for experiments. The concentration of the purified HypB was measured by
UV-Vis spectroscopy using the extinction coefficient of 7,450 M-1 cm-1.7 Protein was also
evaluated for metal content by ICP-OES to ensure no metals were present.

Figure A1.12: HypB Purification gel
Fractions from Q Sepharose column (A) and HiLoad Superdex 75 column (B) from the
purification of HypB protein. Fraction numbers are labeled on top of each gel. The blue lines
underscore fractions that were further purified in the Superdex 75 column, and the red lines
underscore fractions that were considered pure and used for experiments (>90% pure) or were
further purified with additional columns (red dashed line, <90% pure).
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A1.3.2 Size exclusion chromatography
SEC was performed on the AKTA FPLC using a Superdex 75 GL 10/300 column. Pure HypA or
HypB protein were first evaluated by SDS-PAGE and then ICP-OES to ensure the proper purity
and metal content. Ni-bound HypA was prepared as previously described, and Ni-bound HypB
was prepared as described for the XAS sample preparations (see below).
A1.3.3 Isothermal titration calorimetry
ITC was performed on the Auto-ITC200 using purified apo-HypB protein in GF buffer
(20 mM HEPES, 20 mM NaCl, 1 mM TCEP) at either pH 7.2 or 6.3. Ni stock used for titration
into apo-HypB was prepared by diluting a concentrated aqueous NiCl2 solution (500 mM) into
GF buffer to a final concentration between 0.8 and 1.2 mM for use in titration. The actual
concentration of Ni used for fitting was determined by ICP-OES. Apo-ZnHypA and Ni-ZnHypA
used in ITC experiments were prepared as previously described.20 ITC experiments were
performed and the resulting data were fitted using the MicroCal analysis module as previously
described.20
A1.3.4 Microscale thermophoresis
Microscale thermophoresis was used to monitor interaction between purified HypA and
HypB protein using the Monolith NT.115 instrument (NanoTemper). The experiment involved
labeling either HypA or HypB with the NHS640-RED labeling kit (NanoTemper), which
selectively labels amine functional groups with a proprietary fluorophore. In the first
demonstration with NanoTemper (September 2010), the HypA protein was labeled with the
NHS640 fluorophore (as performed by previous post-doc and NanoTemper specialists). All
subsequent experiments were performed with NHS640-labeled HypB. Apo-HypB protein was
diluted to 20 μM using the provided NHS labeling buffer and then mixed with 3:1 excess of the
freshly prepared NHS640 dye, and incubated in the dark for 30 minutes. Excess NHS640 dyes
were removed from the labeled NHS640-HypB proteins either using the gravity desalting
columns that were part of the labeling kit or by using the 0.5 mL Zeba Spin desalting column
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with a 7 kDa MWCO, which were pre-equilibrated with GF buffer at the appropriate pH. Freshly
labeled HypB were evaluated by UV-Vis for protein concentration (A280, ε = 7,450 M-1 cm-1) and
NHS640 dye concentration (A650, ε = 250,000 M-1 cm-1). Labeling efficiency was calculated by
the ratio of dye/protein (typically less than 0.3), which indicated that there are typically fewer
than one label per HypB protein. The fluorescent intensity of the NHS640-HypB was tested by
diluting the protein in the binding buffer (20 mM HEPES, 20 mM NaCl, 1 mM TCEP, 0.02%
Tween20, at pH 7.2 or 6.3) at a dilution factor of 1:100 up to 1:400, and then loaded into the
appropriate capillaries and scanned with the Red LED (between 20 – 100% power). The
concentration of NHS640-HypB and LED power was adjusted to produce the desirable response
of between 150 – 500 RFU fluorescence, which was required for data collection using
thermophoresis. The protein was separated into small aliquots and rapidly frozen with liquid
nitrogen and stored at -80 ˚C for up to one year and thawed for use as needed.
The HypA purified protein used in thermophoresis titrations were prepared as previously
described.20 The concentrated HypA protein (usually > 1 mM) was diluted in half using the
2XBinding buffer (20 mM HEPES, 20 mM NaCl, 1 mM TCEP, 0.04% Tween20, at pH 7.2 or
6.3), and then used as a stock for binding studies. A 1:1 serial dilution of the HypA protein was
prepared in 10 μL aliquots in 16 microtubes, which was mixed with 10 μL of the NHS640-HypB
diluted to the appropriate concentration (15 – 50 nM) for the fluorescence experiment. After a 10minute incubation time at room temperature, the proteins mixtures were loaded into Premium
coated (previously known as hydrophilic coated) capillaries. The capillaries were loaded onto the
scanning tray and the fluorescence was captured by the NT.115 using a fixed % LED power,
where the IR laser (at fixed % MST power) was powered on following a cycle of: 5 seconds off,
30 seconds on, and 5 seconds off (Figure A1.7 top panel). The captured fluorescence from all
titration samples were normalized, and the Thermophoresis plus T-jump was calculated for each
sample in the titration series. The thermophoresis plus T-jump (Figure A1.7) is the ratio of the
normalized fluorescence from 0.97 second immediately prior to turning on the IR laser (at T =
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4.62 seconds) and immediately prior to turning off the IR laser (at T = 34.72 seconds). The
thermophoresis plus T-jump (Figure A1.7 bottom panel) were plotted against the concentration of
unlabeled HypA used in each titration sample to create the binding curve. Three scans were
performed for each titration reported to ensure that photobleaching does not occur within the
sample. The three sets of collected data were fitted in a single titration curve. The binding curve
was fitted with the law of mass action:
𝐹(𝐿) = 𝑈𝑛𝑏𝑜𝑢𝑛𝑑 +

(𝐵𝑜𝑢𝑛𝑑 − 𝑈𝑛𝑏𝑙𝑢𝑛𝑑)
∗ (𝑇𝑎𝑟𝑔𝑒𝑡𝐶𝑜𝑛𝑐 + 𝐿 + 𝐾𝑑 − √(𝑇𝑎𝑟𝑔𝑒𝑡𝐶𝑜𝑛𝑐 + 𝐿 + 𝐾𝑑 )2 − 4 ∗ 𝑇𝑎𝑟𝑔𝑒𝑡𝐶𝑜𝑛𝑐 ∗ 𝐿)
2

Where L is the variable concentration of HypA, Unbound is the concentration of free UreE2, and
Bound is the concentration of the HypA-UreE2 complex, TargetConc is the concentration of total
UreE2, and Kd is the apparent dissociation constant of the HypA-UreE2 complex. In each case the
total UreE2 concentration (TargetConc) is known and set as a constant for fitting. The reported Kd
for each titration were the result of independently prepared titration series, which were quite
different from trial to trial, and does not appear to be reproducible.
A1.3.5 GTPase assays
GTPase assays were performed in triplicates by adding a final concentration of 2 μM of
HypB protein in NTP buffer (20 mM HEPES, 100 mM NaCl, 100 mM KCl, 5 mM MgCl2, 1 mM
TCEP, at pH 7.2 or 6.3) to 0 – 200 μM of GTP (prepared in the same buffer). In assays performed
in the presence of Ni, a final concentration of 5 μM or 200 μM of NiCl2 was added to the GTP
solution, and reaction was initiated by addition of HypB. In assays performed in the presence of
HypA, a final concentration of 2 μM of apo-ZnHypA protein was added to the GTP solutions and
the reaction was initiated by addition of HypB. In assays performed in the presence of Ni and
HypA, a final concentration of 2 μM of apo-ZnHypA protein and 5 μM of NiCl2 was added to the
GTP solutions and the reaction was initiated by addition of HypB. Blank assays (where only NTP
buffer was added in place of HypB enzyme) were performed alongside each set of enzymatic
assays, from which the background phosphate amount was subtracted. After addition of HypB,
reaction mixture was incubated at room temperature for 30 minutes and then was terminated by
189

addition of MG-MO solution (see below) for determination of phosphate production using by
color development. Linearity of response of phosphate production using 2 μM of HypB per assay
was confirmed from 15 to 90 minutes (R2 = 0.998) at the highest concentration of substrate used
for assays (200 μM).
Phosphate production from GTPase assays were evaluated using a modified version of
the malachite green colorimetric assay for detection of phosphates.13, 14 First a malachite green
stock solution was prepared by dissolving 0.44 g of malachite green oxalate in a 16.7% sulfuric
acid, resulting in an orange “MG” solution of 0.122% malachite green stock that was stored in
foil wrapped glass bottles for up to one year. A 7.5% “MO” stock solution was also prepared by
dissolving 0.975 g of ammonium molybdate tetrahydrate in MilliQ water, which was stored for
up to 2 weeks. The green “MG-MO” solution was freshly prepared on the day of the GTPase
assay by mixing one part “MG” with four parts “MO” solutions together and then adding
Tween20 to a final concentration of 0.17%. The amount of phosphate in solution was monitored
by adding 200 μL of MG-MO solution to 800 μL of standard or unknown sample with and
incubating at room temperature for 30 minutes, and the assessed by UV-Vis absorption at 630
nm.
A phosphate standard curve was prepared concurrently with each set of GTPase assay
performed and used for quantitating the amount of phosphate produced in each assayed sample.
The phosphate standards were prepared from a 1000 ppm phosphate standard from RICCA
chemical company. The stock was serially diluted into 800 μL standard solutions in NTP Buffer
that produced linear response (A630) ranging from 0.313 – 20 nmol PO43- in solution. The
phosphate production rate of HypB were calculated for each set of substrate concentrations (0 –
200 μM) and then fitted using the Michaelis-Menton equation in Origin 2016. The reported
GTPase activities for HypB in each condition (apo-, with HypA, with 5 μM Ni, with 200 μM Ni,
with 5 μM Ni and HypA) at each pH were the results from fitting the response from triplicate
experiments.
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A1.3.6 X-ray absorption spectroscopy (XAS)
Ni-HypB2 WT XAS samples were prepared at room temperature by reconstituting the
purified apo-HypB protein with two molar-equivalents of NiCl2 added at 0.5-equivalent intervals
allowing 20 minutes between each addition for equilibration. Excess Ni2+ was removed by
treating with equal volumes of Chelex 100 resin (sodium form) for 45 minutes at room
temperature, and then concentrating the reconstituted protein using an Amicon Ultra-0.5mL 3kDa MWCO spin concentrator at 10,000 x g. The resulting sample was assessed for protein
concentration and then analyzed for metal content by ICP-OES, with the final XAS sample
containing 3 mM of HypB (by monomer concentration) and 1.4 mM of Ni, indicating a Ni-HypB2
complex.
The 1:1 mixtures of apo-ZnHypA WT and Ni-HypB2 WT was prepared from the above
described sample, where an equimolar of the prepared Ni-HypB2 WT sample was mixed with
apo-ZnHypA WT sample (prepared as described in CHAPTER 3, Section 3.4.8) and incubated
for 30 minutes at room temperature prior to concentrating. The final sample has a Ni-Zn-HypAHypB ratio of 0.46-0.76-1-1. The 1:1 mixture of Ni-ZnHypA WT with apo-HypB was prepared
from metallated Ni-ZnHypA WT sample (prepared as described in CHAPTER 3, Section 3.4.8)
mixed with equimolar amount of apo-HypB monomer, incubated at room temperature for 30
minutes prior to concentrating. The final sample has a Ni-Zn-HypA-HypB ratio of 1.3-1.3-1-1.
XAS data collection was performed as previously described at NSLS beamline X3B
using the dedicated ring conditions.21 Data processing and normalization were performed using
SIXpack22 software package built on the IFEFFIT23 engine as previously described.21 EXAFS
analyses was also performed using SIXpack as previously described.17,

18

The 1:1 mixtures of

HypA and HypB were fitted with the “Least Sq. Fitting” module within SIXpack, where the
XANES region (8310 – 8410 eV) of the Ni-ZnHypA WT spectra (see Figure A1.10) and NiHypB2 WT (see Figure A1.10) were used as components in linear least square fits to the mixture
data.
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APPENDIX 2

SUPPORTING DATA FOR HYPA N-TERMINAL NI BINDING
Table A2.1: Selected fits for WT-HypA Ni-complex (in buffer with NaBr)
Shell

r (Å)

σ2 (x 10-3 Å2)

ΔEo
(eV)

χ2

Reduced
χ2

#Var

R factor

6 N/O

2.10 (2)

14 (2)

3 (1)

3442.01

175.26

3

9.61%

3 N/O
3 N/O

2.31 (3)
2.09 (1)

19 (8)
5 (1)

5 (1)

2264.20

128.36

5

6.92%

5 (2)

BBAm

2.10 (1)
1.93 (3)
1.98 (3)

2 (1)

2629.07

149.04

5

4.76%

1 N/O

2.21 (5)

4 (8)

2.08 (2)
1.92 (3)
1.97 (3)

3 (2)
2 (1)

2096.62

134.06

7

3.53%

4N
(1 Imid0˚)

3N
(1 Imid0˚)
BBAm

6 (4)

6 (3)

Uncertainties in the fitted parameters are shown in parentheses (see Section 3.4.9 for detailed fit methods).
Numbers in red are unacceptable values. The best fit is highlighted in orange. Alternative good fits are
highlighted in yellow.
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Table A2.2: Selected fits for the L2*-HypA Ni-complex (in buffer with NaBr)
Shell

r (Å)

σ2 (x 10-3 Å2)

ΔEo (eV)

χ2

Reduced
χ2

#Var

R
factor

5 N/O

1.92 (3)

17 (2)

-1 (2)

6206.92

316.04

3

19.68%

3 N/O
2 N/O

1.89 (2)
1.78 (25)

6 (2)
55 (94)

-4 (6)

4604.52

261.03

5

14.69%

2 N/O
1 N/O
1 Imid7˚
1 Imid7˚

1.86 (1)
2.06 (2)
2.45 (2)
1.96 (3)

1 (1)
2 (3)
3 (3)
4 (4)

0 (1)

1356.41

99.45

9

3.57%

2.01 (1)
1.83 (1)
1.88 (1)

11 (4)
1 (1)

3638.43

206.26

5

8.85%

2.04 (3)
2.42 (2)
1.94 (4)
1.82 (1)
1.87 (1)

4 (4)
11 (3)
5 (5)
0 (1)

1747.12

128.09

9

3.49%

3N
(1 Imid0˚)
BBAm
1N/O
1Br
1 Imid7˚
BBAm

1 (1)

1 (1)

Uncertainties in the fitted parameters are shown in parentheses (see Section 3.4.9 for detailed fit methods).
Numbers in red are unacceptable values. The best fit is highlighted in orange. Alternative good fits are
highlighted in yellow.
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Table A2.3: Select fits for the L2*-HypA Ni-complex (in buffer with NaCl)
Shell

r (Å)

σ2 (x 10-3
Å2)

5 N/O

1.96 (2)

16 (2)

1 (1)

2768.07

140.94

3

12.98%

4 N/O
1 N/O

1.93 (2)
2.13 (5)

11 (2)
3 (5)

1 (1)

2726.65

154.57

5

9.90%

1 N/O
4 N/O
(1 Imid0˚)

1.85 (2)

1 (2)

2.00 (2)

9 (2)

2 (1)

1703.74

96.59

5

9.01%

1S/Cl
4N
(1 Imid0˚)

2.26 (2)

8 (2)

1.88 (1)

9 (1)

-4 (1)

1136.75

64.44

5

4.90%

1 N/O
2N
(1 Imid0˚)

1.86 (3)

2 (3)

2.03 (5)
1.93 (6)
1.98 (6)

9 (7)
13 (11)

2 (2)

1736.28

111.02

7

8.48%

2.25(2)

10 (3)

1.95 (6)
1.84 (2)
1.89 (2)

15 (5)
-2 (1)

1063.53

68.00

7

4.24%

BBAm
1 S/Cl
2N
(1 Imid0˚)
BBAm

6 (3)

ΔEo (eV)

χ2

Reduced
χ2

#Var

R
factor

1 N/O
1 Imid0˚

2.05 (3)
2 (3)
1.99 (5)
7 (6)
1.85 (2)
BBAm
1.90 (2)
2 (1)
1 (1)
1616.67
103.37
7
7.99%
Uncertainties in the fitted parameters are shown in parentheses (see Section 3.4.9 for detailed fit methods).
The best fit is highlighted in orange. Alternative good fits are highlighted in yellow.
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Figure A2.1: XANES overlay of Ni K-edge of Ni-ZnL2*HypA
Overlay of XANES region of the normalized Ni K-edge of Ni-ZnL2*-HypA in buffer with NaBr
(in green) and NaCl (in gray) with 1s  4pz region enlarged in inset.
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Table A2.4: Best fits for EXAFS of Zn-complexes with WT- and L2*-HypA (in buffer with
NaBr)
2
-3
2
2
HypA
Shell
r (Å)
σ (x 10 Å ) ΔEo (eV)
R factor Reduced χ

WT

L2*

4S
1N
(1 imid2˚)

2.33 (5)

4 (0)

2.18 (2)

4 (4)

3S
1N
(1 imid2˚)

2.34 (1)

2 (0)

2.12 (2)

2 (2)

4S

2.33 (1)

3 (1)

4S
1N
(1 imid2˚)

2.34 (1)

4 (0)

2.18 (2)

2 (3)

3S
1N
(1 imid2˚)

2.34 (1)

2 (0)

2.13 (2)

2 (3)

4S

2.33 (5)

4 (0)

-4 (1)

1.89%

569.52

-4 (1)

2.45%

759.10

-6 (1)

3.57%

978.25

-4 (1)

1.73%

281.58

-3 (1)

2.34%

375.00

-6 (1)

3.50%

538.16

Uncertainties in the fitted parameters are shown in parentheses (see Section 3.4.9 for detailed fit methods).
The best fit is highlighted in orange. Alternative good fits are highlighted in yellow.
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Figure A2.2: Zn K-edge of WT- and L2*-HypA
Zn-site XANES overlay and EXAFS plus best fits for Ni-ZnHypA complexes in buffer with
NaBr.(A) Overlay of XANES region of the normalized Zn K-edge of Ni-ZnWTHypA (light blue)
and Ni-ZnL2*HypA (light green). EXAFS data (in color) and best fit models (in black) of the Zn
K-edge EXAFS region (k = 2 – 14 Å-1) represented in unfiltered k3•χ(k) and non-phased corrected
Fourier transformed χ(r) for Ni-ZnWTHypA (B) and Ni-ZnL2*HypA (C) in buffer with NaBr.
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Figure A2.3: SDS-PAGE of protein used in WT- and L2*-HypA titration into UreE
Example of SDS-PAGE showing the purity and integrity of proteins. Sample recovered after ITC
experiments of Ni (lane 1), WT-HypA (lane 2), or L2*-HypA (lane 3) titration into UreE2; and as
purified proteins of WT-HypA (lanes 4 – 6), L2*-HypA (lanes 10 and 11), and WT-UreE2 (lanes
7 – 9). All lanes containing UreE (calculated molecular weight of 19.4 kDa) is always observed
with a small fraction that migrate at a slightly lower molecular weight, which represents the
fraction of the protein that has lost 8-residues from the C-terminus as confirmed by ESI-Mass
Spec. The position of full length UreE (UreE), C-terminally degraded UreE (∆C-UreE), and WTor L2*-HypA (HypA) are as indicated by arrows to the left of the SDS-PAGE.
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APPENDIX 3
SUPPORTING DATA FOR HYPA UREE2 INTERACTIONS

Figure A3.1: SEC-MALS analysis of proteins
Representative size exclusion chromatography and multi-angle light scattering (SEC-MALS)
chromatographs of apo-ZnHypA (gray lines), apo-UreE (cyan lines, and 3:1 mixture of apoZnHypA with apo-UreE2 at pH 7.2 (blue, upper panel) and pH 6.3 (green, lower panel).
Deconvoluted masses of the protein or protein complexes are shown in the middle of each peak.
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Figure A3.2: Raw ITC data and ∆H
Isothermal titration calorimetry (ITC) raw data and corresponding ∆H binding isotherms of apoZnHypA titrations into apoUreE2 (open squares); Ni-ZnHypA titrations into apoUreE2 (half-filled
squares); and Ni titration into apo-ZnHypA (filled circles), apoUreE2 (filled squares), and apoZnHypA-UreE2 protein complex (filled diamonds) performed at pH 7.2 (blue) and 6.3 (green).
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Figure A3.3: ITC TwoSites versus OneSite Fits of Ni binding to apo-ZnHypA-UreE2
Comparison of fitting models with TwoSites (black line) and OneSite (red line) of ITC data for
Ni2+ binding to the preformed ZnHypA-UreE2 complex at pH 7.2 (blue) and 6.3 (green). The
goodness of fit parameter, chi2, for each fit is displayed in corresponding colors.
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Figure A3.4: Loss of High Affinity Ni Site in L2*HypA-UreE2 Complex
Loss of high affinity binding site in Ni2+ titration into the preformed complex of ZnHypA-UreE2
complex when WTHypA (diamonds) is replaced with N-terminal variant L2*HypA (pentagons)
at pH 7.2 (blue) and 6.3 (green).
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Figure A3.5: SDS-PAGE of Purified UreE and HypA Proteins
SDS-PAGE showing the purity of the purified UreE2 (left) and HypA (right) from the HiLoad
Superdex 75 column with the elution volume of the fractions labeled at the top of each lane. (*
indicates the fractions that were not used for experiments, and the black arrow indicates the band
corresponding to degradation of purified HpUreE protein at the C-terminal Ni-binding motif).

205

Figure A3.6: Comparison of ITC isotherms performed in GF and NTP Buffers
Representative ITC binding isotherms of parallel titrations performed in GF buffer (20 mM
HEPES, 200 mM NaCl, 1 mM TCEP) and NTP buffer (20 mM HEPES, 100 mM NaCl, 100 mM
KCl, 5 mM MgCl2, 1 mM TCEP) demonstrating lack of significant differences in titrations
performed between the two buffers. Shown are titrations performed at pH 7.2 (blue) and 6.3
(green) of Ni2+ titrations into HypA (circles) and UreE2 (filled squares), apo-ZnHypA titration
into UreE2 (open squares), and Ni-ZnHypA titration into UreE2 (half-filled squares) with fits
(black lines).
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Figure A3.7: SD Test Control for Fluorescence Binding
Fluorescence response of parallel samples of native and denatured (SD = heat-treated with SDS
and DTT) titration samples containing equal concentrations of NHS640-UreE2 mixed with highand low-concentrations of HypA.
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